
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head id="Head1"><title>
	JAMA Network | JAMA Internal Medicine | The Challenge of Drug-Induced Aseptic Meningitis
</title><meta name="apple-mobile-web-app-capable" content="yes" /><meta name="viewport" content="width=1080, maximum-scale=1.0" /><link id="lnkFavicon1" rel="icon" type="image/png" href="//amaprod.silverchaircdn.com/Images/favicons/INTEMED/favicon.ico" /><link id="lnkFavicon2" rel="shortcut icon" type="image/png" href="//amaprod.silverchaircdn.com/Images/favicons/INTEMED/favicon.ico" />

    <!-- Used to hold meta data -->
    
    <link rel="stylesheet" href="https://display-mathml.googlecode.com/hg/display-mathml.css?r=stable" type="text/css" />
    <link rel="stylesheet" href="//cdn.jsdelivr.net/chartist.js/latest/chartist.min.css" type="text/css" />
    <link rel="stylesheet" type="text/css" href="//amaprod.silverchaircdn.com/combres.axd/article-css/-607092746/" async="true"/>
    <meta property="og:title" content="The Challenge of Drug-Induced Aseptic Meningitis" />
    <meta property="og:type" content="article" />
    <meta property="og:url" content="http://archinte.jamanetwork.com/article.aspx?articleid=485056" />
    <meta property="og:image" content="http://amaprod.silverchaircdn.com/images/logos/logo_INTEMED.png?v=1" />
    <meta property="og:description" content="Several drugs can induce the development of aseptic meningitis. Drug-induced aseptic meningitis (DIAM) can mimic an infectious process as well as meningitides that are secondary to systemic disorders for which these drugs are used. Thus, DIAM constitutes a diagnostic and patient management..." />
    <link rel="alternate" href="http://archinte.jamanetwork.com/mobile/article.aspx?articleid=485056" />
    <meta name="citation_author" content="German Moris" /><meta name="citation_author" content="Juan Carlos Garcia-Monco" /><meta name="citation_title" content="The Challenge of Drug-Induced Aseptic Meningitis" /><meta name="citation_firstpage" content="1185" /><meta name="citation_lastpage" content="1194" /><meta name="citation_doi" content="10.1001/archinte.159.11.1185" /><meta name="citation_keyword" content="antibiotics" /><meta name="citation_keyword" content="muromonab-cd3" /><meta name="citation_keyword" content="aseptic meningitis" /><meta name="citation_keyword" content="meningitis" /><meta name="citation_keyword" content="anti-inflammatory agents, non-steroidal" /><meta name="citation_keyword" content="recombinant colony-stimulating factors" /><meta name="citation_journal_title" content="Archives of Internal Medicine" /><meta name="citation_journal_abbrev" content="Arch Intern Med" /><meta name="citation_volume" content="159" /><meta name="citation_issue" content="11" /><meta name="citation_publication_date" content="1999/06/14" /><meta name="citation_issn" content="0003-9926" /><meta name="citation_publisher" content="American Medical Association" /><meta name="citation_reference" content="citation_title=Ibuprofen-induced meningitis in systemic lupus erythematosus.; citation_authors=Widener  HL; Littman  BL;  citation_journal_title=JAMA.;  citation_year=1978;  citation_volume=239;  citation_pages=1062-1064; " /><meta name="citation_reference" content="citation_title=Ibuprofen, meningitis and systemic lupus erythematosus.; citation_author=Wasner  CK;  citation_journal_title=J Rheumatol.;  citation_year=1978;  citation_volume=5;  citation_pages=162-164; " /><meta name="citation_reference" content="citation_title=Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus.; citation_authors=Samuelson  CO; Williams  HJ;  citation_journal_title=West J Med.;  citation_year=1979;  citation_volume=131;  citation_pages=57-59; " /><meta name="citation_reference" content="citation_title=Ibuprofen-related meningitis in mixed connective tissue disease.; citation_author=Bernstein  RF;  citation_journal_title=Ann Intern Med.;  citation_year=1980;  citation_volume=92;  citation_pages=206" /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with ibuprofen.; citation_authors=Giansiracusa  DF; Blumberg  S; Kantrowitz  FG;  citation_journal_title=Arch Intern Med.;  citation_year=1980;  citation_volume=140;  citation_pages=1553" /><meta name="citation_reference" content="citation_title=Ibuprofen hypersensitivity in a systemic lupus erythematosus.; citation_authors=Ruppert  GB; Barth  WF;  citation_journal_title=South Med J.;  citation_year=1981;  citation_volume=74;  citation_pages=241-243; " /><meta name="citation_reference" content="citation_title=Ibuprofen-associated aseptic meningitis.; citation_authors=Peck  MG; Joyner  PU;  citation_journal_title=Clin Pharmacol.;  citation_year=1982;  citation_volume=1;  citation_pages=561-565; " /><meta name="citation_reference" content="citation_title=Eosinophilic meningitis and ibuprofen therapy.; citation_authors=Quinn  JP; Weinstein  RA; Caplan  LR;  citation_journal_title=Neurology.;  citation_year=1984;  citation_volume=34;  citation_pages=108-109; " /><meta name="citation_reference" content="citation_title=Ibuprofen and meningoencephalitis.; citation_authors=Perera  DR; Seiffert  AK; Greeley  HM;  citation_journal_title=Ann Intern Med.;  citation_year=1984;  citation_volume=100;  citation_pages=619" /><meta name="citation_reference" content="citation_title=Ibuprofen-induced aseptic meningitis in a previously healthy patient.; citation_authors=Lawson  JM; Grady  MJ;  citation_journal_title=West J Med.;  citation_year=1985;  citation_volume=143;  citation_pages=386-387; " /><meta name="citation_reference" content="citation_title=Ibuprofen and aseptic meningitis.; citation_authors=Bouland  DL; Specht  NL; Hegstad  DR;  citation_journal_title=Ann Intern Med.;  citation_year=1986;  citation_volume=104;  citation_pages=731" /><meta name="citation_reference" content="citation_title=Severe systemic hypersensitivity reaction to ibuprofen occurring after prolonged therapy.; citation_authors=Mandell  BF; Raps  EC;  citation_journal_title=Am J Med.;  citation_year=1987;  citation_volume=82;  citation_pages=817-820; " /><meta name="citation_reference" content="citation_title=Ibuprofen-induced meningitis in a male with systemic lupus erythematosus.; citation_authors=Jensen  S; Glud  TK; Bacher  T; Ersgaard  H;  citation_journal_title=Acta Med Scand.;  citation_year=1987;  citation_volume=221;  citation_pages=509-511; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis from over-the-counter ibuprofen.; citation_authors=Katona  BG; Wigley  FM; Walters  JK; Caspi  M;  citation_journal_title=Lancet.;  citation_year=1988;  citation_volume=1;  citation_pages=59" /><meta name="citation_reference" content="citation_title=Drug-related recurrent meningitis.; citation_author=Mifsud  AJ;  citation_journal_title=J Infect.;  citation_year=1988;  citation_volume=17;  citation_pages=151-153; " /><meta name="citation_reference" content="citation_title=Recurrent ibuprofen-induced aseptic meningitis: third episode after only 200 mg of generic ibuprofen.; citation_authors=Durback  MA; Freeman  J; Schumacher  HR;  citation_journal_title=Arthritis Rheum.;  citation_year=1988;  citation_volume=31;  citation_pages=813-815; " /><meta name="citation_reference" content="citation_title=Ibuprofen-induced meningitis in an elderly patient with systemic lupus erythematosus.; citation_authors=Gilbert  GJ; Eichenbaum  HW;  citation_journal_title=South Med J.;  citation_year=1989;  citation_volume=82;  citation_pages=514-515; " /><meta name="citation_reference" content="citation_title=Resident article: ibuprofen-associated meningitis in a woman with only serologic evidence of a reumathologic disorder.; citation_author=Ewert  BH;  citation_journal_title=Am J Med Sci.;  citation_year=1989;  citation_volume=297;  citation_pages=326-327; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with nonprescription ibuprofen use.; citation_authors=Grimm  AM; Wolf  JE;  citation_journal_title=DICP.;  citation_year=1989;  citation_volume=23;  citation_pages=712" /><meta name="citation_reference" content="citation_title=Ibuprofen-induced meningitis: detection of intrathecal IgG synthesis and immune complexes.; citation_authors=Chez  M; Sila  CA; Ransohoff  RM; Longworth  DL; Weida  C;  citation_journal_title=Neurology.;  citation_year=1989;  citation_volume=39;  citation_pages=1578-1580; " /><meta name="citation_reference" content="citation_title=Acute central nervous system symptoms caused by ibuprofen in connective tissue disease.; citation_authors=Agus  B; Nelson  J; Kramer  N; Mahal  SS; Rosenstein  ED;  citation_journal_title=J Rheumatol.;  citation_year=1990;  citation_volume=17;  citation_pages=1094-1096; " /><meta name="citation_reference" content="citation_title=État de mal comitial généralisé aprés prise d'ibuproféne, révélateur d'un lupus érythémateux disséminé.; citation_authors=Lortholary  A; Varache  N; Bouachour  G; Szapiro  N; Bourrier  P; Alquier  P;  citation_journal_title=Rev Med Interne.;  citation_year=1990;  citation_volume=11;  citation_pages=243-244; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis and iridocyclitis related to ibuprofen.; citation_authors=Kaplan  BH; Nevitt  MP; Pach  JM; Herman  DC;  citation_journal_title=Am J Opthalmol.;  citation_year=1994;  citation_volume=117;  citation_pages=119-120; " /><meta name="citation_reference" content="citation_title=Magnetic resonance imaging in drug-induced meningitis.; citation_authors=Eustace  S; Buff  B;  citation_journal_title=Can Assoc Radiol J.;  citation_year=1994;  citation_volume=45;  citation_pages=463-465; " /><meta name="citation_reference" content="citation_title=Ibuprofen-induced meningitis in mixed connective tissue disease.; citation_authors=Hoffman  M; Gray  RG;  citation_journal_title=Clin Rheumatol.;  citation_year=1982;  citation_volume=1;  citation_pages=128-130; " /><meta name="citation_reference" content="citation_title=Recurrent meningitis due to nonsteroidal anti-inflammatory drugs.; citation_authors=Peterson  DI; Chong  MJ;  citation_journal_title=Bull Clin Neurosci.;  citation_year=1987;  citation_volume=53;  citation_pages=40-42; " /><meta name="citation_reference" content="citation_title=Recurrent aseptic meningitis (Mollaret meningitis): spontaneous and drug-induced origin.; citation_authors=Thilmann  AF; Mobius  E; Thilmann  RR; Topper  R;  citation_journal_title=Fortschr Neurol Psychiatr.;  citation_year=1991;  citation_volume=59;  citation_pages=493-497; " /><meta name="citation_reference" content="citation_title=Ibuprofen-induced aseptic meningitis.; citation_author=Hanson  L;  citation_journal_title=J Tenn Med Assoc.;  citation_year=1994;  citation_volume=87;  citation_pages=58" /><meta name="citation_reference" content="citation_title=Aseptic meningitis caused by ibuprofen (Nurofen) in connective tissue disease.; citation_authors=Colamarino  R; Soubrier  M; Zenut-Leaud  M; Prudat  M; Tournillac  M; Bussiere  JC;  citation_journal_title=Therapy.;  citation_year=1993;  citation_volume=48;  citation_pages=516-518; " /><meta name="citation_reference" content="citation_title=Ibuprofen-induced aseptic meningitis in rheumatoid arthritis.; citation_authors=Horn  AC; Jarrett  SW;  citation_journal_title=Ann Pharmacother.;  citation_year=1997;  citation_volume=31;  citation_pages=1009-1011; " /><meta name="citation_reference" content="citation_title=Ibuprofen meningitis.; citation_authors=van der Zwan  A; van Dam  JG;  citation_journal_title=Ned Tijdschr Geneeskd.;  citation_year=1992;  citation_volume=136;  citation_pages=1613-1614; " /><meta name="citation_reference" content="citation_title=Tolmetin-induced aseptic meningitis.; citation_authors=Ruppert  GB; Barth  WF;  citation_journal_title=JAMA.;  citation_year=1981;  citation_volume=245;  citation_pages=67-68; " /><meta name="citation_reference" content="citation_title=Sulindac-induced aseptic meningitis.; citation_authors=Ballas  ZK; Donta  ST;  citation_journal_title=Arch Intern Med.;  citation_year=1982;  citation_volume=142;  citation_pages=165-166; " /><meta name="citation_reference" content="citation_title=Sulindac-induced meningitis in mixed connective tissue disease.; citation_authors=Lorino  GD; Hardin  JG;  citation_journal_title=South Med J.;  citation_year=1983;  citation_volume=76;  citation_pages=1185-1187; " /><meta name="citation_reference" content="citation_title=Recurrent aseptic meningitis due to sulindac.; citation_author=Von Reyn  CF;  citation_journal_title=Ann Intern Med.;  citation_year=1983;  citation_volume=99;  citation_pages=343-344; " /><meta name="citation_reference" content="citation_title=Encephalopathy associated with sulindac.; citation_authors=Neufeld  MY; Korczyn  AD;  citation_journal_title=Hum Toxicol.;  citation_year=1986;  citation_volume=5;  citation_pages=55" /><meta name="citation_reference" content="citation_title=Sulindac-induced aseptic meningitis in mixed connective tissue disease.; citation_authors=Yasuda  Y; Akiguchi  I; Kameyama  M;  citation_journal_title=Clin Neurol Neurosurg.;  citation_year=1989;  citation_volume=91;  citation_pages=257-260; " /><meta name="citation_reference" content="citation_title=Recurrent sulindac-induced aseptic meningitis in a patient tolerant to other nonsteroidal anti-inflammatory drugs.; citation_author=Greenberg  GN;  citation_journal_title=South Med J.;  citation_year=1988;  citation_volume=81;  citation_pages=1463-1464; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with naproxen.; citation_authors=Sylvia  LM; Forlenza  SW; Brocavich  JM;  citation_journal_title=DICP.;  citation_year=1988;  citation_volume=22;  citation_pages=399-401; " /><meta name="citation_reference" content="citation_title=Ketoprofen and aseptic meningitis.; citation_authors=Roel  JE; Gadano  AC; Falcon  JL;  citation_journal_title=Medicina (B Aires).;  citation_year=1991;  citation_volume=51;  citation_pages=186" /><meta name="citation_reference" content="citation_title=Naproxen-induced recurrent aseptic meningitis.; citation_authors=Weksler  BB; Lehany  AM;  citation_journal_title=Ann Pharmacother.;  citation_year=1991;  citation_volume=25;  citation_pages=1183-1184; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis in association with diclofenac treatment in a patient with systemic lupus erythematosus.; citation_authors=Codding  C; Targoff  IN; McCarty  GA;  citation_journal_title=Arthritis Rheum.;  citation_year=1991;  citation_volume=34;  citation_pages=1340-1341; " /><meta name="citation_reference" content="citation_title=Meningitis and pancreatitis associated with sulfamethizole.; citation_authors=Barret  PVD; Thier  SO;  citation_journal_title=N Engl J Med.;  citation_year=1963;  citation_volume=268;  citation_pages=36-37; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis as an adverse effect of co-trimoxazole.; citation_authors=Kremer  I; Ritz  R; Brunner  F;  citation_journal_title=N Engl J Med.;  citation_year=1983;  citation_volume=308;  citation_pages=1481" /><meta name="citation_reference" content="citation_title=Trimethoprim-sulfamethoxazole: another cause of recurrent meningitis.; citation_author=Haas  EJ;  citation_journal_title=JAMA.;  citation_year=1984;  citation_volume=252;  citation_pages=346" /><meta name="citation_reference" content="citation_title=Aseptic meningitis due to trimethoprim-sulfamethoxazole.; citation_authors=Biosca  M; de la Figuera  M; García-Bragado  F; Sampol  G;  citation_journal_title=J Neurol Neurosurg Psychiatry.;  citation_year=1986;  citation_volume=49;  citation_pages=332-333; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis and trimethoprim-sulfamethoxazole.; citation_authors=Streiffer  RH; Hudson  JG;  citation_journal_title=J Fam Pract.;  citation_year=1986;  citation_volume=23;  citation_pages=314" /><meta name="citation_reference" content="citation_title=Trimethoprim-sulfamethoxazole associated aseptic meningitis: case reports and review of the literature.; citation_authors=Joffe  AM; Farley  JD; Linden  D; Goldsand  G;  citation_journal_title=Am J Med.;  citation_year=1989;  citation_volume=87;  citation_pages=332-338; " /><meta name="citation_reference" content="citation_title=Drug-induced meningitis.; citation_authors=Gordon  MF; Allon  M; Coyle  PK;  citation_journal_title=Neurology.;  citation_year=1990;  citation_volume=40;  citation_pages=163-164; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with administration of trimethoprim and sulfamethoxazole.; citation_author=Auxier  GG;  citation_journal_title=AJDC.;  citation_year=1990;  citation_volume=144;  citation_pages=144-145; " /><meta name="citation_reference" content="citation_title=Trimethoprim-sulfamethoxazole–associated aseptic meningitis.; citation_authors=Tunkel  AR; Starr  K;  citation_journal_title=Am J Med.;  citation_year=1990;  citation_volume=88;  citation_pages=696" /><meta name="citation_reference" content="citation_title=Trimethoprim-sulfamethoxazole induced meningitis in systemic lupus erythematosus.; citation_authors=Escalante  A; Stimmler  MM;  citation_journal_title=J Rheumatol.;  citation_year=1992;  citation_volume=19;  citation_pages=800-802; " /><meta name="citation_reference" content="citation_title=Drug-induced aseptic meningitis caused by two medications.; citation_authors=Davis  JD; Thompson  J; Peimann  BS; Bendixen  BH;  citation_journal_title=Neurology.;  citation_year=1994;  citation_volume=44;  citation_pages=984-985; " /><meta name="citation_reference" content="citation_title=Drug-induced meningitis: a case involving trimethoprim-sulfamethoxazole.; citation_authors=Wong  JG; Hathaway  SC; Paat  JJ; Paterson  RW; Steele  GH;  citation_journal_title=Postgrad Med.;  citation_year=1994;  citation_volume=96;  citation_pages=117-124; " /><meta name="citation_reference" content="citation_title=Antibiotic induced meningitis.; citation_authors=River  Y; Averbuch-Heller  L; Weinberger  M;  citation_journal_title=J Neurol Neurosurg Psychiatry.;  citation_year=1994;  citation_volume=57;  citation_pages=705-708; " /><meta name="citation_reference" content="citation_title=Meningoencefalitis recurrente inducida por cotrimoxazol.; citation_authors=Carrillo  F; Cubero  A; Hernádez Gallego  J; Jiménez Santana  P;  citation_journal_title=Rev Neurol.;  citation_year=1995;  citation_volume=23;  citation_pages=142-144; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent.; citation_authors=Rudy  BJ; Rutsein  R;  citation_journal_title=Pediatr Emerg Care.;  citation_year=1997;  citation_volume=13;  citation_pages=216-217; " /><meta name="citation_reference" content="citation_title=Trimethoprim and sulfonamide-associated meningoencephalitis with MRI correlates.; citation_authors=Blumenfeld  H; Cha  JH; Cudkowicz  ME;  citation_journal_title=Neurology.;  citation_year=1996;  citation_volume=46;  citation_pages=556-558; " /><meta name="citation_reference" content="citation_title=Co-trimoxazole induced aseptic meningitis.; citation_authors=Pashankar  D; McArdle  M; Robinson  A;  citation_journal_title=Arch Dis Child.;  citation_year=1995;  citation_volume=73;  citation_pages=257-258; " /><meta name="citation_reference" content="citation_title=Trimethoprim-sulfamethoxazole–induced meningitis.; citation_authors=Poles  L; Theodor  E;  citation_journal_title=Harefuah.;  citation_year=1996;  citation_volume=130;  citation_pages=817-818; " /><meta name="citation_reference" content="citation_title=Case reports: trimethoprim-sulfamethoxazole–induced meningitis in patients with HIV infection.; citation_authors=Jurado  R; Carpenter  SL; Rimland  D;  citation_journal_title=Am J Med Sci.;  citation_year=1996;  citation_volume=312;  citation_pages=27-29; " /><meta name="citation_reference" content="citation_title=Trimethoprim-induced aseptic meningitis.; citation_author=Derbes  SJ;  citation_journal_title=JAMA.;  citation_year=1984;  citation_volume=252;  citation_pages=2865-2866; " /><meta name="citation_reference" content="citation_title=Trimethoprim-associated aseptic meningitis.; citation_authors=Carlson  J; Wihlom  B;  citation_journal_title=Scand J Infect Dis.;  citation_year=1987;  citation_volume=19;  citation_pages=687-691; " /><meta name="citation_reference" content="citation_title=Recurrent encephalitis due to trimethoprim intake.; citation_authors=Hedlund  J; Aurelius  E; Andersson  J;  citation_journal_title=Scand J Infect Dis.;  citation_year=1990;  citation_volume=22;  citation_pages=109-112; " /><meta name="citation_reference" content="citation_title=Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review.; citation_authors=Harrison  MS; Simonte  SJ; Kauffman  CA;  citation_journal_title=Clin Infect Dis.;  citation_year=1994;  citation_volume=19;  citation_pages=431-434; " /><meta name="citation_reference" content="citation_title=Trimethoprim-induced aseptic meningitis and uveitis.; citation_authors=Gilroy  N; Gottlieb  T; Spring  P; Peiris  O;  citation_journal_title=Lancet.;  citation_year=1997;  citation_volume=350;  citation_pages=112" /><meta name="citation_reference" content="citation_title=Acute aseptic meningitis induced by trimethoprim.; citation_authors=Saha  H; Lumio  J; Pasternack  A;  citation_journal_title=Duodecim.;  citation_year=1998;  citation_volume=104;  citation_pages=257-261; " /><meta name="citation_reference" content="citation_title=Acute meningoencephalitis: association with isoniazid administration.; citation_authors=Garagusi  VF; Neefe  LI; Mann  O;  citation_journal_title=JAMA.;  citation_year=1976;  citation_volume=235;  citation_pages=1141-1142; " /><meta name="citation_reference" content="citation_title=Eosinophilic meningitis associated with ciprofloxacin.; citation_authors=Asperilla  MO; Smego  MD;  citation_journal_title=Am J Med.;  citation_year=1989;  citation_volume=87;  citation_pages=589-590; " /><meta name="citation_reference" content="citation_title=Metronidazole-associated aseptic meningitis.; citation_authors=Corson  AP; Chretien  JH;  citation_journal_title=Clin Infect Dis.;  citation_year=1994;  citation_volume=19;  citation_pages=974" /><meta name="citation_reference" content="citation_title=Meningitretning efter Metronidazol.; citation_authors=Sundstrom  O; Svedberg  LE; Carling  L;  citation_journal_title=Lakartidningen.;  citation_year=1984;  citation_volume=81;  citation_pages=3480" /><meta name="citation_reference" content="citation_title=Cephalosporin-induced recurrent aseptic meningitis.; citation_authors=Creel  GB; Hurtt  M;  citation_journal_title=Ann Neurol.;  citation_year=1995;  citation_volume=37;  citation_pages=815-817; " /><meta name="citation_reference" content="citation_title=Meningite aseptique sous pyrazinamide lors de lupus erythemateux.; citation_authors=Bodokh  I; Lacour  J; Costa  I; Botcazou  V; Chichmanian  RM; Ortonne  JP;  citation_journal_title=Presse Med.;  citation_year=1993;  citation_volume=22;  citation_pages=595-596; " /><meta name="citation_reference" content="citation_title=Administration of immune globulin associated with aseptic meningitis.; citation_authors=Kato  E; Shindo  S; Eto  Y;  citation_journal_title=JAMA.;  citation_year=1988;  citation_volume=259;  citation_pages=3269-3271; " /><meta name="citation_reference" content="citation_title=Intravenous immune globulin and acute aseptic meningitis.; citation_authors=Casteels-Van Daele  M; Wijndaele  L; Hunninck  K; Gillis  P;  citation_journal_title=N Engl J Med.;  citation_year=1990;  citation_volume=323;  citation_pages=614-615; " /><meta name="citation_reference" content="citation_title=Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.; citation_authors=Vera-Ramirez  M; Charlet  M; Parry  GJ;  citation_journal_title=Neurology.;  citation_year=1992;  citation_volume=42;  citation_pages=1636-1637; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with high dose intravenous immunoglobulin therapy.; citation_authors=Watson  JDG; Gibson  J; Joshua  DE; Kronenberg  H;  citation_journal_title=J Neurol Neurosurg Psychiatry.;  citation_year=1991;  citation_volume=54;  citation_pages=275-276; " /><meta name="citation_reference" content="citation_title=Acute aseptic meningitis associated with administration of intravenous immune globulin.; citation_authors=Pallares  DE; Marshall  FS;  citation_journal_title=Am J Pediatr Hematol Oncol.;  citation_year=1992;  citation_volume=14;  citation_pages=279" /><meta name="citation_reference" content="citation_title=Aseptic meningitis following administration of intravenous immune globulin.; citation_authors=Molina  J-M; Coffineau  A; Rain  J-D; Letonturier  D; Modai  J;  citation_journal_title=Clin Infect Dis.;  citation_year=1992;  citation_volume=15;  citation_pages=564-565; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis.; citation_authors=Meiner  Z; Ben-Hur  T; River  Y; Reches  A;  citation_journal_title=J Neurol Neurosurg Psychiatry.;  citation_year=1993;  citation_volume=56;  citation_pages=830-831; " /><meta name="citation_reference" content="citation_title=Aseptic granulocytic meningitis following treatment with intravenous immunoglobulin.; citation_authors=De Vlieghere  FC; Peetermans  WE; Vermylen  J;  citation_journal_title=Clin Infect Dis.;  citation_year=1994;  citation_volume=18;  citation_pages=1008" /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors.; citation_authors=Sekul  EA; Cupler  EJ; Dalakas  MC;  citation_journal_title=Ann Intern Med.;  citation_year=1994;  citation_volume=121;  citation_pages=159-262; " /><meta name="citation_reference" content="citation_title=Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura.; citation_authors=Mitterer  M; Pescosta  N; Vogetseder  W; Mair  M; Coser  P;  citation_journal_title=Ann Hematol.;  citation_year=1993;  citation_volume=67;  citation_pages=151-152; " /><meta name="citation_reference" content="citation_title=&quot;Aseptic meningitis syndrome&quot; after intravenous gammaglobulin therapy for ITP.; citation_authors=Jayabose  S; Roseman  B; Gupta  A;  citation_journal_title=Am J Hematol Oncol.;  citation_year=1990;  citation_volume=12;  citation_pages=117" /><meta name="citation_reference" content="citation_title=Intravenous immune globulin and aseptic meningitis.; citation_authors=Rao  SP; Teitlebaum  J; Miller  ST;  citation_journal_title=AJDC.;  citation_year=1992;  citation_volume=146;  citation_pages=539-540; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis.; citation_authors=Ellis  RJ; Swenson  MR; Bajorek  J;  citation_journal_title=Muscle Nerve.;  citation_year=1994;  citation_volume=17;  citation_pages=683-684; " /><meta name="citation_reference" content="citation_title=Méningite aseptique consécutive á un traitement par immunoglobulines: intéret physiopathologique et pronostique de son déspistage.; citation_authors=Oddou  S; Molinier  S; Coso  D; Boulet  JM; Gastaut  JA; Bouabdallah  R;  citation_journal_title=Presse Med.;  citation_year=1995;  citation_volume=24;  citation_pages=916" /><meta name="citation_reference" content="citation_title=Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin?; citation_authors=Preminger-Shapiro  R; Nussinovich  M; Soen  G; Varsano  I;  citation_journal_title=Eur J Pediatr.;  citation_year=1995;  citation_volume=154;  citation_pages=866-867; " /><meta name="citation_reference" content="citation_title=Immunoglobulines intraveineuses et méningite aseptique.; citation_authors=Mselati  JC; Carlier  JC; Routon  MC; Noui Mehidi  F; de Gennes  C;  citation_journal_title=Arch Fr Pediatr.;  citation_year=1992;  citation_volume=49;  citation_pages=216" /><meta name="citation_reference" content="citation_title=Méningite aseptique au cours d'un traitement par immunoglobulines.; citation_authors=Sirvent  N; Monpoux  F; Benet  L; Mariani  R;  citation_journal_title=Arch Pediatr.;  citation_year=1996;  citation_volume=3;  citation_pages=830-831; " /><meta name="citation_reference" content="citation_title=Cerebrospinal fluid inflammation induced by intravenous immunoglobulins.; citation_authors=Kressebuch  H; Schaad  UB; Hirt  A; Bianchetti  MG;  citation_journal_title=Pediatr Infect Dis J.;  citation_year=1992;  citation_volume=11;  citation_pages=894-895; " /><meta name="citation_reference" content="citation_title=Transmission of viral infection by preparations of intravenous immunoglobulin.; citation_authors=Bussel  J; Cunningham-Rundles  C; Feldman  C; Horowitz  B;  citation_journal_title=Plasma Ther Transfus Technol.;  citation_year=1988;  citation_volume=9;  citation_pages=193-205; " /><meta name="citation_reference" content="citation_title=Meningitis aséptica por inmunoglobulinas intravenosas.; citation_authors=Fernández-Carril  JM; Trejo  JM; Sedano  MJ; Goñi  M;  citation_journal_title=Neurología.;  citation_year=1995;  citation_volume=10;  citation_pages=351-352; " /><meta name="citation_reference" content="citation_title=Intravenous immune globulins.; citation_author=Gabor  EP;  citation_journal_title=West J Med.;  citation_year=1995;  citation_volume=162;  citation_pages=277-278; " /><meta name="citation_reference" content="citation_title=Meningitis and hepatitis complicating intravenous immunoglobulin therapy.; citation_authors=Shorr  AF; Kester  KE;  citation_journal_title=Ann Pharmacother.;  citation_year=1996;  citation_volume=30;  citation_pages=1115-1116; " /><meta name="citation_reference" content="citation_title=Neurological complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G.; citation_authors=Kattamis  AC; Shankar  S; Cohen  AR;  citation_journal_title=J Pediatr.;  citation_year=1997;  citation_volume=130;  citation_pages=281-283; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with high dose immunoglobulin: case report.; citation_authors=Picton  P; Chishol  M;  citation_journal_title=BMJ.;  citation_year=1997;  citation_volume=315;  citation_pages=1203-1204; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis as a side effect of intravenous immune gammaglobulin.; citation_authors=Lafferty  TE; DeHoratius  RJ; Smith  JB;  citation_journal_title=J Rheumatol.;  citation_year=1997;  citation_volume=24;  citation_pages=2491-2492; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with high dose intravenous immunoglobulin therapy.; citation_authors=Van der Merché  F; Kleyweg  R;  citation_journal_title=J Neurol Neurosurg Psychiatry.;  citation_year=1992;  citation_volume=55;  citation_pages=981" /><meta name="citation_reference" content="citation_title=Cerebrospinal fluid inflammation during OKT3 therapy.; citation_authors=Emmons  C; Smith  J; Flanigan  M;  citation_journal_title=Lancet.;  citation_year=1986;  citation_volume=2;  citation_pages=510-511; " /><meta name="citation_reference" content="citation_title=Cerebrospinal fluid inflammation during OKT3 therapy.; citation_authors=Roden  J; Klintmalm  GBG; Husberg  BS; Nery  J; Olson  LM;  citation_journal_title=Lancet.;  citation_year=1987;  citation_volume=2;  citation_pages=272" /><meta name="citation_reference" content="citation_title=OKT3 treatment of steroid-resistant renal allograft rejection.; citation_authors=Thistlethwaite  JR; Gaber  AO; Haag  BW;  citation_journal_title=Transplantation.;  citation_year=1987;  citation_volume=43;  citation_pages=176-184; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with muromonab-CD3.; citation_authors=Rello  J; Vallverdú  I; Coll  P; Gurgí  M; Net  A;  citation_journal_title=DICP.;  citation_year=1990;  citation_volume=24;  citation_pages=1233" /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with muromonab-CD3 therapy.; citation_authors=Joy  ME; Michals  ML; Canafax  DM;  citation_journal_title=Clin Pharmacol.;  citation_year=1988;  citation_volume=7;  citation_pages=721" /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with muromonab-CD3.; citation_author=Figg  WD;  citation_journal_title=DICP.;  citation_year=1991;  citation_volume=25;  citation_pages=1395" /><meta name="citation_reference" content="citation_title=Optic disk swelling and abducens palsies associated with OKT3.; citation_authors=Strominger  MB; Liu  GT; Schartz  NJ;  citation_journal_title=Am J Ophthalmol.;  citation_year=1995;  citation_volume=119;  citation_pages=664-665; " /><meta name="citation_reference" content="citation_title=Successful reversal of acute cardiac allograft rejection with OKT3 monoclonal antibody.; citation_authors=Costanzo-Nordin  MR; Silver  MA; O'Conell  JB;  citation_journal_title=Circulation.;  citation_year=1987;  citation_volume=76;  citation_pages=71-80; " /><meta name="citation_reference" content="citation_title=Monitoring and complications of monoclonal therapy: complications and monitoring of OKT3 therapy.; citation_authors=Thistlethwaite  JR; Stuart  JK; Mayes  JT;  citation_journal_title=Am J Kidney Dis.;  citation_year=1988;  citation_volume=11;  citation_pages=112-119; " /><meta name="citation_reference" content="citation_title=OKT3 encephalophaty.; citation_authors=Coleman  AE; Norman  DJ;  citation_journal_title=Ann Neurol.;  citation_year=1990;  citation_volume=28;  citation_pages=837-838; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis following cardiac transplantation: clinical characteristics and relationship to immunosuppressive regimen.; citation_authors=Adair  JC; Woodley  SL; O'Conell  JB; Call  GK; Baringer  JR;  citation_journal_title=Neurology.;  citation_year=1991;  citation_volume=41;  citation_pages=249-252; " /><meta name="citation_reference" content="citation_title=Encephalopathy associated with OKT3 administration: possible interaction with indomethacin.; citation_authors=Chan  GL; Weinstein  SS; Wright  CE;  citation_journal_title=Transplantation.;  citation_year=1991;  citation_volume=52;  citation_pages=148-150; " /><meta name="citation_reference" content="citation_title=OKT3 and cerebral oedema.; citation_authors=Thomas  DM; Nicholls  AJ; Feest  TG; Riad  H;  citation_journal_title=BMJ.;  citation_year=1987;  citation_volume=295;  citation_pages=1486" /><meta name="citation_reference" content="citation_title=Seizures and cerebritis associated with administration of OKT3.; citation_authors=Capone  PM; Cohen  ME;  citation_journal_title=Pediatr Neurol.;  citation_year=1991;  citation_volume=7;  citation_pages=299-301; " /><meta name="citation_reference" content="citation_title=Transient hemiparesis associated with monoclonal CD3 antibody (OKT3) therapy.; citation_authors=Osterman  JD; Trauner  DA; Reznik  VM; Lemire  J;  citation_journal_title=Pediatr Neurol.;  citation_year=1993;  citation_volume=9;  citation_pages=482-484; " /><meta name="citation_reference" content="citation_title=Tumor necrosis factor and interleukin-6 in cerebrospinal fluid of a patient with recurrent adverse central nervous system events following OKT3.; citation_authors=Agarwal  RK; Ostaszewski  ML; Feld  LG; Springate  JE; Moxey-Mims  MM; O'Neill  KM;  citation_journal_title=Transplant Proc.;  citation_year=1993;  citation_volume=25;  citation_pages=3143-3144; " /><meta name="citation_reference" content="citation_title=Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin.; citation_authors=Kormos  RL; Arnitage  JM; Dummer  JS; Miyamoto  Y; Griffith  BP; Hardesty  RL;  citation_journal_title=Transplantation.;  citation_year=1990;  citation_volume=49;  citation_pages=306-311; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis among kidney transplant recipients receiving a newly marketed murine monoclonal antibody preparation.; citation_authors=Massanari  R; Martin  M; Smith  J;  citation_journal_title=JAMA.;  citation_year=1986;  citation_volume=256;  citation_pages=1873" /><meta name="citation_reference" content="citation_title=Aseptic meningitis due to OKT3.; citation_authors=Uribe Roca  MC; Zurru  MC; Gatto  EM; Maggiora  EC; Agost Carreno  C; Luciano  M;  citation_journal_title=Neurologia.;  citation_year=1998;  citation_volume=13;  citation_pages=98-99; " /><meta name="citation_reference" content="citation_title=Meningism in a ten-month-old infant during OKT3 therapy.; citation_authors=Rizzo  JD; Rowe  SA;  citation_journal_title=J Heart Transplant.;  citation_year=1990;  citation_volume=9;  citation_pages=727-728; " /><meta name="citation_reference" content="citation_title=Pachymeningitis apparently due to penicillin hypersensitivity.; citation_authors=Farmer  L; Echlin  FA; Loughin  WC; Breakey  AS; Duvoisin  R;  citation_journal_title=Ann Intern Med.;  citation_year=1960;  citation_volume=54;  citation_pages=910-914; " /><meta name="citation_reference" content="citation_title=Acute bacterial meningitis in adults: a review of 493 episodes.; citation_authors=Durand  ML; Calderwood  SB; Weber  DJ;  citation_journal_title=N Engl J Med.;  citation_year=1993;  citation_volume=328;  citation_pages=21-28; " /><meta name="citation_reference" content="citation_title=Populations at risk for penicillin-induced seizures.; citation_authors=Barrons  RW; Murray  KM; Richey  RM;  citation_journal_title=Ann Pharmacother.;  citation_year=1992;  citation_volume=26;  citation_pages=26-29; " /><meta name="citation_reference" content="citation_title=Prevalence of migraine headache in the United States.; citation_authors=Stewart  WF; Lipton  RB; Celentano  DD;  citation_journal_title=JAMA.;  citation_year=1992;  citation_volume=267;  citation_pages=64-69; " /><meta name="citation_reference" content="citation_title=Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus.; citation_authors=Montalbán  J; Cervera  R; Font  J;  citation_journal_title=Neurology.;  citation_year=1992;  citation_volume=42;  citation_pages=681-682; " /><meta name="citation_reference" content="citation_title=Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids.; citation_authors=Markus  HS; Hopkinson  N;  citation_journal_title=J Neurol.;  citation_year=1992;  citation_volume=239;  citation_pages=39-42; " /><meta name="citation_reference" content="citation_title=Community-acquired purulent meningitis: a review of 1316 cases during the antibiotic era, 1954-1976.; citation_authors=Geiseler  PJ; Nelson  KE; Levin  S; Reddi  KT; Moses  VK;  citation_journal_title=Rev Infect Dis.;  citation_year=1980;  citation_volume=2;  citation_pages=725-745; " /><meta name="citation_reference" content="citation_title=Acute bacterial meningitis in children and adults.; citation_authors=Roos  KL (eds); Tunkel  AR (eds); Scheld  WM (eds); Scheld  WM (eds); Whitley  RJ (eds); Durack  DT (eds);  citation_publisher_name=Raven Press; citation_publisher_loc=New York, NY;  citation_journal_title=Infections of the Central Nervous System;  citation_year=1991;  citation_pages=335-409; " /><meta name="citation_reference" content="citation_title=The acute aseptic meningitis syndrome.; citation_authors=Connolly  KJ; Hammer  SM;  citation_journal_title=Infect Dis Clin North Am.;  citation_year=1990;  citation_volume=4;  citation_pages=599-622; " /><meta name="citation_reference" content="citation_title=Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results.; citation_authors=Jeffery  KJM; Read  SJ; Peto  TEA; Mayon-White  RT; Bangham  CRM;  citation_journal_title=Lancet.;  citation_year=1997;  citation_volume=349;  citation_pages=313-317; " /><meta name="citation_reference" content="citation_title=Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977.; citation_authors=Ellis  SG; Verity  MA;  citation_journal_title=Semin Arthritis Rheum.;  citation_year=1979;  citation_volume=8;  citation_pages=212-221; " /><meta name="citation_reference" content="citation_title=Nervous system involvement in systemic lupus erythematosus.; citation_authors=Gibson  T; Myers  AR;  citation_journal_title=Ann Rheum Dis.;  citation_year=1975;  citation_volume=35;  citation_pages=398-406; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis in systemic lupus erythematosus.; citation_authors=Canoso  JJ; Cohen  AS;  citation_journal_title=Arthritis Rheum.;  citation_year=1975;  citation_volume=18;  citation_pages=369-373; " /><meta name="citation_reference" content="citation_title=Cerebrospinal fluid investigations in migraine.; citation_authors=Kovacs  K; Bors  L; Tóthfalusi  L;  citation_journal_title=Cephalagia.;  citation_year=1989;  citation_volume=9;  citation_pages=53-57; " /><meta name="citation_reference" content="citation_title=Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis.; citation_authors=Gómez-Aranda  F; Cañadillas  F; Martí-Massó  JF;  citation_journal_title=Brain.;  citation_year=1997;  citation_volume=120;  citation_pages=1105-1113; " /><meta name="citation_reference" content="citation_title=Nonsteroidal anti-inflammatory drugs: differences and similarities.; citation_authors=Brooks  PM; Day  RO;  citation_journal_title=N Engl J Med.;  citation_year=1991;  citation_volume=324;  citation_pages=1716-1725; " /><meta name="citation_reference" content="citation_title=Ibuprofen may induce meningitis in (NZB × NZW) F1 mice.; citation_authors=Berliner  S; Weisberg  A; Schoenfeld  Y;  citation_journal_title=Arthritis Rheum.;  citation_year=1985;  citation_volume=28;  citation_pages=104-107; " /><meta name="citation_reference" content="citation_title=Sensitization to ibuprofen in systemic lupus erythematosus.; citation_authors=Shoenfeld  Y; Livni  E; Shaklai  M; Pinkhas  J;  citation_journal_title=JAMA.;  citation_year=1980;  citation_volume=244;  citation_pages=547-548; " /><meta name="citation_reference" content="citation_title=Immunoregulatory aberrations in systemic lupus erythematosus.; citation_authors=Fauci  AS; Steinberg  AD; Haynes  BF;  citation_journal_title=J Immunol.;  citation_year=1978;  citation_volume=121;  citation_pages=1473-1474; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis, trimethoprim, and Sjögren's syndrome.; citation_author=Derbes  SJ;  citation_journal_title=JAMA.;  citation_year=1985;  citation_volume=253;  citation_pages=2192" /><meta name="citation_reference" content="citation_title=Aseptic meningitis, trimethoprim, and Sjögren's syndrome.; citation_authors=de la Monte  SM; Hutchins  GM; Gupta  PK;  citation_journal_title=JAMA.;  citation_year=1985;  citation_volume=253;  citation_pages=2192" /><meta name="citation_reference" content="citation_title=Aseptic meningitis and intravenous inmmunoglobulin therapy.; citation_author=Dalakas  MC;  citation_journal_title=Ann Intern Med.;  citation_year=1995;  citation_volume=122;  citation_pages=316-317; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis and intravenous immunoglobulin therapy.; citation_authors=Scribner  CL; Kapit  RM; Phillips  ET; Rickles  NM;  citation_journal_title=Ann Intern Med.;  citation_year=1994;  citation_volume=121;  citation_pages=105-306; " /><meta name="citation_reference" content="citation_title=Nosocomial aseptic meningitis associated with administration of OKT3.; citation_authors=Martin  MA; Massanari  RM; Nghiem  DD; Smith  JL; Cany  RT;  citation_journal_title=JAMA.;  citation_year=1988;  citation_volume=259;  citation_pages=2002-2005; " /><meta name="citation_reference" content="citation_title=In vivo cell activation following OKT3 administration.; citation_authors=Chatenaud  L; Ferran  C; Legendre  C;  citation_journal_title=Transplantation.;  citation_year=1990;  citation_volume=49;  citation_pages=692-702; " /><meta name="citation_reference" content="citation_title=Acute clinical syndrome associated with OKT3 administration: prevention by single injection of an anti-human TNF monoclonal antibody.; citation_authors=Charpentier  B; Hiesse  C; Ferran  C;  citation_journal_title=Presse Med.;  citation_year=1991;  citation_volume=20;  citation_pages=2009-2011; " /><meta name="citation_reference" content="citation_title=Neuronal cell thy-1 glycoprotein: homology with immunoglobulin.; citation_authors=Williams  AF; Gagnon  J;  citation_journal_title=Science.;  citation_year=1982;  citation_volume=216;  citation_pages=696-703; " /><meta name="citation_reference" content="citation_title=Studies on brain thymus cross-reactive antigens.; citation_author=Bienbaum  G;  citation_journal_title=Brain Res.;  citation_year=1975;  citation_volume=84;  citation_pages=111-121; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with administration of carbamazepine.; citation_authors=Hilton  E; Stroh  EM;  citation_journal_title=J Infect Dis.;  citation_year=1989;  citation_volume=159;  citation_pages=363-364; " /><meta name="citation_reference" content="citation_title=Carbamazepine-induced aseptic meningitis.; citation_authors=Simon  LT; Hsu  B; Dornato  BT;  citation_journal_title=Ann Intern Med.;  citation_year=1990;  citation_volume=112;  citation_pages=627-628; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis secondary to carbamazepine treatment of manic-depressive illness.; citation_authors=Hemet  C; Chassagne  P; Levade  M;  citation_journal_title=Am J Psychiatry.;  citation_year=1994;  citation_volume=151;  citation_pages=1393" /><meta name="citation_reference" content="citation_title=Aseptic meningitis secondary to carbamazepine therapy.; citation_authors=Dang  CT; Riley  DK;  citation_journal_title=Clin Infect Dis.;  citation_year=1996;  citation_volume=22;  citation_pages=729-730; " /><meta name="citation_reference" content="citation_title=Meningitis associated with sulphasalazine in a patient with Sjögren's syndrome and polyarthritis.; citation_authors=Merrin  P; Williams  IA;  citation_journal_title=Ann Rheum Dis.;  citation_year=1991;  citation_volume=50;  citation_pages=645-646; " /><meta name="citation_reference" content="citation_title=Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature.; citation_authors=Alloway  JA; Mitchell  SR;  citation_journal_title=J Rheumatol.;  citation_year=1993;  citation_volume=20;  citation_pages=409-411; " /><meta name="citation_reference" content="citation_title=Phenazopiridine and aseptic meningitis.; citation_author=Herlihy  TE;  citation_journal_title=Ann Intern Med.;  citation_year=1987;  citation_volume=106;  citation_pages=172-135; " /><meta name="citation_reference" content="citation_org=Swedish Adverse Drug Reactions Advisory Committee; citation_title=Survey of Adverse Effects: Zimeldin.;  citation_journal_title=Swedish Adverse Drug Reactions Advisory Committee; 1983. Bulletin 39/40.; " /><meta name="citation_reference" content="citation_title=Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy.; citation_authors=Thordarson  H; Talstad  I;  citation_journal_title=Acta Med Scand.;  citation_year=1986;  citation_volume=220;  citation_pages=493-495; " /><meta name="citation_reference" content="citation_title=Central nervous system disease in systemic lupus erythematosus: therapy and prognosis.; citation_authors=Sergent  JS; Lockshin  MD; Klemper  MS; Lipsky  BA;  citation_journal_title=Am J Med.;  citation_year=1975;  citation_volume=58;  citation_pages=644-654; " /><meta name="citation_reference" content="citation_title=Aseptic meningitis associated with salicylate overdose.; citation_authors=Nair  J; Stacy  M;  citation_journal_title=Psychosomatics.;  citation_year=1993;  citation_volume=34;  citation_pages=372" /><meta name="citation_reference" content="citation_title=Meningite aigue aseptique apres vaccination contre l'hepatite B.; citation_authors=Heinzlef  O; Moguilewski  A; Roullet  E;  citation_journal_title=Presse Med.;  citation_year=1997;  citation_volume=26;  citation_pages=328" /><meta name="citation_reference" content="citation_title=Ranitidine and aseptic meningitis.; citation_authors=Durand  JM; Suchet  L;  citation_journal_title=BMJ.;  citation_year=1997;  citation_volume=312;  citation_pages=886" /><meta name="citation_fulltext_world_readable" content="" /><meta name="citation_pdf_url" content="http://archinte.jamanetwork.com/data/Journals/INTEMED/11945/ira80415.pdf" />
    <meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@JAMAInternalMed" />
    


    
    


    
    <script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/jquery/1.6.4/jquery.min.js"></script>
    <script type="text/javascript">        window.jQuery || document.write('<script type="text/javascript" src="/JS/plugins/jquery-1.6.4.min.js"><\/script>')</script>
    
    <script type="text/javascript">
        document.createElement('header');
        document.createElement('hgroup');
        document.createElement('nav');
        document.createElement('menu');
        document.createElement('section');
        document.createElement('article');
        document.createElement('aside');
        document.createElement('footer');
	</script>
  

    <input name="ctl00$tam_id" type="hidden" id="tam_id" value="Unknown" /><input name="ctl00$cust_id" type="hidden" id="cust_id" value="Unknown" /><input name="ctl00$inst_id" type="hidden" id="inst_id" value="Unknown" /><link rel="canonical" href="http://archinte.jamanetwork.com/article.aspx?articleid=485056" /><script type="text/javascript">var gptadslots=[];(function() {var useSSL = 'https:' == document.location.protocol;var src = (useSSL ? 'https:' : 'http:') + '//www.googletagservices.com/tag/js/gpt.js';       document.write('<scr' + 'ipt src="' + src + '"></scr' + 'ipt>');})();</script><script type='text/javascript'>
gptadslots[1] = googletag.defineSlot('/6479/ama.archinte/abstract', [728,90], 'advertisingBlocksLeaderboard').setTargeting('pos', ['atf']).addService(googletag.pubads());
gptadslots[2]  = googletag.defineOutOfPageSlot('/6479/ama.archinte/abstract', 'advertisingBlocksInterstitial').setTargeting('pos', ['interstitial']).addService(googletag.pubads());
gptadslots[3] = googletag.defineSlot('/6479/ama.archinte/abstract', [[300,250],[300,600]], 'advertisingBlocksRightSkyscraperArticle').setTargeting('pos', ['mid']).addService(googletag.pubads());
googletag.pubads().enableSingleRequest();googletag.pubads().setTargeting('site', ['ama.archinte']).setTargeting('test', ['']).setTargeting('sect', ['abstract']).setTargeting('sub', ['no']).setTargeting('device', ['Wget%2F1.16%20(linux-gnu);']).setTargeting('usaphys', ['no']).setTargeting('memberstat', ['no']).setTargeting('pracset', ['']).setTargeting('specialty', ['']).setTargeting('occupation', ['']).setTargeting('useraffinity', ['']).setTargeting('direct', ['yes']);googletag.pubads().enableSyncRendering();googletag.enableServices();
</script><meta name="description" content="Review from JAMA Internal Medicine — The Challenge of Drug-Induced Aseptic Meningitis" /></head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"8d76ca6f26","applicationID":"8568821","transactionName":"ZQBRMkVUCEtRVkINXlxKcjVnGgdKRFxVCFQcBEAWTw==","queueTime":0,"applicationTime":2230,"ttGuid":"CE3F7B86195F53E4","agent":"js-agent.newrelic.com/nr-768.min.js"}</script><script type="text/javascript">(window.NREUM||(NREUM={})).loader_config={xpid:"XAYBV15WGwsFUllaBQA="};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({QJf3ax:[function(t,e){function n(t){function e(e,n,a){t&&t(e,n,a),a||(a={});for(var c=s(e),f=c.length,u=i(a,o,r),d=0;f>d;d++)c[d].apply(u,n);return u}function a(t,e){f[t]=s(t).concat(e)}function s(t){return f[t]||[]}function c(){return n(e)}var f={};return{on:a,emit:e,create:c,listeners:s,_events:f}}function r(){return{}}var o="nr@context",i=t("gos");e.exports=n()},{gos:"7eSDFh"}],ee:[function(t,e){e.exports=t("QJf3ax")},{}],3:[function(t){function e(t){try{i.console&&console.log(t)}catch(e){}}var n,r=t("ee"),o=t(1),i={};try{n=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(i.console=!0,-1!==n.indexOf("dev")&&(i.dev=!0),-1!==n.indexOf("nr_dev")&&(i.nrDev=!0))}catch(a){}i.nrDev&&r.on("internal-error",function(t){e(t.stack)}),i.dev&&r.on("fn-err",function(t,n,r){e(r.stack)}),i.dev&&(e("NR AGENT IN DEVELOPMENT MODE"),e("flags: "+o(i,function(t){return t}).join(", ")))},{1:24,ee:"QJf3ax"}],4:[function(t){function e(t,e,n,i,s){try{c?c-=1:r("err",[s||new UncaughtException(t,e,n)])}catch(f){try{r("ierr",[f,(new Date).getTime(),!0])}catch(u){}}return"function"==typeof a?a.apply(this,o(arguments)):!1}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function n(t){r("err",[t,(new Date).getTime()])}var r=t("handle"),o=t(6),i=t("ee"),a=window.onerror,s=!1,c=0;t("loader").features.err=!0,t(5),window.onerror=e;try{throw new Error}catch(f){"stack"in f&&(t(1),t(2),"addEventListener"in window&&t(3),window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&!/CriOS/.test(navigator.userAgent)&&t(4),s=!0)}i.on("fn-start",function(){s&&(c+=1)}),i.on("fn-err",function(t,e,r){s&&(this.thrown=!0,n(r))}),i.on("fn-end",function(){s&&!this.thrown&&c>0&&(c-=1)}),i.on("internal-error",function(t){r("ierr",[t,(new Date).getTime(),!0])})},{1:11,2:10,3:8,4:12,5:3,6:25,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],5:[function(t){if(window.addEventListener){var e=t("handle"),n=t("ee");t(1),window.addEventListener("click",function(){e("inc",["ck"])},!1),window.addEventListener("hashchange",function(){e("inc",["hc"])},!1),n.on("pushState-start",function(){e("inc",["ps"])})}},{1:9,ee:"QJf3ax",handle:"D5DuLP"}],6:[function(t){t("loader").features.ins=!0},{loader:"G9z0Bl"}],7:[function(t){function e(){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var n=t("ee"),r=t("handle"),o=t(1),i=t(2);t("loader").features.stn=!0,t(3);var a=Event;n.on("fn-start",function(t){var e=t[0];e instanceof a&&(this.bstStart=Date.now())}),n.on("fn-end",function(t,e){var n=t[0];n instanceof a&&r("bst",[n,e,this.bstStart,Date.now()])}),o.on("fn-start",function(t,e,n){this.bstStart=Date.now(),this.bstType=n}),o.on("fn-end",function(t,e){r("bstTimer",[e,this.bstStart,Date.now(),this.bstType])}),i.on("fn-start",function(){this.bstStart=Date.now()}),i.on("fn-end",function(t,e){r("bstTimer",[e,this.bstStart,Date.now(),"requestAnimationFrame"])}),n.on("pushState-start",function(){this.time=Date.now(),this.startPath=location.pathname+location.hash}),n.on("pushState-end",function(){r("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),"addEventListener"in window.performance&&(window.performance.addEventListener("webkitresourcetimingbufferfull",function(){r("bstResource",[window.performance.getEntriesByType("resource")]),window.performance.webkitClearResourceTimings()},!1),window.performance.addEventListener("resourcetimingbufferfull",function(){r("bstResource",[window.performance.getEntriesByType("resource")]),window.performance.clearResourceTimings()},!1)),document.addEventListener("scroll",e,!1),document.addEventListener("keypress",e,!1),document.addEventListener("click",e,!1)}},{1:11,2:10,3:9,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],8:[function(t,e){function n(t){i.inPlace(t,["addEventListener","removeEventListener"],"-",r)}function r(t){return t[1]}var o=t("ee").create(),i=t(1)(o),a=t("gos");if(e.exports=o,n(window),"getPrototypeOf"in Object){for(var s=document;s&&!s.hasOwnProperty("addEventListener");)s=Object.getPrototypeOf(s);s&&n(s);for(var c=XMLHttpRequest.prototype;c&&!c.hasOwnProperty("addEventListener");)c=Object.getPrototypeOf(c);c&&n(c)}else XMLHttpRequest.prototype.hasOwnProperty("addEventListener")&&n(XMLHttpRequest.prototype);o.on("addEventListener-start",function(t,e){function n(){return s}if(t[1]){var r=t[1];if("function"==typeof r){var s=a(r,"nr@wrapped",function(){return i(r,"fn-",n,r.name||"anonymous")});this.wrapped=t[1]=s,o.emit("initEventContext",[t,e],this.wrapped)}else"function"==typeof r.handleEvent&&i.inPlace(r,["handleEvent"],"fn-")}}),o.on("removeEventListener-start",function(t){var e=this.wrapped;e&&(t[1]=e)})},{1:26,ee:"QJf3ax",gos:"7eSDFh"}],9:[function(t,e){var n=t("ee").create(),r=t(1)(n);e.exports=n,r.inPlace(window.history,["pushState","replaceState"],"-")},{1:26,ee:"QJf3ax"}],10:[function(t,e){var n=t("ee").create(),r=t(1)(n);e.exports=n,r.inPlace(window,["requestAnimationFrame","mozRequestAnimationFrame","webkitRequestAnimationFrame","msRequestAnimationFrame"],"raf-"),n.on("raf-start",function(t){t[0]=r(t[0],"fn-")})},{1:26,ee:"QJf3ax"}],11:[function(t,e){function n(t,e,n){t[0]=i(t[0],"fn-",null,n)}function r(t,e,n){function r(){return a}this.ctx={};var a={"nr@context":this.ctx};o.emit("initTimerContext",[t,n],a),t[0]=i(t[0],"fn-",r,n)}var o=t("ee").create(),i=t(1)(o);e.exports=o,i.inPlace(window,["setTimeout","setImmediate"],"setTimer-"),i.inPlace(window,["setInterval"],"setInterval-"),i.inPlace(window,["clearTimeout","clearImmediate"],"clearTimeout-"),o.on("setInterval-start",n),o.on("setTimer-start",r)},{1:26,ee:"QJf3ax"}],12:[function(t,e){function n(){f.inPlace(this,p,"fn-",o)}function r(t,e){f.inPlace(e,["onreadystatechange"],"fn-")}function o(t,e){return e}function i(t,e){for(var n in t)e[n]=t[n];return e}var a=t("ee").create(),s=t(1),c=t(2),f=c(a),u=c(s),d=window.XMLHttpRequest,p=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"];e.exports=a,window.XMLHttpRequest=function(t){var e=new d(t);try{a.emit("new-xhr",[],e),e.hasOwnProperty("addEventListener")&&u.inPlace(e,["addEventListener","removeEventListener"],"-",o),e.addEventListener("readystatechange",n,!1)}catch(r){try{a.emit("internal-error",[r])}catch(i){}}return e},i(d,XMLHttpRequest),XMLHttpRequest.prototype=d.prototype,f.inPlace(XMLHttpRequest.prototype,["open","send"],"-xhr-",o),a.on("send-xhr-start",r),a.on("open-xhr-start",r)},{1:8,2:26,ee:"QJf3ax"}],13:[function(t){function e(t){var e=this.params,r=this.metrics;if(!this.ended){this.ended=!0;for(var i=0;c>i;i++)t.removeEventListener(s[i],this.listener,!1);if(!e.aborted){if(r.duration=(new Date).getTime()-this.startTime,4===t.readyState){e.status=t.status;var a=t.responseType,f="arraybuffer"===a||"blob"===a||"json"===a?t.response:t.responseText,u=n(f);if(u&&(r.rxSize=u),this.sameOrigin){var d=t.getResponseHeader("X-NewRelic-App-Data");d&&(e.cat=d.split(", ").pop())}}else e.status=0;r.cbTime=this.cbTime,o("xhr",[e,r,this.startTime])}}}function n(t){if("string"==typeof t&&t.length)return t.length;if("object"!=typeof t)return void 0;if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if("undefined"!=typeof FormData&&t instanceof FormData)return void 0;try{return JSON.stringify(t).length}catch(e){return void 0}}function r(t,e){var n=i(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.sameOrigin=n.sameOrigin}if(window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&!/CriOS/.test(navigator.userAgent)){t("loader").features.xhr=!0;var o=t("handle"),i=t(2),a=t("ee"),s=["load","error","abort","timeout"],c=s.length,f=t(1),u=window.XMLHttpRequest;t(4),t(3),a.on("new-xhr",function(){this.totalCbs=0,this.called=0,this.cbTime=0,this.end=e,this.ended=!1,this.xhrGuids={}}),a.on("open-xhr-start",function(t){this.params={method:t[0]},r(this,t[1]),this.metrics={}}),a.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),a.on("send-xhr-start",function(t,e){var r=this.metrics,o=t[0],i=this;if(r&&o){var f=n(o);f&&(r.txSize=f)}this.startTime=(new Date).getTime(),this.listener=function(t){try{"abort"===t.type&&(i.params.aborted=!0),("load"!==t.type||i.called===i.totalCbs&&(i.onloadCalled||"function"!=typeof e.onload))&&i.end(e)}catch(n){try{a.emit("internal-error",[n])}catch(r){}}};for(var u=0;c>u;u++)e.addEventListener(s[u],this.listener,!1)}),a.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),a.on("xhr-load-added",function(t,e){var n=""+f(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),a.on("xhr-load-removed",function(t,e){var n=""+f(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),a.on("addEventListener-end",function(t,e){e instanceof u&&"load"===t[0]&&a.emit("xhr-load-added",[t[1],t[2]],e)}),a.on("removeEventListener-end",function(t,e){e instanceof u&&"load"===t[0]&&a.emit("xhr-load-removed",[t[1],t[2]],e)}),a.on("fn-start",function(t,e,n){e instanceof u&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=(new Date).getTime()))}),a.on("fn-end",function(t,e){this.xhrCbStart&&a.emit("xhr-cb-time",[(new Date).getTime()-this.xhrCbStart,this.onload,e],e)})}},{1:"XL7HBI",2:14,3:12,4:8,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],14:[function(t,e){e.exports=function(t){var e=document.createElement("a"),n=window.location,r={};e.href=t,r.port=e.port;var o=e.href.split("://");return!r.port&&o[1]&&(r.port=o[1].split("/")[0].split("@").pop().split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]?"443":"80"),r.hostname=e.hostname||n.hostname,r.pathname=e.pathname,r.protocol=o[0],"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname),r.sameOrigin=!e.hostname||e.hostname===document.domain&&e.port===n.port&&e.protocol===n.protocol,r}},{}],15:[function(t,e){function n(t){return function(){r(t,[(new Date).getTime()].concat(i(arguments)))}}var r=t("handle"),o=t(1),i=t(2);"undefined"==typeof window.newrelic&&(newrelic=window.NREUM);var a=["setPageViewName","addPageAction","setCustomAttribute","finished","addToTrace","inlineHit","noticeError"];o(a,function(t,e){window.NREUM[e]=n("api-"+e)}),e.exports=window.NREUM},{1:24,2:25,handle:"D5DuLP"}],gos:[function(t,e){e.exports=t("7eSDFh")},{}],"7eSDFh":[function(t,e){function n(t,e,n){if(r.call(t,e))return t[e];var o=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:o,writable:!0,enumerable:!1}),o}catch(i){}return t[e]=o,o}var r=Object.prototype.hasOwnProperty;e.exports=n},{}],D5DuLP:[function(t,e){function n(t,e,n){return r.listeners(t).length?r.emit(t,e,n):void(r.q&&(r.q[t]||(r.q[t]=[]),r.q[t].push(e)))}var r=t("ee").create();e.exports=n,n.ee=r,r.q={}},{ee:"QJf3ax"}],handle:[function(t,e){e.exports=t("D5DuLP")},{}],XL7HBI:[function(t,e){function n(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:i(t,o,function(){return r++})}var r=1,o="nr@id",i=t("gos");e.exports=n},{gos:"7eSDFh"}],id:[function(t,e){e.exports=t("XL7HBI")},{}],G9z0Bl:[function(t,e){function n(){var t=p.info=NREUM.info,e=f.getElementsByTagName("script")[0];if(t&&t.licenseKey&&t.applicationID&&e){s(d,function(e,n){e in t||(t[e]=n)});var n="https"===u.split(":")[0]||t.sslForHttp;p.proto=n?"https://":"http://",a("mark",["onload",i()]);var r=f.createElement("script");r.src=p.proto+t.agent,e.parentNode.insertBefore(r,e)}}function r(){"complete"===f.readyState&&o()}function o(){a("mark",["domContent",i()])}function i(){return(new Date).getTime()}var a=t("handle"),s=t(1),c=window,f=c.document;t(2);var u=(""+location).split("?")[0],d={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-768.min.js"},p=e.exports={offset:i(),origin:u,features:{}};f.addEventListener?(f.addEventListener("DOMContentLoaded",o,!1),c.addEventListener("load",n,!1)):(f.attachEvent("onreadystatechange",r),c.attachEvent("onload",n)),a("mark",["firstbyte",i()])},{1:24,2:15,handle:"D5DuLP"}],loader:[function(t,e){e.exports=t("G9z0Bl")},{}],24:[function(t,e){function n(t,e){var n=[],o="",i=0;for(o in t)r.call(t,o)&&(n[i]=e(o,t[o]),i+=1);return n}var r=Object.prototype.hasOwnProperty;e.exports=n},{}],25:[function(t,e){function n(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(0>o?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=n},{}],26:[function(t,e){function n(t){return!(t&&"function"==typeof t&&t.apply&&!t[i])}var r=t("ee"),o=t(1),i="nr@original",a=Object.prototype.hasOwnProperty;e.exports=function(t){function e(t,e,r,a){function nrWrapper(){var n,i,s,f;try{i=this,n=o(arguments),s=r&&r(n,i)||{}}catch(d){u([d,"",[n,i,a],s])}c(e+"start",[n,i,a],s);try{return f=t.apply(i,n)}catch(p){throw c(e+"err",[n,i,p],s),p}finally{c(e+"end",[n,i,f],s)}}return n(t)?t:(e||(e=""),nrWrapper[i]=t,f(t,nrWrapper),nrWrapper)}function s(t,r,o,i){o||(o="");var a,s,c,f="-"===o.charAt(0);for(c=0;c<r.length;c++)s=r[c],a=t[s],n(a)||(t[s]=e(a,f?s+o:o,i,s))}function c(e,n,r){try{t.emit(e,n,r)}catch(o){u([o,e,n,r])}}function f(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){u([r])}for(var o in t)a.call(t,o)&&(e[o]=t[o]);return e}function u(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=r),e.inPlace=s,e.flag=i,e}},{1:25,ee:"QJf3ax"}]},{},["G9z0Bl",4,13,7,6,5]);</script><body class="SCM6 journal INTEMED article">
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-WNKSNP"
            height="0" width="0" style="display: none; visibility: hidden"></iframe>
    </noscript>

    <script>(function (w, d, s, l, i) {
    w[l] = w[l] || []; w[l].push(
    { 'gtm.start': new Date().getTime(), event: 'gtm.js' }
    ); var f = d.getElementsByTagName(s)[0],
    j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
    '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
})(window, document, 'script', 'dataLayer', 'GTM-WNKSNP');</script>
    <!-- End Google Tag Manager -->
    
    
    
    
    

    <div class="mobileDetection">
    </div>
    <span id="authenticationDetection" class="authenticationDetection">0</span>
    <form method="post" action="article.aspx?articleid=485056" id="Form1">
<input type="hidden" name="scm6ScriptManager_HiddenField" id="scm6ScriptManager_HiddenField" value="" />
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" />


<script type="text/javascript">
//<![CDATA[
function CallBack(arg,context){WebForm_DoCallback('ctl00$scm6MainContent$ucUserComments',arg,DatafromServer,context,null,false);}function callBackSaveAlert(arg,context){WebForm_DoCallback('ctl00$scm6MainContent$ucArticleToolbox$ucUserAlerts',arg,displayAlertMessage,null,null,false);}function scm6MainContent_ucRelatedArticlesCallback(arg,context){WebForm_DoCallback('ctl00$scm6MainContent$ucRelatedArticles',arg,ArticleDatafromServer,context,null,false);}//]]>
</script>

<script src="/WebResource.axd?d=KJ8322KRWRH7EDqhNXuW7IXtP95VIAagIxSIMIP7dlxn042H3bCAR7rhbqR_PqxLqbNG7XfOrbEQXP5n7uPBNhjSaN_QP0QXx4W7F8ctDkhLR920RyYwFsAJmiJI81aSSv3lPGxyEid3eGozKdQgZz0oCSA1&amp;t=635786365130161811" type="text/javascript"></script>
<script src="/ScriptResource.axd?d=sC8KCCOS4h_2FFhdBSSI_lDarFqxLRocBYyLjCsUxQaR9QQbQnnurrrvpafeig5qJjIXPs-Iclc5kjIUUK_ysV-jnzvv9fQDDE5NDn7Jlc5EO7Fm0&amp;t=11e6618b" type="text/javascript"></script>
<script src="/ScriptResource.axd?d=uGMzEwF2jTP6M8IfUjkuma7IkpCNxkDim87vZePrQBL7kVUDlCsJmOMmLUmNPknLgwBTZzd9m_YgOGNmeHdbdbCrOEdTAh3O0_nU_3dhOori6iXdUOPl7egAaCJ1iSnY59lTow2&amp;t=6811d392" type="text/javascript"></script>
<script src="/ScriptResource.axd?d=8yhG95ORBCdFcnQMiG7SKCkD7fZE_-0QfrcOcMeSd0iByYMyQoN8n6P2Wockd7G3m_urLLH950OSn9bLbQ75XNXB2XfWbNDcxAGwQB7wJDBvcGPlDeYm-FLeqx7t2_Ae6wOe8Q2&amp;t=6811d392" type="text/javascript"></script>
<script src="/article.aspx?_TSM_HiddenField_=scm6ScriptManager_HiddenField&amp;_TSM_CombinedScripts_=%3b%3bAjaxControlToolkit%2c+Version%3d3.5.40412.0%2c+Culture%3dneutral%2c+PublicKeyToken%3d28f01b0e84b6d53e%3aen-US%3a1547e793-5b7e-48fe-8490-03a375b13a33%3ade1feab2%3af9cec9bc%3a35576c48" type="text/javascript"></script>
<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="2173C2F0" />
<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="/wEWMgKsxdPsDQLs6I/rAwKO1Pr0DQLw/cSXDwKT7rCNDwLhqu+1DAL7qcJKApTBn+UOArLdi8gKAp6ixdcNAo7I/dYFApKzla0LAsWmyskEAqC9h8QEAvCCxeILApea6cIFArC3u9cMAoX2jQYCkcOCTgLJkunPBwK6rsbpAwKszauiCAKrwvqfDAKN+KDqDwLtor7wCQLt+tP3CALWvsT7BwLb0OsrApTwxrQGAoy+yCwCsIew4wwC/qyH/AECoc7qlwECsMm6hAQCg/zo1A0C8oqyVgLv0NO7AwLC24iJBwKZ4+/1DgLu+NPRCwKyn7HaDQLV1suEBwK1vuXsAgK/2veICQL9ypaVDwKHvc7pBALFwrSVBgKeq7bJDAKNrPv5DwKg0qrTDRiLeNwZ1sDgqP0Z/JD7Iqh6Lsb7" />
        <!--Global Page Content Section-->
        <div class="pageContentHolder">
            
            <div class="contentWrapper">
                
<div class="bannerTop">
    <div id="globalHeader_divAd" class="addBanner navbar">
        


<div id="advertisingBlocksLeaderboard" class="advertisingBlocks" contentplaceholderid="Leaderboard">
    
    
        
        <a href="http://jamanetwork.com/SS/Advertising_Disclaimer.aspx"><span id="leaderboardAdLabel" class="sprite-globalHeader sprite-ad_label_vert"></span></a>
    <div class="center-block center">
		<script type='text/javascript'>
		    googletag.cmd.push(function () { googletag.display('advertisingBlocksLeaderboard') });
		</script>
    </div>

    
    

</div>



























    </div>
    
</div>

























<div id="advertisingBlocksInterstitial" class="advertisingBlocks" contentplaceholderid="Interstitial">
    
    

		<script type='text/javascript'>
		    googletag.cmd.push(function () { googletag.display('advertisingBlocksInterstitial') });
		</script>
        
     

</div>







<div id="rmnheader">
    <div class="sso-header-wrap">
        <div class="sso-header left">
            
        </div>
        <div class="acct-wrap right">
            <ul id="ulInstitutionAuth" class="sso-header-signed-in">
                <li id="globalHeader_SSOHeader_liInstitutionalSignIn" class="institutional-sign-in">
                    <span id="globalHeader_SSOHeader_lblInstitutionName">Institutional Sign In ></span>
                    <span class="pipe">|</span>
                    <ul id="globalHeader_SSOHeader_ulUniversalLinks" class="institutional-links">
                        <li id="liAthensLoginLink" class="dotted-border">
                            <a id="globalHeader_SSOHeader_hplAthensLoginLink" rel="nofollow" href="http://jamanetwork.com/athens/athensProtectedResource.aspx?RedirectUrl=http://archinte.jamanetwork.com/article.aspx?articleid=485056">Sign in via Athens</a>
                        </li>
                        <li id="shibboleth-login-link"><a rel="nofollow" href="../SignInShibboleth.aspx">Sign in via Shibboleth</a>
                        </li>
                    </ul>
                </li>
                <li id="individual-auth-name" class="auth-name">
                    <span id="globalHeader_SSOHeader_lblIndividualAuthName" class="sprite-globalHeader sprite-icon_user"></span>
                </li>
                <li class="auth-functions">
					<div id="globalHeader_SSOHeader_dvSigninMenu" class="sign-in">
						<a rel="nofollow" href="/OAuthSignin.aspx?return_url=http%3a%2f%2farchinte.jamanetwork.com%2farticle.aspx%3farticleid%3d485056"
							id="rmn-signin" onmousedown="dcsMultiTrack('DCS.dcsuri', location.pathname,'WT.ti', document.title, 'WT.z_login', '1')">
							Sign In</a><span class="pipe">|</span>
                            <a id="globalHeader_SSOHeader_hlSignup" rel="nofollow" class="register" onmousedown="dcsMultiTrack(&#39;DCS.dcsuri&#39;, location.pathname,&#39;WT.ti&#39;, document.title, &#39;WT.z_login&#39;, &#39;1&#39;)" href="https://login.ama-assn.org/account/signup?appId=scweb&amp;returnurl=http://archinte.jamanetwork.com/OAuthSignIn.aspx?return_url=http%3a%2f%2farchinte.jamanetwork.com%2farticle.aspx%3farticleid%3d485056">Create an Account</a>
					</div>
				</li>
                
            </ul>
        </div>
    </div>
</div>

<div class="errorStates">
	<div id="divOAuthError">
		<span class="errorMessageHeader">
			We're unable to sign you in at this time.  Please try again in a few minutes.
		</span>
		<div class="clearAll"></div>
		<a id="globalHeader_SSOHeader_hypRetry" class="button" rel="nofollow" href="/OAuthSignIn.aspx">Retry</a>
		
		<div class="clearAll"></div>
	</div>

	<div id="divAdvantageDownError">
		<span class="errorMessageHeader">
			We were able to sign you in, but your subscription(s) could not be found.  Please try again in a few minutes.
		</span>
		<div class="clearAll"></div>
		<a id="globalHeader_SSOHeader_hypRetry2" class="button" rel="nofollow" href="/OAuthSignIn.aspx">Retry</a>
		<div class="clearAll"></div>
	</div>
	
	<div id="divUnableToVerifyTamId">
		<span class="errorMessageHeader">
			There may be a problem with your account.  Please contact the AMA Service Center to resolve this issue.
		</span>
		<div class="contactAMA">
			<span>Contact the AMA Service Center:</span>
		</div>
		<div class="contactInfo">
			<span class="telephoneNumber">Telephone: 1 (800) 262-2350 or 1 (312) 670-7827&nbsp;&nbsp;*&nbsp;&nbsp;</span>
			<span class="emailInfo">Email:&nbsp;</span><a href="mailto:subscriptions@jamanetwork.com">subscriptions@jamanetwork.com</a>
		</div>
		<div class="clearAll"></div>
		
		<div class="additionalInfo">
			<div class="separator"></div>
			<span id="globalHeader_SSOHeader_errorMessage" class="errorMessage">Error Message ......</span>
		</div>
	</div>
	<script language="javascript" type="text/javascript">
		function showOAuthErrorDialog() {
			$('#divOAuthError').dialog({
				closeText: "X Close",
				width: 775,
				height: 125,
				title: "",
				modal: true,
				overlay: { opacity: 0.7, background: 'gray' }
			});
			$('#divOAuthError').parent().appendTo($('#Form1'));
		}

		function showAdvantageDownErrorDialog() {
			$('#divAdvantageDownError').dialog({
				closeText: "X Close",
				width: 775,
				height: 125,
				title: "",
				modal: true,
				overlay: { opacity: 0.7, background: 'gray' }
			});
			$('#divAdvantageDownError').parent().appendTo($('#Form1'));
		}

		function showConfirmUniqueIdErrorDialog() {
			$('#divUnableToVerifyTamId').dialog({
				closeText: "X Close",
				width: 775,
				height: 225,
				title: "",
				modal: true,
				overlay: { opacity: 0.7, background: 'gray' }
			});
			$('#divUnableToVerifyTamId').parent().appendTo($('#Form1'));
		}

	</script>

</div>
<div id="globalHeader_dvMastHead" class="mastHead">
    
    <div id="dvTopNav" class="topNav">
        <div class="globalNavContainer navbar clearfix">
            <div id="globalHeader_divUmbrellaNavigationBar" class="umbrellaNavBar clearfix"><ul class="nav"><li><a href="http://jamanetwork.com/index.aspx">The JAMA Network</a></li>
<li><a href="http://#">Journals</a><ul id="globalNav_Journals" class="subNav"><li><a href="http://jama.jamanetwork.com"><strong>JAMA</strong><br />The Journal of the American Medical Association</a></li><li><a href="http://archderm.jamanetwork.com">JAMA Dermatology</a></li><li><a href="http://archfaci.jamanetwork.com">JAMA Facial Plastic Surgery</a></li><li><a href="http://archinte.jamanetwork.com">JAMA Internal Medicine</a></li><li><a href="http://archneur.jamanetwork.com">JAMA Neurology</a></li><li><a href="http://oncology.jamanetwork.com">JAMA Oncology</a></li><li><a href="http://archopht.jamanetwork.com">JAMA Ophthalmology</a></li><li><a href="http://archotol.jamanetwork.com">JAMA Otolaryngology–Head & Neck Surgery</a></li><li><a href="http://archpedi.jamanetwork.com">JAMA Pediatrics</a></li><li><a href="http://archpsyc.jamanetwork.com">JAMA Psychiatry</a></li><li><a href="http://archsurg.jamanetwork.com">JAMA Surgery</a></li><li><a href="http://archneurpsyc.jamanetwork.com">Archives of Neurology & Psychiatry (1919-1959)</a></li></ul><li><a href="http://jamanetwork.com/collections.aspx">Collections</a></li>
<li><a href="http://store.jamanetwork.com/index.aspx?journalid=71" rel="nofollow">Store</a></li>
<li><a href="http://www.jamacareercenter.com/">Physician Jobs</a></li>
<li><a href="http://mobile.jamanetwork.com">About Mobile</a></li>
</ul></div>
            <div id="globalHeader_dvSearchBar" class="searchBar">
                <span id="divtextSearch2" class="searchTerm">
                    <input name="ctl00$globalHeader$txtSearchTerm2" type="text" id="txtSearchTerm2" autocomplete="off" />
                    <input type="text" id="topNavSearchInputHint" autocomplete="off" class="search-input" />
                    <ul id="topNavSearchAutoCompleteResults" class="term-list hidden"></ul>
                    <input type="hidden" name="ctl00$globalHeader$txtWaterMark2_ClientState" id="globalHeader_txtWaterMark2_ClientState" />
                </span>
                <span class="searchButton3 icon-search search-umbrella"></span>
                <input type="hidden" name="hiddenGlobalSearchSiteURL" id="hiddenGlobalSearchSiteURL" value="http://jamanetwork.com/" />
            </div>
        </div>
    </div>
    <div id="globalHeader_divMicrositeHeader" class="siteHeader navbar clearfix">
        <div class="left">
            <a id="siteLogo" class="sprite-logos ir" href="/">[JAMA Internal Medicine]</a>
        </div>
        <div id="globalHeader_divSearchSection" class="searchSection">
            <div class="searchTerm">
                <div id="divtextSearch">
                    <input type="text" name="txtSearchTerm" id="txtSearchTerm" autocomplete="off" title="Search Internal Medicine" />
                    <input type="text" id="microSiteSearchInputHint" autocomplete="off" class="search-input" />
                    <ul id="microSiteAutoCompleteResults" class="term-list hidden"></ul>

                    <input type="hidden" name="hiddenSearchTerm" id="hiddenSearchTerm" value="" />
                    <input type="hidden" name="searchBoxHintText" id="hiddenSearchBoxHintText" value="Search Internal Medicine" />
                </div>
            </div>
            <div class="searchCriteria">
                <div class="searchButton">
                    <label style="cursor: pointer">Search</label>
                    <span class="icon-search search-journal"></span>
                </div>
                <!--TE-6211 Solr Search Switch-->
                <a href="/Solr/advancedSearch.aspx" id="globalHeader_hlnkMicrositeAdvancedSearch" class="advancedSearch">Advanced<br />
                    Search</a>
                <div class="searchLink">
                    <a rel="nofollow" href="/aboutsearch.aspx">About Search</a>
                </div>
            </div>
        </div>
    </div>
    <div id="globalHeader_divMicroNavBar" class="microNavBar navbar serif clearfix"><ul><li><a href="/journal.aspx">Home</a></li>
<li><a href="/issue.aspx">Current Issue</a></li>
<li><a href="/issues.aspx">All Issues</a></li>
<li><a href="/onlineFirst.aspx">Online First</a></li>
<li><a href="/collections.aspx">Collections</a></li>
<li><a href="/cme.aspx">CME</a></li>
<li><a href="/multimedia.aspx">Multimedia</a></li>
<li><a href="/public/forauthors.aspx">For Authors</a></li>
<li><a href="http://store.jamanetwork.com/productdetails.aspx?journalID=71" rel="nofollow">Subscribe</a></li>
<li class="clearfix"></li></ul></div>
    <div id="displaypopup" class="expMsg" style="display: none;">
        <div class="cme-modal-header">You've earned it</div>
        <div class="cme-modal-text">
            <label id="globalHeader_lblNumberOfFreeCmeTokens" class="bold"></label>
            <span class="bold">free CME tokens</span>, redeemable for
            <label id="globalHeader_lblNumberOfFreeCmeCredits"></label>
            CME Credits, have been added to your personal account courtesy of The JAMA Network and
            <label id="globalHeader_lblNameOfTheSponsorInstitution"></label>
            .
        </div>
        <div class="cme-modal-link">
            <a id="lnkExploreCme" href="http://jamanetwork.com/cme.aspx">Explore CME</a>
        </div>
        <a onclick="$(this).parent().dialog('close');">Close Window</a>
        <a onclick="$(this).parent().dialog('close');" id="fancybox-close1"></a>
    </div>

    <!--TE-6211 Solr Search Switch-->

    <input name="ctl00$globalHeader$hfIsSolrSearchEnabled" type="hidden" id="hfIsSolrSearchEnabled" value="1" />
    <input name="ctl00$globalHeader$hfSolrJournalID" type="hidden" id="hfSolrJournalID" value="J71" />
    <input name="ctl00$globalHeader$hfSolrJournalName" type="hidden" id="hfSolrJournalName" value="JAMA Internal Medicine" />
    <input name="ctl00$globalHeader$hfSolrMaxAllowSearchChar" type="hidden" id="hfSolrMaxAllowSearchChar" value="255" />
    <input name="ctl00$globalHeader$hfSolrAutoSuggestMinimumCharactersLength" type="hidden" id="hfSolrAutoSuggestMinimumCharactersLength" value="2" />
    <input name="ctl00$globalHeader$hfNewPdfAccessMode" type="hidden" id="hfNewPdfAccessMode" value="True" />
    <input name="ctl00$globalHeader$hfFreeCme" type="hidden" id="hfFreeCme" value="0" />

    <script type="text/javascript">
        $(document).ready(function () {
            if ($('#hfFreeCme').val() > 0) {
                displayGrantedCmeTokenAlert();
            }
            $(".ui-dialog-titlebar.ui-widget-header.ui-corner-all.ui-helper-clearfix").hide();
        });

        function displayGrantedCmeTokenAlert() {
            $("#displaypopup").dialog({
                position: 'center',
                modal: true,
                width: 525,
                dialogClass: 'boxshadow',
                closeOnEscape: false,
                close: function (evnt, args) {
                }
            });

        }


    </script>
</div>

                
    <input type="hidden" name="ctl00$scm6MainContent$hfArticleId" id="hfArticleId" value="485056" />
    <input type="hidden" name="ctl00$scm6MainContent$hfPersonalUserLoggedIn" id="hfPersonalUserLoggedIn" />
    <input type="hidden" name="ctl00$scm6MainContent$hfPersonalUserOrInstUser" id="hfPersonalUserOrInstUser" value="0" />
    <input type="hidden" name="ctl00$scm6MainContent$hfRedirectURLForMyPOLFiguresAndTables" id="hfRedirectURLForMyPOLFiguresAndTables" value="signinpopup.aspx?alerts=true&amp;RedirectURL=~/article.aspx?articleid=485056" />
    <input type="hidden" name="ctl00$scm6MainContent$hfDataSupplement" id="hfDataSupplement" value="1" />   
    <div itemscope itemtype='http://schema.org/Article'><meta itemprop='inLanguage' content='en-US'/><meta itemprop='name headline' content='The Challenge of Drug-Induced Aseptic Meningitis' /><meta itemprop='description' content='Several drugs can induce the development of aseptic meningitis. Drug-induced aseptic meningitis (DIAM) can mimic an infectious process as well as meningitides that are secondary to systemic disorders for which these drugs are used. Thus, DIAM constitutes a diagnostic and patient management challenge. Cases of DIAM were reviewed through a ...'/><meta itemprop='author' content='German Moris, MD' /><meta itemprop='url' content='http://jamanetwork.com/article.aspx?articleid=485056' /><meta datetime='1999-06-14' itemprop='datePublished' content='1999-06-14' /><meta itemprop='image' content='http://amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t1.png' /><meta itemprop='image' content='http://amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t2.png' /><meta itemprop='image' content='http://amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t3.png' /><meta itemprop='image' content='http://amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t4.png' /><meta itemprop='image' content='http://amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t5.png' /><meta itemprop='articleSection' content='CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM' /><meta itemprop='articleSection' content='UNDERLYING CONDITIONS IN PATIENTS WITH DIAM' /><meta itemprop='articleSection' content='RECURRENT DIAM' /><meta itemprop='articleSection' content='DIFFERENTIAL DIAGNOSIS' /><meta itemprop='articleSection' content='PATHOGENESIS' /><meta itemprop='articleSection' content='NSAID-INDUCED MENINGITIS' /><meta itemprop='articleSection' content='ANTIBIOTIC-INDUCED MENINGITIS' /><meta itemprop='articleSection' content='IMMUNOGLOBULIN-INDUCED MENINGITIS' /><meta itemprop='articleSection' content='OKT3 ANTIBODY-INDUCED MENINGITIS' /><meta itemprop='articleSection' content='OTHER AGENTS ASSOCIATED WITH DIAM' /><meta itemprop='articleSection' content='References' /><meta itemprop='keywords' content='antibiotics,muromonab-cd3,aseptic meningitis,meningitis,anti-inflammatory agents, non-steroidal,recombinant colony-stimulating factors' /></div>
    
    <div class="wrapper">
        <a id="triggerJumpLocation"></a>
        <div class="mainContainer clearfix">
            <!-- AddThis Button BEGIN -->
            <div class="stickyContent">
                <div class="addthis_toolbox addthis_floating_style addthis_32x32_style">
                    <a class="addthis_button_twitter" target="_blank"></a>
                    <a class="addthis_button_facebook" target="_blank"></a>
                    <a class="addthis_button_citeulike" target="_blank"></a>
                    <a class="addthis_button_google_plusone_share" target="_blank"></a>
                    <a class="addthis_button_compact"></a>
                </div>
            </div>
            <!-- AddThis Button END -->
            <div class="pageHeaderContentHolder">
                <div class="siteVolume">
                    <a id="scm6MainContent_lnkFullIssueName" href="issue.aspx?journalid=71&amp;issueid=11945">June 14, 1999, Vol 159, No. 11</a>
                    >
                </div>
            </div>
            <div class="left contentColumn eqColumn">
                <div class="contentHeaderContainer" style="background: #fff;">
                    <div class="contentPageHeader">
                        <div class="articleNavLinks clearfix">
                            <div>
                                
                            </div>
                            <div class="pageJump">
                                <a id="scm6MainContent_lnkPrev" class="prev" href="/article.aspx?articleid=485057">&lt;&#160;Previous Article</a>
                                
                                <a id="scm6MainContent_lnkNext" class="next" href="/article.aspx?articleid=485049">Next Article&#160;&gt;</a>
                            </div>
                        </div>
                    </div>
                    <div class="contentSection">
                        <span id="scm6MainContent_lblArticleType" class="articleType">Review Article</span>
                        <span class="separator">|</span>
                         <span class="contentDate">
                            <span id="scm6MainContent_lblArticleDate"><span class="epub"><span class="month">June </span><span class="day">14, </span><span class="year">1999</span></span></span>
                        </span>
                        <span id="lblSuperClass"></span>
                    </div>

                    <h1 class="aTitle">
                        <span id="scm6MainContent_lblArticleTitle">The Challenge of Drug-Induced Aseptic Meningitis</span>
                        
                        <span id="scm6MainContent_lblFreeArticle" class="flag freeArticle">FREE</span>
                        
                        
                    </h1>
                    <div id="scm6MainContent_dvAuthorSection" class="authorSection sans">
                        <span id="scm6MainContent_lblAuthors" class="authorNames">German Moris, MD; Juan Carlos Garcia-Monco, MD</span>
                    </div>
                    <div id="scm6MainContent_divDisclosures" class="disclosures">
                        <a href="#" class="disclosureLink special">[<span class="spanPlus">+</span><span style="display: none;" class="spanMinus">-</span>] Author Affiliations</a>
                        <div id="scm6MainContent_DisclosureAndother" class="disclosureText">
                            
                            
                            <div id="scm6MainContent_divAuthorNotes">
                                
                                        <p class="para">From the Department of Neurology, Hospital Universitario Marqués de Valdecilla, Santander, Spain (Dr Moris); and the Department of Neurology, Hospital de Galdacano, Vizcaya, Spain (Dr Garcia-Monco).</p>
                                    
                                <br />
                            </div>
                            
                            
                            
                        </div>
                    </div>
                    <div class="doi clearfix">
                        <div class="left aShortDesc">
                            <span id="scm6MainContent_lblClientName"><i>Arch Intern Med. </i>1999;159(11):1185-1194. doi:10.1001/archinte.159.11.1185. </span>
                        </div>
                        <div class="textSize">
                            Text Size: <a id="text1" href="#" class="selected" onclick="return false;">A</a> <a href="#" id="text2" onclick="return false;">A</a> <a href="#" id="text3" onclick="return false;">A</a>
                        </div>
                    </div>
                    
                <div class="articleLinks">
                    
                    
                    
                    
                    
                    
                </div>

                    <div id="ePrePrintDate">
                        Published online
                    </div>
                    <div class="highlighted">
                        
                    </div>
                    <div id="scm6MainContent_divTabAccessState" style="display: none;">
                    </div>
                    <div class="atabs">
                        <div class="tabNav clearfix">
                            <div class="atab tab1Div">
                                <a href="#tab1" id="scm6MainContent_ArticleTab" class="tabtracking" name="CanAccess">Article</a>
                            </div>
                            <div class="atab tab2Div">
                                
                            </div>
                            <div class="atab tab3Div">
                                
                            </div>
                            <div class="atab tab4Div">
                                <a href="#tab4" id="scm6MainContent_Tabletab" class="tabtracking" name="CanAccess">Tables</a>
                            </div>
                            <div class="atab tab5Div">
                                
                            </div>
                            <div class="atab tab12Div">
                                
                            </div>
                            <div class="atab tab6Div">
                                <a href="#tab6" id="scm6MainContent_reftab" class="tabtracking" name="CanAccess">References</a>
                            </div>
                            <div class="atab tab7Div">
                                
                            </div>
                            <div class="atab tab10Div">
                                <a href="#tab10" id="scm6MainContent_Commenttab" class="tabtracking" name="CanAccess">
                                    <span id="scm6MainContent_lblCommentsTab">Comments</span>
                                </a>
                            </div>
                            <div class="atab tab8Div">
                                
                            </div>
                            <div class="atab tab9Div">
                                
                            </div>
                            
                        </div>
                        <div class="clearAll">
                        </div>
                    </div>
                </div>
                <div class="contentBodyContainer">
                    <div class="contentContainer" id="tab1">
                        
                        
                        <span id="scm6MainContent_lblExtract"></span>
                        
        
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_0" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_0" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_0"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_0" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_0" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_0" class="PubHistory 0"><p class="para"></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_1" class="jumpLinkAnchor" name="Abstract"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_1" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_1">ABSTRACT</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_1" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_1" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_1" class="next" href="#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_1" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_1" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_1" class="Abstract 0"><p class="para">Several drugs can induce the development of aseptic meningitis. Drug-induced aseptic meningitis (DIAM) can mimic an infectious process as well as meningitides that are secondary to systemic disorders for which these drugs are used. Thus, DIAM constitutes a diagnostic and patient management challenge. Cases of DIAM were reviewed through a MEDLINE literature search (up to June 1998) to identify possible clinical and laboratory characteristics that would be helpful in distinguishing DIAM from other forms of meningitis or in identifying a specific drug as the culprit of DIAM. Our review showed that nonsteroidal anti-inflammatory drugs (NSAIDs), antibiotics, intravenous immunoglobulins, and OKT3 antibodies (monoclonal antibodies against the T3 receptor) are the most frequent cause of DIAM. Resolution occurs several days after drug discontinuation and the clinical and cerebrospinal fluid profile (neutrophilic pleocytosis) do not allow DIAM to be distinguished from infectious meningitis. Nor are there any specific characteristics associated with a specific drug. Systemic lupus erythematosus seems to predispose to NSAID-related meningitis. We conclude that a thorough history on prior drug intake must be conducted in every case of meningitis, with special focus on those aforementioned drugs. If there is a suspicion of DIAM, a third-generation cephalosporin seems a reasonable treatment option until cerebrospinal fluid cultures are available.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_2" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_2" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_2"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_2" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_2" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_2" class="Paragraph 0"><p class="para">Several drugs can induce meningitis, resulting in a diagnostic and therapeutic challenge. The situation becomes more complex if the offending drug is an antibiotic, where the decision of withdrawing the drug needs to be weighed against the risk of missing the treatment of an underlying infectious disorder. Furthermore, these drugs are often used to treat disorders that in turn may cause meningitis. Therefore, physicians should be aware of this possibility and a careful drug history should be obtained in every case of meningitis that could obviate inappropriate therapies, such as prolonged antimicrobial therapy or high-dose steroids.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_3" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_3" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_3"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_3" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_3" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_3" class="Paragraph 0"><p class="para">The incidence of drug-induced meningitis is unknown. Recent series have allowed for an approximation to the extent of the problem. Four groups of drugs have been associated with drug-induced aseptic meningitis (DIAM) (<a href="#ira80415t1" class="tablink">Table 1</a>): nonsteroidal anti-inflammatory drugs (NSAIDs),<sup><a href="#ref-ira80415-1" class="reflink">1</a></sup><sup>- <a href="#ref-ira80415-1" class="reflink">42</a></sup> antibiotics,<sup><a href="#ref-ira80415-43" class="reflink">43</a></sup><sup>- <a href="#ref-ira80415-43" class="reflink">73</a></sup> intravenous immunoglobulins (IVIGs),<sup><a href="#ref-ira80415-74" class="reflink">74</a></sup><sup>- <a href="#ref-ira80415-74" class="reflink">99</a></sup> and OKT3 monoclonal antibodies (directed against the T3 receptor and, therefore, pan T-cell antibodies).<sup><a href="#ref-ira80415-100" class="reflink">100</a></sup><sup>- <a href="#ref-ira80415-100" class="reflink">119</a></sup> These drugs are frequently prescribed by different specialists (rheumatologists, neurologists, internists, etc), who should be aware of this problem. The internal medicine literature, however, lacks a review on this topic. Thus, our purpose was to review critically those published cases of meningitis associated with the use of drugs. We have compared the characteristics associated with the different drugs to see if differences exist among them so as to suggest a specific drug as the culprit of the disorder and to distinguish it from other types of meningitides.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_4" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_4" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_4"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_4" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_4" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_4" class="Table 0"><a name="ira80415t1"><span style="display:none;">Table Graphic Jump Location</span></a><span class="figureLabel">Table 1.</span> <span class="figureCaption"><span class="figureCaption">Drugs Involved in Drug-Induced Aseptic Meningitis*</span></span><div class="inlineFigureImage"><span class="enlargeImage"><a class="btnImageEnlarger"><span style="display:none;">+</span></a></span><span class="inlineFigureImageContainer"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/s_ira80415t1.png" alt="Image not available." class="contentFigures lazy" /></span><div class="figureLinks"><a class="popUpTable">View Large</a>  | 
    <a class="saveMyStuffs" id="26751640" onclick="addtoMyStuffs(this);">Save Table</a>  | 
    <a rel="nofollow" href="DownloadImage.aspx?image=/data/Journals/INTEMED/11945/ira80415t1.png&sec=26751640&ar=485056&sectionType=1&imagename=" class="downloadSlide">Download Slide (.ppt)</a><span class="viewInContext">
       | 
      <a href="#ira80415t1" class="special">View in Article Context</a></span><div class="tableDialog"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t1.png" alt="Image not available." class="contentFigures lazy" /></div></div></div></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_5" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_5" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_5"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_5" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_5" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_5" class="Paragraph 0"><p class="para">Using the MEDLINE database, we searched the literature up to June 1998 and have included only those cases that specified the cerebrospinal fluid (CSF) findings and provided sufficient information to exclude other causes. We only included cases that met the following criteria: a temporal relationship with the drug intake, CSF pleocytosis (&gt;5 cells/mm<sup>3</sup>) and negative cultures, absence of any other explanation for the meningitis, and the resolution of the syndrome on drug withdrawal. We discarded cases with normal or absent CSF parameters (2 cases each by Sekul and colleagues<sup><a href="#ref-ira80415-82" class="reflink">82</a></sup>) as well as a case of pachymeningitis associated with penicillin therapy<sup><a href="#ref-ira80415-120" class="reflink">120</a></sup> and 1 case of myelopathy and brainstem dysfunction with CSF pleocytosis after trimethoprim-sulfamethoxazole administration suggestive of systemic lupus erythematosus (SLE) exacerbation (case 2).<sup><a href="#ref-ira80415-55" class="reflink">55</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_6" class="jumpLinkAnchor" name="CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_6" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_6">CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_6" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_6" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_6" class="prev" href="#Abstract"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_6" class="next" href="#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_6" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_6" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_6" class="Section 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_7" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_7" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_7"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_7" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_7" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_7" class="Paragraph 26751642"><p class="para">The vast majority of patients with DIAM, irrespective of the offending drug, presented with headache, fever, meningismus, and changes in mental status (<a href="#ira80415t2" class="tablink">Table 2</a>). This is also characteristic of infectious meningitis,<sup><a href="#ref-ira80415-121" class="reflink">121</a></sup> and, therefore, the clinical presentation does not help in differentiating DIAM from infectious meningitis. Other findings less frequently reported included rash, arthralgias, myalgias, facial edema, and lymph node or liver test abnormalities, which can also occur in infectious meningitis, mainly of viral origin, with variable frequency.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_8" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_8" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_8"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_8" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_8" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_8" class="Table 26751642"><a name="ira80415t2"><span style="display:none;">Table Graphic Jump Location</span></a><span class="figureLabel">Table 2.</span> <span class="figureCaption"><span class="figureCaption">Clinical Signs and Symptoms of Patients With Drug-Induced Aseptic Meningitis*</span></span><div class="inlineFigureImage"><span class="enlargeImage"><a class="btnImageEnlarger"><span style="display:none;">+</span></a></span><span class="inlineFigureImageContainer"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/s_ira80415t2.png" alt="Image not available." class="contentFigures lazy" /></span><div class="figureLinks"><a class="popUpTable">View Large</a>  | 
    <a class="saveMyStuffs" id="26751644" onclick="addtoMyStuffs(this);">Save Table</a>  | 
    <a rel="nofollow" href="DownloadImage.aspx?image=/data/Journals/INTEMED/11945/ira80415t2.png&sec=26751644&ar=485056&sectionType=1&imagename=" class="downloadSlide">Download Slide (.ppt)</a><span class="viewInContext">
       | 
      <a href="#ira80415t2" class="special">View in Article Context</a></span><div class="tableDialog"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t2.png" alt="Image not available." class="contentFigures lazy" /></div></div></div></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_9" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_9" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_9"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_9" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_9" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_9" class="Paragraph 26751642"><p class="para">There are statistically significant differences in the presentation of the meningitides induced by the different drugs, but these involve nonspecific symptoms that may be accounted for by differences in data collection. For instance, patients in the OKT3 monoclonal antibody group had less vomiting and meningismus and those in the antibiotic group had more abnormalities of consciousness, but we do not believe that these data differentiate or suggest a specific drug as the culprit. Overall, seizures were recorded in 7% to 16% of the patients. Although it is well known that some antibiotics can cause seizures,<sup><a href="#ref-ira80415-122" class="reflink">122</a></sup> in this case they cannot be attributed to the drugs, since they also appear in up to 20% of patients with bacterial meningitis irrespective of therapy.<sup><a href="#ref-ira80415-121" class="reflink">121</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_10" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_10" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_10"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_10" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_10" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_10" class="Paragraph 26751642"><p class="para">The interval between drug intake and the development of meningitis varies between several minutes and 4 months for all patients in the drug groups and prior exposure to the drug is present in 45% of patients taking NSAIDs; antibiotics and IVIGs, 35%; and OKT3, 3% (<a href="#ira80415t1" class="tablink">Table 1</a>). This rate of prior exposure can be anticipated considering the high frequency with which NSAIDs and antibiotics are prescribed and that IVIGs are usually used periodically to treat recurrent disorders such as idiopathic thrombocytopenic purpura. On the contrary, OKT3 antibodies are used for cases of transplant rejection, which gives the patient little opportunity for prior exposure. There was no relation between the development of DIAM and the dose of the drug used, which was always within the recommended therapeutic range.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_11" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_11" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_11"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_11" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_11" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_11" class="Paragraph 26751642"><p class="para">The CSF of patients with DIAM typically shows pleocytosis of several hundred to several thousand cells per cubic millimeter, normal-to-low glucose values, and increased protein values (<a href="#ira80415t3" class="tablink">Table 3</a>). The number of cells was significantly lower in the OKT3 group (<i>P</i>=.01, Kruskal-Wallis analysis of variance [ANOVA]) than in the other 3 groups. The protein values were significantly lower in the IVIG and OKT3 groups compared with the other 2 groups (<i>P</i>=.01, Kruskal-Wallis ANOVA). Characteristically, neutrophils predominate, with a percentage more than the total cell count that varies between an average of 57% in OKT3 and 78% in IVIG. Eosinophils were noted in 9 patients: 2 patients from the NSAIDs group (between 13% and 60% of the total cell count),<sup><a href="#ref-ira80415-8" class="reflink">8</a></sup><sup>,<a href="#ref-ira80415-41" class="reflink">41</a></sup> 3 from the antibiotic group (2% and 24%, respectively; no counts were given in the third case),<sup><a href="#ref-ira80415-51" class="reflink">51</a></sup><sup>,<a href="#ref-ira80415-61" class="reflink">61</a></sup><sup>,<a href="#ref-ira80415-69" class="reflink">69</a></sup> and 4 in IVIG (1%, 3%, 3%, and 100%, respectively).<sup><a href="#ref-ira80415-82" class="reflink">82</a></sup><sup>,<a href="#ref-ira80415-97" class="reflink">97</a></sup> The degree of pleocytosis correlated directly with the severity of fever and inversely with the interval from drug exposure in a series of OKT3-associated DIAM, but neither association reached statistical significance.<sup><a href="#ref-ira80415-110" class="reflink">110</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_12" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_12" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_12"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_12" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_12" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_12" class="Table 26751642"><a name="ira80415t3"><span style="display:none;">Table Graphic Jump Location</span></a><span class="figureLabel">Table 3.</span> <span class="figureCaption"><span class="figureCaption">CSF Characteristics of Patients With Drug-Induced Aseptic Meningitis*</span></span><div class="inlineFigureImage"><span class="enlargeImage"><a class="btnImageEnlarger"><span style="display:none;">+</span></a></span><span class="inlineFigureImageContainer"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/s_ira80415t3.png" alt="Image not available." class="contentFigures lazy" /></span><div class="figureLinks"><a class="popUpTable">View Large</a>  | 
    <a class="saveMyStuffs" id="26751648" onclick="addtoMyStuffs(this);">Save Table</a>  | 
    <a rel="nofollow" href="DownloadImage.aspx?image=/data/Journals/INTEMED/11945/ira80415t3.png&sec=26751648&ar=485056&sectionType=1&imagename=" class="downloadSlide">Download Slide (.ppt)</a><span class="viewInContext">
       | 
      <a href="#ira80415t3" class="special">View in Article Context</a></span><div class="tableDialog"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t3.png" alt="Image not available." class="contentFigures lazy" /></div></div></div></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_13" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_13" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_13"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_13" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_13" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_13" class="Paragraph 26751642"><p class="para">When performed, neuroimaging was normal in all patients except for 2 with NSAID-induced DIAM where diffuse contrast hemispheric enhancement was evident (by magnetic resonance imaging [MRI] in one case and by computed tomographic [CT] scan in the other), probably reflecting a blood-brain barrier breakdown.<sup><a href="#ref-ira80415-24" class="reflink">24</a></sup><sup>,<a href="#ref-ira80415-37" class="reflink">37</a></sup> In 2 additional patients with antibiotic-related meningitis, MRI showed bilateral supratentorial white matter T<sub>2</sub>-signal abnormalities without gadolinium enhancement with complete resolution in several months.<sup><a href="#ref-ira80415-58" class="reflink">58</a></sup> Neuroimaging was performed in 8 patients with OKT3-associated DIAM and was abnormal in 3: a patient showed cerebral edema on brain CT scan<sup><a href="#ref-ira80415-109" class="reflink">109</a></sup> and MRI disclosed high intensities on T<sub>2</sub>-weighted sequences in 2 additional patients that disappeared in 10 days.<sup><a href="#ref-ira80415-113" class="reflink">113</a></sup><sup>,<a href="#ref-ira80415-114" class="reflink">114</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_14" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_14" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_14"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_14" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_14" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_14" class="Paragraph 26751642"><p class="para">The outcome was always excellent provided that the offending drug was withdrawn, with complete recovery in all cases. In the case of OKT3, it resolved even without withdrawal in 45% of the patients.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_15" class="jumpLinkAnchor" name="UNDERLYINGCONDITIONSINPATIENTSWITHDIAM"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_15" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_15">UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_15" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_15" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_15" class="prev" href="#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_15" class="next" href="#RECURRENTDIAM"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_15" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_15" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_15" class="Section 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_16" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_16" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_16"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_16" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_16" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_16" class="Paragraph 26751651"><p class="para">Systemic lupus erythematosus stands as the single most frequent underlying condition associated with DIAM (<a href="#ira80415t4" class="tablink">Table 4</a>). We pooled and analyzed the clinical and CSF profiles of this group of patients to see if they shared any special or distinctive characteristic. The predominance of females was marked (90%), as expected for SLE, but there were no other obvious indicators (<a href="#ira80415t1" class="tablink">Table 1</a>, <a href="#ira80415t2" class="tablink">Table 2</a>, and <a href="#ira80415t4" class="tablink">Table 4</a>).</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_17" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_17" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_17"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_17" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_17" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_17" class="Table 26751651"><a name="ira80415t4"><span style="display:none;">Table Graphic Jump Location</span></a><span class="figureLabel">Table 4.</span> <span class="figureCaption"><span class="figureCaption">Underlying Disorder in Patients With Drug-Induced Aseptic Meningitis*</span></span><div class="inlineFigureImage"><span class="enlargeImage"><a class="btnImageEnlarger"><span style="display:none;">+</span></a></span><span class="inlineFigureImageContainer"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/s_ira80415t4.png" alt="Image not available." class="contentFigures lazy" /></span><div class="figureLinks"><a class="popUpTable">View Large</a>  | 
    <a class="saveMyStuffs" id="26751653" onclick="addtoMyStuffs(this);">Save Table</a>  | 
    <a rel="nofollow" href="DownloadImage.aspx?image=/data/Journals/INTEMED/11945/ira80415t4.png&sec=26751653&ar=485056&sectionType=1&imagename=" class="downloadSlide">Download Slide (.ppt)</a><span class="viewInContext">
       | 
      <a href="#ira80415t4" class="special">View in Article Context</a></span><div class="tableDialog"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t4.png" alt="Image not available." class="contentFigures lazy" /></div></div></div></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_18" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_18" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_18"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_18" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_18" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_18" class="Paragraph 26751651"><p class="para">Although migraine has been suggested as a predisposing condition to DIAM and reported in several patients,<sup><a href="#ref-ira80415-10" class="reflink">10</a></sup><sup>,<a href="#ref-ira80415-12" class="reflink">12</a></sup><sup>,<a href="#ref-ira80415-34" class="reflink">34</a></sup><sup>,<a href="#ref-ira80415-49" class="reflink">49</a></sup><sup>,<a href="#ref-ira80415-82" class="reflink">82</a></sup><sup>,<a href="#ref-ira80415-98" class="reflink">98</a></sup> the retrospective analysis of these heterogeneous case reports does not allow for the determination of the exact prevalence of prior, potentially predisposing conditions such as migraine. To further complicate matters, the high prevalence of migraine in healthy populations (6%-12%)<sup><a href="#ref-ira80415-123" class="reflink">123</a></sup> and its even higher prevalence in populations also prone to DIAM, such as patients with SLE, should be considered.<sup><a href="#ref-ira80415-124" class="reflink">124</a></sup><sup>,<a href="#ref-ira80415-125" class="reflink">125</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_19" class="jumpLinkAnchor" name="RECURRENTDIAM"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_19" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_19">RECURRENT DIAM</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_19" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_19" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_19" class="prev" href="#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_19" class="next" href="#DIFFERENTIALDIAGNOSIS"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_19" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_19" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_19" class="Section 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_20" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_20" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_20"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_20" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_20" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_20" class="Paragraph 26751655"><p class="para">We found 29 patients with recurrent DIAM, totaling 71 episodes, and analyzed their clinical and CSF characteristics (<a href="#ira80415t5" class="tablink">Table 5</a>). In 8 patients, meningitis was associated with NSAIDs<sup><a href="#ref-ira80415-1" class="reflink">1</a></sup><sup>- <a href="#ref-ira80415-1" class="reflink">3</a>,<a href="#ref-ira80415-12" class="reflink">12</a></sup><sup>,<a href="#ref-ira80415-18" class="reflink">18</a></sup><sup>,<a href="#ref-ira80415-21" class="reflink">21</a></sup><sup>,<a href="#ref-ira80415-35" class="reflink">35</a></sup><sup>,<a href="#ref-ira80415-41" class="reflink">41</a></sup> (18 episodes), with antibiotics in 18 patients<sup><a href="#ref-ira80415-43" class="reflink">43</a></sup><sup>,<a href="#ref-ira80415-45" class="reflink">45</a></sup><sup>- <a href="#ref-ira80415-45" class="reflink">50</a>,<a href="#ref-ira80415-55" class="reflink">55</a></sup><sup>- <a href="#ref-ira80415-55" class="reflink">57</a>,<a href="#ref-ira80415-62" class="reflink">62</a></sup><sup>- <a href="#ref-ira80415-62" class="reflink">65</a>,<a href="#ref-ira80415-72" class="reflink">72</a></sup> (47 episodes), with OKT3 in 1<sup><a href="#ref-ira80415-115" class="reflink">115</a></sup> (2 episodes), and with IVIGs in 2<sup><a href="#ref-ira80415-74" class="reflink">74</a></sup><sup>,<a href="#ref-ira80415-84" class="reflink">84</a></sup> (4 episodes). The highest number of episodes<sup><a href="#ref-ira80415-48" class="reflink">48</a></sup> reported in a single patient was 5, but we have only analyzed the first 3 episodes due to the low number of patients with more episodes and to the lack of information on fourth and fifth episodes. Overall, there was a female predominance (81%) with a mean age of 40 ± 22 years (range, 2-82 years). There was an underlying disorder in 18 (59%) patients, with SLE being the most frequent (8 patients),<sup><a href="#ref-ira80415-1" class="reflink">1</a></sup><sup>- <a href="#ref-ira80415-1" class="reflink">3</a>,<a href="#ref-ira80415-12" class="reflink">12</a></sup><sup>,<a href="#ref-ira80415-40" class="reflink">40</a></sup><sup>,<a href="#ref-ira80415-46" class="reflink">46</a></sup><sup>,<a href="#ref-ira80415-63" class="reflink">63</a></sup> followed by Sjögren syndrome (2 patients),<sup><a href="#ref-ira80415-62" class="reflink">62</a></sup><sup>,<a href="#ref-ira80415-63" class="reflink">63</a></sup> idiopathic thrombocytopenic purpura (2 patients),<sup><a href="#ref-ira80415-74" class="reflink">74</a></sup><sup>,<a href="#ref-ira80415-84" class="reflink">84</a></sup> rheumatoid arthritis (1 patient),<sup><a href="#ref-ira80415-48" class="reflink">48</a></sup> human immunodeficiency virus (2 patients),<sup><a href="#ref-ira80415-57" class="reflink">57</a></sup><sup>,<a href="#ref-ira80415-65" class="reflink">65</a></sup> Crohn disease (1 patient),<sup><a href="#ref-ira80415-49" class="reflink">49</a></sup> undifferentiated connective tissue disease (1 patient),<sup><a href="#ref-ira80415-21" class="reflink">21</a></sup> and positive rheumatoid factor and SS-A antigen (1 patient).<sup><a href="#ref-ira80415-18" class="reflink">18</a></sup> Cerebrospinal fluid analysis of these episodes revealed a polymorphonuclear pleocytosis that tended (did not reach statistical significance) to be more pronounced with subsequent episodes. A significant increase in protein content during the second and third episodes in relation to the first one (<i>P</i>=.005, Kruskal-Wallis ANOVA) was also noted. There was no change in the differential cell count or in the glucose contents. The latency from exposure to the drug and the recovery rate was also similar among the different episodes.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_21" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_21" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_21"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_21" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_21" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_21" class="Table 26751655"><a name="ira80415t5"><span style="display:none;">Table Graphic Jump Location</span></a><span class="figureLabel">Table 5.</span> <span class="figureCaption"><span class="figureCaption">CSF Characteristics in Recurrent Episodes of Drug-Induced Aseptic Meningitis*</span></span><div class="inlineFigureImage"><span class="enlargeImage"><a class="btnImageEnlarger"><span style="display:none;">+</span></a></span><span class="inlineFigureImageContainer"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/s_ira80415t5.png" alt="Image not available." class="contentFigures lazy" /></span><div class="figureLinks"><a class="popUpTable">View Large</a>  | 
    <a class="saveMyStuffs" id="26751657" onclick="addtoMyStuffs(this);">Save Table</a>  | 
    <a rel="nofollow" href="DownloadImage.aspx?image=/data/Journals/INTEMED/11945/ira80415t5.png&sec=26751657&ar=485056&sectionType=1&imagename=" class="downloadSlide">Download Slide (.ppt)</a><span class="viewInContext">
       | 
      <a href="#ira80415t5" class="special">View in Article Context</a></span><div class="tableDialog"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t5.png" alt="Image not available." class="contentFigures lazy" /></div></div></div></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_22" class="jumpLinkAnchor" name="DIFFERENTIALDIAGNOSIS"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_22" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_22">DIFFERENTIAL DIAGNOSIS</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_22" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_22" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_22" class="prev" href="#RECURRENTDIAM"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_22" class="next" href="#PATHOGENESIS"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_22" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_22" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_22" class="Section 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_23" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_23" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_23"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_23" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_23" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_23" class="Paragraph 26751658"><p class="para">The differential diagnosis of DIAM is broad and includes infectious causes. A meningeal syndrome accompanied by CSF neutrophilic pleocytosis suggests acute bacterial meningitis, which needs to be ruled out by CSF culture. More than 85% of the patients with bacterial meningitis present with fever, headache, meningismus, and signs of cerebral dysfunction (ie, confusion, delirium, or a declining level of consciousness ranging from lethargy to coma).<sup><a href="#ref-ira80415-126" class="reflink">126</a></sup><sup>,<a href="#ref-ira80415-127" class="reflink">127</a></sup> Therefore, distinction on clinical grounds alone is not possible.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_24" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_24" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_24"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_24" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_24" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_24" class="Paragraph 26751658"><p class="para">Even more problematic is the case of a patient treated with an antibiotic who develops meningitis and in whom the possibility of a partially treated meningitis should be considered first but needs to be separated from an antibiotic-related DIAM. Again, these entities cannot be distinguished on clinical and CSF grounds alone. Of help may be to consider the type of antibiotic, since DIAM is mainly caused by certain antibiotics (<a href="#ira80415t1" class="tablink">Table 1</a>) In cases where bacterial meningitis is a possibility, we suggest the patient be treated with third-generation cephalosporins, which are known to cause DIAM only exceptionally<sup><a href="#ref-ira80415-72" class="reflink">72</a></sup> and that would be active against the most frequent organisms in a healthy individual until the appropriate CSF studies are available. Although corticosteroids have been used in several patients, their effectiveness in DIAM has not been proven and therefore cannot be recommended routinely.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_25" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_25" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_25"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_25" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_25" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_25" class="Paragraph 26751658"><p class="para">Since recovery on drug discontinuation is the rule, chronic infectious meningitis (tuberculous, fungal, etc) would only rarely pose a diagnostic problem. If such is the case, appropriate CSF studies (culture in appropriate media and adequate stains) will be necessary. Meningitis due to parasites may need to be ruled out in those cases with CSF eosinophilia that occur in the appropriate epidemiological context.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_26" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_26" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_26"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_26" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_26" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_26" class="Paragraph 26751658"><p class="para">Viral aseptic meningitis is another important consideration in terms of frequency, although less critical in terms of prognosis and management. Clinically, it is marked by fever (76%-100%), nuchal rigidity, and headache that may be accompanied by vomiting, rash, diarrhea, pharyngitis, arthralgias, and myalgias.<sup><a href="#ref-ira80415-128" class="reflink">128</a></sup> Neutrophils may occasionally dominate the CSF profile early in the infection, although there is usually a shift to lymphocytic predominance during the first 48 hours. Cerebrospinal fluid glucose levels are usually normal. Again, clinical and CSF overlapping with DIAM may occur. It could also be argued whether certain cases of DIAM would in fact correspond to viral meningitis considering the difficulty of making a definitive diagnosis in viral infections. Polymerase chain reaction could have been of help in elucidating a possible viral origin,<sup><a href="#ref-ira80415-129" class="reflink">129</a></sup> but this information was not available in any of the reported cases, since most of them predate the use of polymerase chain reaction. In any case, the time to recovery after drug withdrawal may be of help, since it is rapid in DIAM (1-5 days) but usually takes 10 to 14 days in viral meningitis.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_27" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_27" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_27"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_27" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_27" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_27" class="Paragraph 26751658"><p class="para">Many other noninfectious causes of aseptic meningitis exist, an important fact considering that many patients with DIAM harbor underlying systemic disorders that may cause meningitis and that can also predispose them to neurologic infections by diverse organisms. In the setting of SLE, DIAM needs to be specifically distinguished from lupus aseptic meningitis. Although signs of meningeal inflammation are present at autopsy in 18% of patients with SLE,<sup><a href="#ref-ira80415-130" class="reflink">130</a></sup> aseptic meningitis is infrequently diagnosed, since the clinical presentation can be overwhelmed by other neuropsychiatric manifestations. Unlike DIAM, the cellular infiltrate of the CSF in lupus meningitis is usually lymphocytic (&lt;50 cells) and is accompanied by other data consistent with a lupus flare-up.<sup><a href="#ref-ira80415-131" class="reflink">131</a></sup><sup>,<a href="#ref-ira80415-132" class="reflink">132</a></sup> In turn, DIAM could mimic a drug-induced exacerbation in SLE if accompanied by systemic manifestations. The rapid onset and resolution of the signs and symptoms as well as the lack of data of SLE activity, especially a fall in serum complement levels, argue against an exacerbation of SLE.<sup><a href="#ref-ira80415-1" class="reflink">1</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_28" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_28" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_28"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_28" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_28" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_28" class="Paragraph 26751658"><p class="para">Antibiotics are probably underrecognized as etiologic agents of meningitis and must be considered also in the differential diagnosis of recurrent meningitis, particularly in relation to anatomical skull defects, parameningeal infectious foci, immunodeficiencies, and Mollaret meningitis.<sup><a href="#ref-ira80415-45" class="reflink">45</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_29" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_29" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_29"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_29" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_29" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_29" class="Paragraph 26751658"><p class="para">The abrupt onset in some patients with DIAM may suggest intracranial bleeding, especially in patients with idiopathic thrombocytopenic purpura and low platelet counts. Computed tomographic scans can be used to rule out hemorrhage.<sup><a href="#ref-ira80415-91" class="reflink">91</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_30" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_30" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_30"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_30" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_30" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_30" class="Paragraph 26751658"><p class="para">Cerebrospinal fluid pleocytosis<sup><a href="#ref-ira80415-133" class="reflink">133</a></sup> may occasionally accompany migraine, but the cell count is almost always lymphocytic and rarely exceeds 100 cells/mm<sup>3</sup>. Since NSAIDs are commonly used to treat migraines and can lead to DIAM, these drugs could play a role in producing pleocytosis, but this aspect has never been assessed systematically. Some patients develop the "pseudomigraine with pleocytosis" syndrome, which is characterized by variable neurologic deficits, headache, fever, and lymphocytic pleocytosis.<sup><a href="#ref-ira80415-134" class="reflink">134</a></sup> The predominance of lymphocytic pleocytosis in the CSF and the concomitant focal neurologic deficit (present in 86% of patients with pseudomigraine but only in 10%-16% of DIAM) might be of help to differentiate this entity from DIAM. As for migraine, the hypothetical role of drugs, such as NSAIDs, should be assessed in pseudomigraine with pleocytosis. The only confirmatory test of DIAM would be a rechallenge with the drug, which has been previously reported in the literature but does not seem ethically justified.<sup><a href="#ref-ira80415-1" class="reflink">1</a></sup><sup>,<a href="#ref-ira80415-12" class="reflink">12</a></sup><sup>,<a href="#ref-ira80415-49" class="reflink">49</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_31" class="jumpLinkAnchor" name="PATHOGENESIS"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_31" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_31">PATHOGENESIS</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_31" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_31" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_31" class="prev" href="#DIFFERENTIALDIAGNOSIS"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_31" class="next" href="#NSAID-INDUCEDMENINGITIS"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_31" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_31" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_31" class="Section 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_32" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_32" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_32"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_32" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_32" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_32" class="Paragraph 26751667"><p class="para">The pathogenic mechanisms of DIAM are not fully understood, but there is evidence to suggest that they may be diverse, perhaps different for the various types of drugs. Most of the authors invoke a hypersensitivity mechanism (especially type 1 and 3) for NSAID-, IVIG- and antibiotic-related cases. OKT3 cases are likely mediated, at least in part, by cytokine release. However, it is striking that such reactions are mainly or exclusively confined to the CSF compartment.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_33" class="jumpLinkAnchor" name="NSAID-INDUCEDMENINGITIS"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_33" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_33">NSAID-INDUCED MENINGITIS</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_33" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_33" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_33" class="prev" href="#PATHOGENESIS"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_33" class="next" href="#ANTIBIOTIC-INDUCEDMENINGITIS"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_33" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_33" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_33" class="Section 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_34" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_34" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_34"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_34" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_34" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_34" class="Paragraph 26751669"><p class="para">In the case of NSAIDs, it seems clear that inhibition of the cyclooxygenase pathway is not involved. It has been reported that patients can tolerate other NSAIDs both before and after the meningitis episode and that not all the drugs in this group lead to meningitis.<sup><a href="#ref-ira80415-3" class="reflink">3</a></sup><sup>- <a href="#ref-ira80415-3" class="reflink">7</a>,<a href="#ref-ira80415-13" class="reflink">13</a></sup><sup>,<a href="#ref-ira80415-25" class="reflink">25</a></sup><sup>,<a href="#ref-ira80415-33" class="reflink">33</a></sup><sup>,<a href="#ref-ira80415-37" class="reflink">37</a></sup> Cerebrospinal fluid penetration does not seem relevant since it is similar for all the NSAIDs.<sup><a href="#ref-ira80415-135" class="reflink">135</a></sup> Some data point to a hypersensitivity reaction: the temporal relationship between drug intake and the development of meningitis; prior exposure to the offensive drug and disappearance of symptoms after drug discontinuation; the presence of accompanying "allergic" signs, such as facial edema and conjunctivitis (NSAIDs 25%, antibiotics 21%) and rash (NSAIDs 22%, antibiotics 10%); and more severe symptoms on drug reexposure. Latency after drug intake, however, was not shorter with reexposure. In those patients who developed meningitis on their first exposure to the NSAIDs, it has been suggested that a prior contact with a chemical cross-reactive with the offending drug could have mediated the sensitization.<sup><a href="#ref-ira80415-33" class="reflink">33</a></sup> A few patients have developed meningitis after the intake of several unrelated drugs, which could suggest an individual predisposition,<sup><a href="#ref-ira80415-32" class="reflink">32</a></sup><sup>,<a href="#ref-ira80415-53" class="reflink">53</a></sup> although CSF data that confirm the meningitis are lacking or incomplete.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_35" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_35" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_35"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_35" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_35" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_35" class="Paragraph 26751669"><p class="para">In SLE-susceptible mice (NZB and NZW), meningitis developed and was more intense in older animals that had been exposed to ibuprofen longer. The mice developed meningitis (100% of the animals), only if exposed to ibuprofen and not to ketoprofen (another propionic acid derivative), suggesting that only certain drugs lead to meningitis.<sup><a href="#ref-ira80415-136" class="reflink">136</a></sup> Furthermore, a specific cell-mediated immunity to ibuprofen has been described in patients with SLE who had not been previously exposed to this drug, perhaps due to cross-reactivity with some natural constituents to which the autoimmune reaction is directed.<sup><a href="#ref-ira80415-137" class="reflink">137</a></sup> Also, presumably a lack of suppressor cells as noted in SLE, could allow for a greater magnitude of responsiveness.<sup><a href="#ref-ira80415-138" class="reflink">138</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_36" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_36" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_36"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_36" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_36" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_36" class="Paragraph 26751669"><p class="para">Some authors<sup><a href="#ref-ira80415-1" class="reflink">1</a></sup><sup>,<a href="#ref-ira80415-4" class="reflink">4</a></sup><sup>,<a href="#ref-ira80415-17" class="reflink">17</a></sup><sup>,<a href="#ref-ira80415-20" class="reflink">20</a></sup> have proposed a role for immune complexes, but controversial findings have been reported. Chez and colleagues<sup><a href="#ref-ira80415-20" class="reflink">20</a></sup> found an 8.75-fold increase in CSF-immune complexes over the normal serum values in a healthy patient with ibuprofen-induced meningitis. They and others<sup><a href="#ref-ira80415-17" class="reflink">17</a></sup> have also found evidence of intrathecal IgG production. However, serum immune complex levels were found to be normal in another study<sup><a href="#ref-ira80415-1" class="reflink">1</a></sup> and high in another.<sup><a href="#ref-ira80415-4" class="reflink">4</a></sup> Based on these findings, some authors have concluded that ibuprofen-induced meningitis is an antigen-specific humoral immune process confined to the central nervous system, where the drug, and not a metabolite, would potentiate the activity of a preexisting autoantibody, resulting in complement fixation and development of an acute meningitis.<sup><a href="#ref-ira80415-20" class="reflink">20</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_37" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_37" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_37"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_37" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_37" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_37" class="Paragraph 26751669"><p class="para">Bernstein<sup><a href="#ref-ira80415-4" class="reflink">4</a></sup> has proposed that the drug combines with a CSF or meningeal protein that acts as a hapten, leading to an inflammatory response in the meninges. However, ibuprofen does not reach high concentrations in the CSF, even with high serum concentrations, which indicates that DIAM is not due to accumulation of antigenic determinants of the drug in the CSF.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_38" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_38" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_38"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_38" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_38" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_38" class="Paragraph 26751669"><p class="para">Two authors<sup><a href="#ref-ira80415-8" class="reflink">8</a></sup><sup>,<a href="#ref-ira80415-41" class="reflink">41</a></sup> reported eosinophilic pleocytosis in the CSF of patients with ibuprofen-induced meningitis without concomitant eosinophilia, which suggests a process confined to the meningeal compartment.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_39" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_39" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_39"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_39" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_39" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_39" class="Paragraph 26751669"><p class="para">Taken together, the available data suggest that NSAID-related meningitis develops in individuals rendered susceptible by an underlying autoimmune disorder who were previously sensitized or had a natural immunity to the drug. Why the reaction is confined to the meninges is obscure but might involve cross-reactive mechanisms with antigenic determinants of the central nervous system.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_40" class="jumpLinkAnchor" name="ANTIBIOTIC-INDUCEDMENINGITIS"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_40" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_40">ANTIBIOTIC-INDUCED MENINGITIS</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_40" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_40" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_40" class="prev" href="#NSAID-INDUCEDMENINGITIS"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_40" class="next" href="#IMMUNOGLOBULIN-INDUCEDMENINGITIS"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_40" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_40" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_40" class="Section 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_41" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_41" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_41"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_41" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_41" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_41" class="Paragraph 26751676"><p class="para">The mechanism of action of antibiotic-induced meningitis is also supposed to be due to a hypersensitivity reaction for the same reasons described for NSAIDs. Unlike NSAIDs, immune complexes have been detected in the serum of 3 patients with meningitis induced by trimethroprim-sulfamethoxazole–induced meningitis, but these were not found in their CSF.<sup><a href="#ref-ira80415-48" class="reflink">48</a></sup><sup>,<a href="#ref-ira80415-62" class="reflink">62</a></sup> In a case of cephalosporin-related DIAM,<sup><a href="#ref-ira80415-72" class="reflink">72</a></sup> immune complexes were present both in serum and CSF as well as an increased IgG value in the CSF. This may suggest either that transfer of immune complexes to the CSF is not involved in the pathogenesis of the illness or that they are not accesible for assay. Joffe and coworkers<sup><a href="#ref-ira80415-48" class="reflink">48</a></sup> suggest that immune complexes consisting in part of trimethroprim-sulfamethoxazole may have a predilection for deposition in the choroid plexus, inducing a necrotizing small-vessel vasculitis and leading to an aseptic meningitis.<sup><a href="#ref-ira80415-48" class="reflink">48</a></sup> Gordon and colleagues<sup><a href="#ref-ira80415-49" class="reflink">49</a></sup> found high levels of immune complexes in the CSF, suggestive of an intrathecal immune response. This patient was rechallenged and the level of CSF trimethroprim-sulfamethoxazole was below the therapeutic range, excluding also a meningeal toxic effect.<sup><a href="#ref-ira80415-49" class="reflink">49</a></sup> An underlying defect involving the meninges has also been proposed and also that certain drugs may "trigger" a reaction leading to clinical meningitis.<sup><a href="#ref-ira80415-139" class="reflink">139</a></sup><sup>,<a href="#ref-ira80415-140" class="reflink">140</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_42" class="jumpLinkAnchor" name="IMMUNOGLOBULIN-INDUCEDMENINGITIS"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_42" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_42">IMMUNOGLOBULIN-INDUCED MENINGITIS</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_42" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_42" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_42" class="prev" href="#ANTIBIOTIC-INDUCEDMENINGITIS"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_42" class="next" href="#OKT3ANTIBODY-INDUCEDMENINGITIS"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_42" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_42" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_42" class="Section 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_43" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_43" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_43"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_43" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_43" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_43" class="Paragraph 26751678"><p class="para">The possibility that this type of DIAM is caused by sensitivity to the stabilizing agents of the commercial preparations, such as polyethylene glycol, maltose, sucrose, or glycine, seems unlikely since this syndrome developed in the same patients who received other prior immunoglobulin preparations,<sup><a href="#ref-ira80415-74" class="reflink">74</a></sup><sup>,<a href="#ref-ira80415-141" class="reflink">141</a></sup> and there are at least 6 different commercial products that induced aseptic meningitis.<sup><a href="#ref-ira80415-142" class="reflink">142</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_44" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_44" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_44"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_44" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_44" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_44" class="Paragraph 26751678"><p class="para">Considering the presence of eosinophils in the CSF of some patients, Sekul et al<sup><a href="#ref-ira80415-82" class="reflink">82</a></sup> have suggested a hypersensitivity reaction caused by the direct entry of the immunoglobulins into the cerebrospinal compartment. They also propose an alternative mechanism involving IgG. It was increased in all the patients in whom it was measured, although IgG indexes did not reveal intrathecal synthesis.<sup><a href="#ref-ira80415-82" class="reflink">82</a></sup> Shorr and Kester<sup><a href="#ref-ira80415-95" class="reflink">95</a></sup> also found increased levels of CSF IgG (1130 g/L, 28% of the total CSF protein). Serum immunoglobulins, especially IgG, can enter the CSF mainly if there is a blood-brain (or blood-nerve) barrier breakdown. Since the infused IgG, derived from a pool of more than 5000 donors, is allogenic, it could interact with antigenic determinants on the endothelial cells of the meningeal vasculature, resulting in a cytokine-mediated inflammatory reaction.<sup><a href="#ref-ira80415-82" class="reflink">82</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_45" class="jumpLinkAnchor" name="OKT3ANTIBODY-INDUCEDMENINGITIS"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_45" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_45">OKT3 ANTIBODY-INDUCED MENINGITIS</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_45" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_45" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_45" class="prev" href="#IMMUNOGLOBULIN-INDUCEDMENINGITIS"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_45" class="next" href="#OTHERAGENTSASSOCIATEDWITHDIAM"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_45" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_45" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_45" class="Section 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_46" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_46" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_46"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_46" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_46" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_46" class="Paragraph 26751681"><p class="para">Most authors believe that T cells are opsonized by OKT3 in the presence of complement and are phagocytized by the reticuloendothelial system, resulting in the release of circulating mediators, which induce inflammation in the meninges<sup><a href="#ref-ira80415-110" class="reflink">110</a></sup><sup>,<a href="#ref-ira80415-113" class="reflink">113</a></sup><sup>,<a href="#ref-ira80415-143" class="reflink">143</a></sup> and fluid leakage leading to brain swelling.<sup><a href="#ref-ira80415-109" class="reflink">109</a></sup> These cytokines include tumor necrosis factor, interleukin 2, and interleukin 6.<sup><a href="#ref-ira80415-114" class="reflink">114</a></sup> Moreover, administration of OKT3 antibodies increases systemic cytokine levels, which may contribute to the inflammatory response.<sup><a href="#ref-ira80415-144" class="reflink">144</a></sup> It has been suggested that prior administration of antihuman tumor necrosis factor–monoclonal antibodies could prevent the systemic syndrome (DIAM is not mentioned), although it has not yet been proven.<sup><a href="#ref-ira80415-145" class="reflink">145</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_47" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_47" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_47"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_47" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_47" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_47" class="Paragraph 26751681"><p class="para">Other mechanisms implicate certain surface antigens that are common to both circulating lymphocytes and to cells in the central nervous system.<sup><a href="#ref-ira80415-146" class="reflink">146</a></sup><sup>,<a href="#ref-ira80415-147" class="reflink">147</a></sup> The OKT3 monoclonal antibodies might bind to these cross-reacting neural antigens inciting local inflammation. This would likely implicate that OKT3 antibodies cross the blood-brain barrier, a phenomenon disputed by some authors.<sup><a href="#ref-ira80415-110" class="reflink">110</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_48" class="jumpLinkAnchor" name="OTHERAGENTSASSOCIATEDWITHDIAM"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_48" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_48">OTHER AGENTS ASSOCIATED WITH DIAM</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_48" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_48" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_48" class="prev" href="#OKT3ANTIBODY-INDUCEDMENINGITIS"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_48" class="next" href="#ArticleInformation"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_48" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_48" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_48" class="Section 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_49" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_49" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_49"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_49" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_49" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_49" class="Paragraph 26751684"><p class="para">Four patients have been described who developed meningitis after carbamazepine therapy, one of them with Sjögren syndrome and trigeminal neuralgia, 2 with manic depressive syndrome and another with isolated trigeminal neuralgia.<sup><a href="#ref-ira80415-148" class="reflink">148</a></sup><sup>- <a href="#ref-ira80415-148" class="reflink">151</a></sup> The clinical case was indistinguishable from other DIAM, although 1 patient had myoclonus with normal carbamazepine levels.<sup><a href="#ref-ira80415-149" class="reflink">149</a></sup> There was peripheral eosinophilia (30% of total white blood cell count) in 2 of them <sup><a href="#ref-ira80415-148" class="reflink">148</a></sup><sup>,<a href="#ref-ira80415-150" class="reflink">150</a></sup> and 2% eosinophils in the CSF in 1.<sup><a href="#ref-ira80415-150" class="reflink">150</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_50" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_50" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_50"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_50" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_50" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_50" class="Paragraph 26751684"><p class="para">As noted by Quinn and colleagues,<sup><a href="#ref-ira80415-8" class="reflink">8</a></sup> counting CSF eosinophils is challenging because of technical difficulties, inexperience of the examiner, and the fragility of this cell. It is thus likely that the presence of eosinophils in the CSF is underreported.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_51" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_51" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_51"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_51" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_51" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_51" class="Paragraph 26751684"><p class="para">Merrin and Williams<sup><a href="#ref-ira80415-152" class="reflink">152</a></sup> reported a case of aseptic meningitis in a 37-year-old woman with Sjögren syndrome and polyarthritis, 3 weeks after starting sulfasalazine and 8 hours after subsequent rechallenge with 0.5 g of the drug. Another case of aseptic meningitis induced by sulfasalazine has been reported in a 41-year-old man with rheumatoid arthritis.<sup><a href="#ref-ira80415-153" class="reflink">153</a></sup></p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_52" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_52" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_52"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_52" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_52" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_52" class="Paragraph 26751684"><p class="para">We found 3 cases of isolated DIAM associated with phenazopyridine hydrochloride,<sup><a href="#ref-ira80415-154" class="reflink">154</a></sup> zimeldine hydrochloride (a serotonin uptake inhibitor unavailable since 1983),<sup><a href="#ref-ira80415-155" class="reflink">155</a></sup> and cytarabine hydrochloride.<sup><a href="#ref-ira80415-156" class="reflink">156</a></sup> In the latter, meningitis was associated with cerebellar dysfunction.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_53" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_53" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_53"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_53" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_53" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_53" class="Paragraph 26751684"><p class="para">Sergent and colleagues<sup><a href="#ref-ira80415-157" class="reflink">157</a></sup> described 2 patients with SLE who developed a meningeal reaction after azathioprine therapy, but both patients had clinical and laboratory evidence of active SLE and they also had meningitis not associated with the administration of the offending drug.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_54" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_54" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_54"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_54" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_54" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_54" class="Paragraph 26751684"><p class="para">Also, single case reports of DIAM in relation with salicylate overdose,<sup><a href="#ref-ira80415-158" class="reflink">158</a></sup> hepatitis B vaccination,<sup><a href="#ref-ira80415-159" class="reflink">159</a></sup> and ranitidine intake<sup><a href="#ref-ira80415-160" class="reflink">160</a></sup> have been published.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_55" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_55" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_55"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_55" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_55" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_55" class="Paragraph 26751684"><p class="para">In conclusion, the possibility of DIAM should be considered in every patient with neutrophilic meningitis and negative CSF culture, especially in the presence of an underlying autoimmune disorder. Most commonly, NSAIDs, antibiotics, IVIGs, and OKT3 monoclonal antibodies are the causative drugs, acting through different and partially understood mechanisms, including hypersensitivity reactions and cytokine release. A third-generation cephalosporin seems the therapy of choice when there is a prior antibiotic treatment until the CSF results are available.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_56" class="jumpLinkAnchor" name="ArticleInformation"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_56" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_56">ARTICLE INFORMATION</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_56" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_56" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_56" class="prev" href="#OTHERAGENTSASSOCIATEDWITHDIAM"></a>
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkNext_56" class="next" href="#References"></a>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_56" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_56" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_56" class="BackExtra 0"></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_57" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_57" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_57"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_57" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_57" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_57" class="Paragraph 26751692"><p class="para">Accepted for publication September 3, 1998.</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_58" class="jumpLinkAnchor"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_58" class="sectionTop" style="display:none;">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_58"></span></h2>
                            
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_58" class="subTitleSection" style="display:none;">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_58" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_58" class="Paragraph 26751692"><p class="para">Corresponding author: Juan C. Garcia-Monco, MD, Department of Neurology, Hospital de Galdacano, 48960 Galdacano, Vizcaya, Spain (e-mail: <a href="mailto:hospit05@sarenet.es" target="_blank">hospit05@sarenet.es</a>).</p></span>
                    </div>
                    
                </div>
            
                <div class="contentSectionTab clearfix">
                    <a id="scm6MainContent_ucArticleContent_rptSections_aJumplinkAnchor_59" class="jumpLinkAnchor" name="References"></a>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSectionTop_59" class="sectionTop">
                        <div class="contentJump clearfix">
                            <h2 class="sectionHeader"><span id="scm6MainContent_ucArticleContent_rptSections_lblSectionTitle_59">REFERENCES</span></h2>
                            <div id="scm6MainContent_ucArticleContent_rptSections_divcontentJumpLinks_59" class="contentJumpLinks clearfix">
                                <div id="scm6MainContent_ucArticleContent_rptSections_divContentJumpLinksRepeater_59" class="jumpLinks left">
                                    
                                            
                                            <a class="trackjumplinks" href='#Abstract'> ABSTRACT</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#CLINICALCHARACTERISTICSANDCSFPROFILESOFPATIENTSWITHDIAM'> CLINICAL CHARACTERISTICS AND CSF PROFILES OF PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#UNDERLYINGCONDITIONSINPATIENTSWITHDIAM'> UNDERLYING CONDITIONS IN PATIENTS WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#RECURRENTDIAM'> RECURRENT DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#DIFFERENTIALDIAGNOSIS'> DIFFERENTIAL DIAGNOSIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#PATHOGENESIS'> PATHOGENESIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#NSAID-INDUCEDMENINGITIS'> NSAID-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ANTIBIOTIC-INDUCEDMENINGITIS'> ANTIBIOTIC-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#IMMUNOGLOBULIN-INDUCEDMENINGITIS'> IMMUNOGLOBULIN-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OKT3ANTIBODY-INDUCEDMENINGITIS'> OKT3 ANTIBODY-INDUCED MENINGITIS</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#OTHERAGENTSASSOCIATEDWITHDIAM'> OTHER AGENTS ASSOCIATED WITH DIAM</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#ArticleInformation'> ARTICLE INFORMATION</a>
                                        
                                            |
                                            
                                            <a class="trackjumplinks" href='#References'> REFERENCES</a>
                                        
                                </div>
                                <div class="contentPrevNext right">
                                    <a id="scm6MainContent_ucArticleContent_rptSections_hlkPrevious_59" class="prev" href="#"></a>
                                    
                                </div>
                            </div>
                        </div>
                    </div>
                    <div id="scm6MainContent_ucArticleContent_rptSections_divSubsectionTitle_59" class="subTitleSection">
                        <h6><span id="scm6MainContent_ucArticleContent_rptSections_lblSubsectionTitle_59" class="lblSubTitle"></span></h6>
                    </div>
                    <div class="contentBody clearfix">
                        <span id="scm6MainContent_ucArticleContent_rptSections_lblSection_59" class="References 0"><div class="refContainer"><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-1">1 <span style="display:none;">+</span></a></div><div class="refContent">Widener
         HLLittman
         BL Ibuprofen-induced meningitis in systemic lupus erythematosus. <i>JAMA.</i> 1978;2391062- 1064<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1978.03280380062020" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-2">2 <span style="display:none;">+</span></a></div><div class="refContent">Wasner
         CK Ibuprofen, meningitis and systemic lupus erythematosus. <i>J Rheumatol.</i> 1978;5162- 164<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-3">3 <span style="display:none;">+</span></a></div><div class="refContent">Samuelson
         COWilliams
         HJ Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus. <i>West J Med.</i> 1979;13157- 59<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-4">4 <span style="display:none;">+</span></a></div><div class="refContent">Bernstein
         RF Ibuprofen-related meningitis in mixed connective tissue disease. <i>Ann Intern Med.</i> 1980;92206<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-92-2-206" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-5">5 <span style="display:none;">+</span></a></div><div class="refContent">Giansiracusa
         DFBlumberg
         SKantrowitz
         FG Aseptic meningitis associated with ibuprofen. <i>Arch Intern Med.</i> 1980;1401553<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/archinte.1980.00330220091037" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-6">6 <span style="display:none;">+</span></a></div><div class="refContent">Ruppert
         GBBarth
         WF Ibuprofen hypersensitivity in a systemic lupus erythematosus. <i>South Med J.</i> 1981;74241- 243<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007611-198102000-00032" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-7">7 <span style="display:none;">+</span></a></div><div class="refContent">Peck
         MGJoyner
         PU Ibuprofen-associated aseptic meningitis. <i>Clin Pharmacol.</i> 1982;1561- 565<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-8">8 <span style="display:none;">+</span></a></div><div class="refContent">Quinn
         JPWeinstein
         RACaplan
         LR Eosinophilic meningitis and ibuprofen therapy. <i>Neurology.</i> 1984;34108- 109<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.34.1.108" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-9">9 <span style="display:none;">+</span></a></div><div class="refContent">Perera
         DRSeiffert
         AKGreeley
         HM Ibuprofen and meningoencephalitis. <i>Ann Intern Med.</i> 1984;100619<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-100-4-619_2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-10">10 <span style="display:none;">+</span></a></div><div class="refContent">Lawson
         JMGrady
         MJ Ibuprofen-induced aseptic meningitis in a previously healthy patient. <i>West J Med.</i> 1985;143386- 387<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-11">11 <span style="display:none;">+</span></a></div><div class="refContent">Bouland
         DLSpecht
         NLHegstad
         DR Ibuprofen and aseptic meningitis. <i>Ann Intern Med.</i> 1986;104731<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-104-5-731_1" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-12">12 <span style="display:none;">+</span></a></div><div class="refContent">Mandell
         BFRaps
         EC Severe systemic hypersensitivity reaction to ibuprofen occurring after prolonged therapy. <i>Am J Med.</i> 1987;82817- 820<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0002-9343(87)90021-0" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-13">13 <span style="display:none;">+</span></a></div><div class="refContent">Jensen
         SGlud
         TKBacher
         TErsgaard
         H Ibuprofen-induced meningitis in a male with systemic lupus erythematosus. <i>Acta Med Scand.</i> 1987;221509- 511<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1111/j.0954-6820.1987.tb01289.x" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-14">14 <span style="display:none;">+</span></a></div><div class="refContent">Katona
         BGWigley
         FMWalters
         JKCaspi
         M Aseptic meningitis from over-the-counter ibuprofen. <i>Lancet.</i> 1988;159<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0140-6736(88)91040-9" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-15">15 <span style="display:none;">+</span></a></div><div class="refContent">Mifsud
         AJ Drug-related recurrent meningitis. <i>J Infect.</i> 1988;17151- 153<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0163-4453(88)91739-2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-16">16 <span style="display:none;">+</span></a></div><div class="refContent">Durback
         MAFreeman
         JSchumacher
         HR Recurrent ibuprofen-induced aseptic meningitis: third episode after only 200 mg of generic ibuprofen. <i>Arthritis Rheum.</i> 1988;31813- 815<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/(ISSN)1529-0131" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-17">17 <span style="display:none;">+</span></a></div><div class="refContent">Gilbert
         GJEichenbaum
         HW Ibuprofen-induced meningitis in an elderly patient with systemic lupus erythematosus. <i>South Med J.</i> 1989;82514- 515<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007611-198904000-00025" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-18">18 <span style="display:none;">+</span></a></div><div class="refContent">Ewert
         BH Resident article: ibuprofen-associated meningitis in a woman with only serologic evidence of a reumathologic disorder. <i>Am J Med Sci.</i> 1989;297326- 327<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00000441-198905000-00010" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-19">19 <span style="display:none;">+</span></a></div><div class="refContent">Grimm
         AMWolf
         JE Aseptic meningitis associated with nonprescription ibuprofen use. <i>DICP.</i> 1989;23712<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-20">20 <span style="display:none;">+</span></a></div><div class="refContent">Chez
         MSila
         CARansohoff
         RMLongworth
         DLWeida
         C Ibuprofen-induced meningitis: detection of intrathecal IgG synthesis and immune complexes. <i>Neurology.</i> 1989;391578- 1580<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.39.12.1578" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-21">21 <span style="display:none;">+</span></a></div><div class="refContent">Agus
         BNelson
         JKramer
         NMahal
         SSRosenstein
         ED Acute central nervous system symptoms caused by ibuprofen in connective tissue disease. <i>J Rheumatol.</i> 1990;171094- 1096<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-22">22 <span style="display:none;">+</span></a></div><div class="refContent">Lortholary
         AVarache
         NBouachour
         GSzapiro
         NBourrier
         PAlquier
         P État de mal comitial généralisé aprés prise d'ibuproféne, révélateur d'un lupus érythémateux disséminé. <i>Rev Med Interne.</i> 1990;11243- 244<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0248-8663(10)80010-4" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-23">23 <span style="display:none;">+</span></a></div><div class="refContent">Kaplan
         BHNevitt
         MPPach
         JMHerman
         DC Aseptic meningitis and iridocyclitis related to ibuprofen. <i>Am J Opthalmol.</i> 1994;117119- 120<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-24">24 <span style="display:none;">+</span></a></div><div class="refContent">Eustace
         SBuff
         B Magnetic resonance imaging in drug-induced meningitis. <i>Can Assoc Radiol J.</i> 1994;45463- 465<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-25">25 <span style="display:none;">+</span></a></div><div class="refContent">Hoffman
         MGray
         RG Ibuprofen-induced meningitis in mixed connective tissue disease. <i>Clin Rheumatol.</i> 1982;1128- 130<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1007/BF02275603" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-26">26 <span style="display:none;">+</span></a></div><div class="refContent">Peterson
         DIChong
         MJ Recurrent meningitis due to nonsteroidal anti-inflammatory drugs. <i>Bull Clin Neurosci.</i> 1987;5340- 42<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-27">27 <span style="display:none;">+</span></a></div><div class="refContent">Thilmann
         AFMobius
         EThilmann
         RRTopper
         R Recurrent aseptic meningitis (Mollaret meningitis): spontaneous and drug-induced origin. <i>Fortschr Neurol Psychiatr.</i> 1991;59493- 497<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1055/s-2007-1000725" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-28">28 <span style="display:none;">+</span></a></div><div class="refContent">Hanson
         L Ibuprofen-induced aseptic meningitis. <i>J Tenn Med Assoc.</i> 1994;8758<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-29">29 <span style="display:none;">+</span></a></div><div class="refContent">Colamarino
         RSoubrier
         MZenut-Leaud
         MPrudat
         MTournillac
         MBussiere
         JC Aseptic meningitis caused by ibuprofen (Nurofen) in connective tissue disease. <i>Therapy.</i> 1993;48516- 518<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-30">30 <span style="display:none;">+</span></a></div><div class="refContent">Horn
         ACJarrett
         SW Ibuprofen-induced aseptic meningitis in rheumatoid arthritis. <i>Ann Pharmacother.</i> 1997;311009- 1011<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-31">31 <span style="display:none;">+</span></a></div><div class="refContent">van der Zwan
         Avan Dam
         JG Ibuprofen meningitis. <i>Ned Tijdschr Geneeskd.</i> 1992;1361613- 1614<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-32">32 <span style="display:none;">+</span></a></div><div class="refContent">Ruppert
         GBBarth
         WF Tolmetin-induced aseptic meningitis. <i>JAMA.</i> 1981;24567- 68<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1981.03310260045029" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-33">33 <span style="display:none;">+</span></a></div><div class="refContent">Ballas
         ZKDonta
         ST Sulindac-induced aseptic meningitis. <i>Arch Intern Med.</i> 1982;142165- 166<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/archinte.1982.00340140167031" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-34">34 <span style="display:none;">+</span></a></div><div class="refContent">Lorino
         GDHardin
         JG Sulindac-induced meningitis in mixed connective tissue disease. <i>South Med J.</i> 1983;761185- 1187<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007611-198309000-00036" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-35">35 <span style="display:none;">+</span></a></div><div class="refContent">Von Reyn
         CF Recurrent aseptic meningitis due to sulindac. <i>Ann Intern Med.</i> 1983;99343- 344<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-99-3-343" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-36">36 <span style="display:none;">+</span></a></div><div class="refContent">Neufeld
         MYKorczyn
         AD Encephalopathy associated with sulindac. <i>Hum Toxicol.</i> 1986;555<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1177/096032718600500112" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-37">37 <span style="display:none;">+</span></a></div><div class="refContent">Yasuda
         YAkiguchi
         IKameyama
         M Sulindac-induced aseptic meningitis in mixed connective tissue disease. <i>Clin Neurol Neurosurg.</i> 1989;91257- 260<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0303-8467(89)90121-2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-38">38 <span style="display:none;">+</span></a></div><div class="refContent">Greenberg
         GN Recurrent sulindac-induced aseptic meningitis in a patient tolerant to other nonsteroidal anti-inflammatory drugs. <i>South Med J.</i> 1988;811463- 1464<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007611-198811000-00034" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-39">39 <span style="display:none;">+</span></a></div><div class="refContent">Sylvia
         LMForlenza
         SWBrocavich
         JM Aseptic meningitis associated with naproxen. <i>DICP.</i> 1988;22399- 401<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-40">40 <span style="display:none;">+</span></a></div><div class="refContent">Roel
         JEGadano
         ACFalcon
         JL Ketoprofen and aseptic meningitis. <i>Medicina (B Aires).</i> 1991;51186<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-41">41 <span style="display:none;">+</span></a></div><div class="refContent">Weksler
         BBLehany
         AM Naproxen-induced recurrent aseptic meningitis. <i>Ann Pharmacother.</i> 1991;251183- 1184<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-42">42 <span style="display:none;">+</span></a></div><div class="refContent">Codding
         CTargoff
         INMcCarty
         GA Aseptic meningitis in association with diclofenac treatment in a patient with systemic lupus erythematosus. <i>Arthritis Rheum.</i> 1991;341340- 1341<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-43">43 <span style="display:none;">+</span></a></div><div class="refContent">Barret
         PVDThier
         SO Meningitis and pancreatitis associated with sulfamethizole. <i>N Engl J Med.</i> 1963;26836- 37<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1056/NEJM196301032680109" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-44">44 <span style="display:none;">+</span></a></div><div class="refContent">Kremer
         IRitz
         RBrunner
         F Aseptic meningitis as an adverse effect of co-trimoxazole. <i>N Engl J Med.</i> 1983;3081481<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-45">45 <span style="display:none;">+</span></a></div><div class="refContent">Haas
         EJ Trimethoprim-sulfamethoxazole: another cause of recurrent meningitis. <i>JAMA.</i> 1984;252346<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1984.03350030020014" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-46">46 <span style="display:none;">+</span></a></div><div class="refContent">Biosca
         Mde la Figuera
         MGarcía-Bragado
         FSampol
         G Aseptic meningitis due to trimethoprim-sulfamethoxazole. <i>J Neurol Neurosurg Psychiatry.</i> 1986;49332- 333<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/jnnp.49.3.332" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-47">47 <span style="display:none;">+</span></a></div><div class="refContent">Streiffer
         RHHudson
         JG Aseptic meningitis and trimethoprim-sulfamethoxazole. <i>J Fam Pract.</i> 1986;23314<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-48">48 <span style="display:none;">+</span></a></div><div class="refContent">Joffe
         AMFarley
         JDLinden
         DGoldsand
         G Trimethoprim-sulfamethoxazole associated aseptic meningitis: case reports and review of the literature. <i>Am J Med.</i> 1989;87332- 338<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0002-9343(89)80160-3" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-49">49 <span style="display:none;">+</span></a></div><div class="refContent">Gordon
         MFAllon
         MCoyle
         PK Drug-induced meningitis. <i>Neurology.</i> 1990;40163- 164<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.40.1.163" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-50">50 <span style="display:none;">+</span></a></div><div class="refContent">Auxier
         GG Aseptic meningitis associated with administration of trimethoprim and sulfamethoxazole. <i>AJDC.</i> 1990;144144- 145<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-51">51 <span style="display:none;">+</span></a></div><div class="refContent">Tunkel
         ARStarr
         K Trimethoprim-sulfamethoxazole–associated aseptic meningitis. <i>Am J Med.</i> 1990;88696<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0002-9343(90)90546-P" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-52">52 <span style="display:none;">+</span></a></div><div class="refContent">Escalante
         AStimmler
         MM Trimethoprim-sulfamethoxazole induced meningitis in systemic lupus erythematosus. <i>J Rheumatol.</i> 1992;19800- 802<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-53">53 <span style="display:none;">+</span></a></div><div class="refContent">Davis
         JDThompson
         JPeimann
         BSBendixen
         BH Drug-induced aseptic meningitis caused by two medications. <i>Neurology.</i> 1994;44984- 985<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.44.5.984" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-54">54 <span style="display:none;">+</span></a></div><div class="refContent">Wong
         JGHathaway
         SCPaat
         JJPaterson
         RWSteele
         GH
         Jr Drug-induced meningitis: a case involving trimethoprim-sulfamethoxazole. <i>Postgrad Med.</i> 1994;96117- 124<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-55">55 <span style="display:none;">+</span></a></div><div class="refContent">River
         YAverbuch-Heller
         LWeinberger
         M
     et al.  Antibiotic induced meningitis. <i>J Neurol Neurosurg Psychiatry.</i> 1994;57705- 708<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/jnnp.57.6.705" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-56">56 <span style="display:none;">+</span></a></div><div class="refContent">Carrillo
         FCubero
         AHernádez Gallego
         JJiménez Santana
         P Meningoencefalitis recurrente inducida por cotrimoxazol. <i>Rev Neurol.</i> 1995;23142- 144<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-57">57 <span style="display:none;">+</span></a></div><div class="refContent">Rudy
         BJRutsein
         R Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent. <i>Pediatr Emerg Care.</i> 1997;13216- 217<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00006565-199706000-00010" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-58">58 <span style="display:none;">+</span></a></div><div class="refContent">Blumenfeld
         HCha
         JHCudkowicz
         ME Trimethoprim and sulfonamide-associated meningoencephalitis with MRI correlates. <i>Neurology.</i> 1996;46556- 558<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.46.2.556" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-59">59 <span style="display:none;">+</span></a></div><div class="refContent">Pashankar
         DMcArdle
         MRobinson
         A Co-trimoxazole induced aseptic meningitis. <i>Arch Dis Child.</i> 1995;73257- 258<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/adc.73.3.257" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-60">60 <span style="display:none;">+</span></a></div><div class="refContent">Poles
         LTheodor
         E Trimethoprim-sulfamethoxazole–induced meningitis. <i>Harefuah.</i> 1996;130817- 818<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-61">61 <span style="display:none;">+</span></a></div><div class="refContent">Jurado
         RCarpenter
         SLRimland
         D Case reports: trimethoprim-sulfamethoxazole–induced meningitis in patients with HIV infection. <i>Am J Med Sci.</i> 1996;31227- 29<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00000441-199607000-00005" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-62">62 <span style="display:none;">+</span></a></div><div class="refContent">Derbes
         SJ Trimethoprim-induced aseptic meningitis. <i>JAMA.</i> 1984;2522865- 2866<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1984.03350200051023" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-63">63 <span style="display:none;">+</span></a></div><div class="refContent">Carlson
         JWihlom
         B Trimethoprim-associated aseptic meningitis. <i>Scand J Infect Dis.</i> 1987;19687- 691<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.3109/00365548709117205" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-64">64 <span style="display:none;">+</span></a></div><div class="refContent">Hedlund
         JAurelius
         EAndersson
         J Recurrent encephalitis due to trimethoprim intake. <i>Scand J Infect Dis.</i> 1990;22109- 112<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.3109/00365549009023129" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-65">65 <span style="display:none;">+</span></a></div><div class="refContent">Harrison
         MSSimonte
         SJKauffman
         CA Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review. <i>Clin Infect Dis.</i> 1994;19431- 434<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clinids/19.3.431" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-66">66 <span style="display:none;">+</span></a></div><div class="refContent">Gilroy
         NGottlieb
         TSpring
         PPeiris
         O Trimethoprim-induced aseptic meningitis and uveitis. <i>Lancet.</i> 1997;350112<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0140-6736(05)61813-2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-67">67 <span style="display:none;">+</span></a></div><div class="refContent">Saha
         HLumio
         JPasternack
         A Acute aseptic meningitis induced by trimethoprim. <i>Duodecim.</i> 1998;104257- 261<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-68">68 <span style="display:none;">+</span></a></div><div class="refContent">Garagusi
         VFNeefe
         LIMann
         O Acute meningoencephalitis: association with isoniazid administration. <i>JAMA.</i> 1976;2351141- 1142<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1976.03260370049035" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-69">69 <span style="display:none;">+</span></a></div><div class="refContent">Asperilla
         MOSmego
         MD Eosinophilic meningitis associated with ciprofloxacin. <i>Am J Med.</i> 1989;87589- 590<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0002-9343(89)80620-5" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-70">70 <span style="display:none;">+</span></a></div><div class="refContent">Corson
         APChretien
         JH Metronidazole-associated aseptic meningitis. <i>Clin Infect Dis.</i> 1994;19974<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clinids/19.5.974" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-71">71 <span style="display:none;">+</span></a></div><div class="refContent">Sundstrom
         OSvedberg
         LECarling
         L Meningitretning efter Metronidazol. <i>Lakartidningen.</i> 1984;813480<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-72">72 <span style="display:none;">+</span></a></div><div class="refContent">Creel
         GBHurtt
         M Cephalosporin-induced recurrent aseptic meningitis. <i>Ann Neurol.</i> 1995;37815- 817<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/(ISSN)1531-8249" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-73">73 <span style="display:none;">+</span></a></div><div class="refContent">Bodokh
         ILacour
         JCosta
         IBotcazou
         VChichmanian
         RMOrtonne
         JP Meningite aseptique sous pyrazinamide lors de lupus erythemateux. <i>Presse Med.</i> 1993;22595- 596<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-74">74 <span style="display:none;">+</span></a></div><div class="refContent">Kato
         EShindo
         SEto
         Y
     et al.  Administration of immune globulin associated with aseptic meningitis. <i>JAMA.</i> 1988;2593269- 3271<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1988.03720220017011" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-75">75 <span style="display:none;">+</span></a></div><div class="refContent">Casteels-Van Daele
         MWijndaele
         LHunninck
         KGillis
         P Intravenous immune globulin and acute aseptic meningitis. <i>N Engl J Med.</i> 1990;323614- 615<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-76">76 <span style="display:none;">+</span></a></div><div class="refContent">Vera-Ramirez
         MCharlet
         MParry
         GJ Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. <i>Neurology.</i> 1992;421636- 1637<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.42.8.1636-a" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-77">77 <span style="display:none;">+</span></a></div><div class="refContent">Watson
         JDGGibson
         JJoshua
         DEKronenberg
         H Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. <i>J Neurol Neurosurg Psychiatry.</i> 1991;54275- 276<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/jnnp.54.3.275" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-78">78 <span style="display:none;">+</span></a></div><div class="refContent">Pallares
         DEMarshall
         FS Acute aseptic meningitis associated with administration of intravenous immune globulin. <i>Am J Pediatr Hematol Oncol.</i> 1992;14279<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00043426-199208000-00019" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-79">79 <span style="display:none;">+</span></a></div><div class="refContent">Molina
         J-MCoffineau
         ARain
         J-DLetonturier
         DModai
         J Aseptic meningitis following administration of intravenous immune globulin. <i>Clin Infect Dis.</i> 1992;15564- 565<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clind/15.3.564" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-80">80 <span style="display:none;">+</span></a></div><div class="refContent">Meiner
         ZBen-Hur
         TRiver
         YReches
         A Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis. <i>J Neurol Neurosurg Psychiatry.</i> 1993;56830- 831<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/jnnp.56.7.830-a" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-81">81 <span style="display:none;">+</span></a></div><div class="refContent">De Vlieghere
         FCPeetermans
         WEVermylen
         J Aseptic granulocytic meningitis following treatment with intravenous immunoglobulin. <i>Clin Infect Dis.</i> 1994;181008<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clinids/18.6.1008" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-82">82 <span style="display:none;">+</span></a></div><div class="refContent">Sekul
         EACupler
         EJDalakas
         MC Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. <i>Ann Intern Med.</i> 1994;121159- 262<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-121-4-199408150-00004" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-83">83 <span style="display:none;">+</span></a></div><div class="refContent">Mitterer
         MPescosta
         NVogetseder
         WMair
         MCoser
         P Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura. <i>Ann Hematol.</i> 1993;67151- 152<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1007/BF01701743" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-84">84 <span style="display:none;">+</span></a></div><div class="refContent">Jayabose
         SRoseman
         BGupta
         A "Aseptic meningitis syndrome" after intravenous gammaglobulin therapy for ITP. <i>Am J Hematol Oncol.</i> 1990;12117<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-85">85 <span style="display:none;">+</span></a></div><div class="refContent">Rao
         SPTeitlebaum
         JMiller
         ST Intravenous immune globulin and aseptic meningitis. <i>AJDC.</i> 1992;146539- 540<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-86">86 <span style="display:none;">+</span></a></div><div class="refContent">Ellis
         RJSwenson
         MRBajorek
         J Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis. <i>Muscle Nerve.</i> 1994;17683- 684<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/mus.v17:6" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-87">87 <span style="display:none;">+</span></a></div><div class="refContent">Oddou
         SMolinier
         SCoso
         DBoulet
         JMGastaut
         JABouabdallah
         R Méningite aseptique consécutive á un traitement par immunoglobulines: intéret physiopathologique et pronostique de son déspistage. <i>Presse Med.</i> 1995;24916<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-88">88 <span style="display:none;">+</span></a></div><div class="refContent">Preminger-Shapiro
         RNussinovich
         MSoen
         GVarsano
         I Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin? <i>Eur J Pediatr.</i> 1995;154866- 867<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1007/BF01959803" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-89">89 <span style="display:none;">+</span></a></div><div class="refContent">Mselati
         JCCarlier
         JCRouton
         MCNoui Mehidi
         Fde Gennes
         C Immunoglobulines intraveineuses et méningite aseptique. <i>Arch Fr Pediatr.</i> 1992;49216<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-90">90 <span style="display:none;">+</span></a></div><div class="refContent">Sirvent
         NMonpoux
         FBenet
         LMariani
         R Méningite aseptique au cours d'un traitement par immunoglobulines. <i>Arch Pediatr.</i> 1996;3830- 831<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0929-693X(96)82172-5" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-91">91 <span style="display:none;">+</span></a></div><div class="refContent">Kressebuch
         HSchaad
         UBHirt
         ABianchetti
         MG Cerebrospinal fluid inflammation induced by intravenous immunoglobulins. <i>Pediatr Infect Dis J.</i> 1992;11894- 895<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00006454-199210000-00020" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-92">92 <span style="display:none;">+</span></a></div><div class="refContent">Bussel
         JCunningham-Rundles
         CFeldman
         CHorowitz
         B Transmission of viral infection by preparations of intravenous immunoglobulin. <i>Plasma Ther Transfus Technol.</i> 1988;9193- 205<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0278-6222(88)90051-4" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-93">93 <span style="display:none;">+</span></a></div><div class="refContent">Fernández-Carril
         JMTrejo
         JMSedano
         MJGoñi
         M Meningitis aséptica por inmunoglobulinas intravenosas. <i>Neurología.</i> 1995;10351- 352<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-94">94 <span style="display:none;">+</span></a></div><div class="refContent">Gabor
         EP Intravenous immune globulins. <i>West J Med.</i> 1995;162277- 278<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-95">95 <span style="display:none;">+</span></a></div><div class="refContent">Shorr
         AFKester
         KE Meningitis and hepatitis complicating intravenous immunoglobulin therapy. <i>Ann Pharmacother.</i> 1996;301115- 1116<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-96">96 <span style="display:none;">+</span></a></div><div class="refContent">Kattamis
         ACShankar
         SCohen
         AR Neurological complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G. <i>J Pediatr.</i> 1997;130281- 283<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0022-3476(97)70355-X" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-97">97 <span style="display:none;">+</span></a></div><div class="refContent">Picton
         PChishol
         M Aseptic meningitis associated with high dose immunoglobulin: case report. <i>BMJ.</i> 1997;3151203- 1204<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/bmj.315.7117.1203" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-98">98 <span style="display:none;">+</span></a></div><div class="refContent">Lafferty
         TEDeHoratius
         RJSmith
         JB Aseptic meningitis as a side effect of intravenous immune gammaglobulin. <i>J Rheumatol.</i> 1997;242491- 2492<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-99">99 <span style="display:none;">+</span></a></div><div class="refContent">Van der Merché
         FKleyweg
         R Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. <i>J Neurol Neurosurg Psychiatry.</i> 1992;55981<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-100">100 <span style="display:none;">+</span></a></div><div class="refContent">Emmons
         CSmith
         JFlanigan
         M Cerebrospinal fluid inflammation during OKT3 therapy. <i>Lancet.</i> 1986;2510- 511<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0140-6736(86)90375-2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-101">101 <span style="display:none;">+</span></a></div><div class="refContent">Roden
         JKlintmalm
         GBGHusberg
         BSNery
         JOlson
         LM Cerebrospinal fluid inflammation during OKT3 therapy. <i>Lancet.</i> 1987;2272<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0140-6736(87)90852-X" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-102">102 <span style="display:none;">+</span></a></div><div class="refContent">Thistlethwaite
         JRGaber
         AOHaag
         BW
     et al.  OKT3 treatment of steroid-resistant renal allograft rejection. <i>Transplantation.</i> 1987;43176- 184<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007890-198702000-00003" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-103">103 <span style="display:none;">+</span></a></div><div class="refContent">Rello
         JVallverdú
         IColl
         PGurgí
         MNet
         A Aseptic meningitis associated with muromonab-CD3. <i>DICP.</i> 1990;241233<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-104">104 <span style="display:none;">+</span></a></div><div class="refContent">Joy
         MEMichals
         MLCanafax
         DM Aseptic meningitis associated with muromonab-CD3 therapy. <i>Clin Pharmacol.</i> 1988;7721<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-105">105 <span style="display:none;">+</span></a></div><div class="refContent">Figg
         WD Aseptic meningitis associated with muromonab-CD3. <i>DICP.</i> 1991;251395<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-106">106 <span style="display:none;">+</span></a></div><div class="refContent">Strominger
         MBLiu
         GTSchartz
         NJ Optic disk swelling and abducens palsies associated with OKT3. <i>Am J Ophthalmol.</i> 1995;119664- 665<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-107">107 <span style="display:none;">+</span></a></div><div class="refContent">Costanzo-Nordin
         MRSilver
         MAO'Conell
         JB
     et al.  Successful reversal of acute cardiac allograft rejection with OKT3 monoclonal antibody. <i>Circulation.</i> 1987;76(suppl 5)71- 80<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-108">108 <span style="display:none;">+</span></a></div><div class="refContent">Thistlethwaite
         JRStuart
         JKMayes
         JT
     et al.  Monitoring and complications of monoclonal therapy: complications and monitoring of OKT3 therapy. <i>Am J Kidney Dis.</i> 1988;11112- 119<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0272-6386(88)80192-6" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-109">109 <span style="display:none;">+</span></a></div><div class="refContent">Coleman
         AENorman
         DJ OKT3 encephalophaty. <i>Ann Neurol.</i> 1990;28837- 838<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/(ISSN)1531-8249" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-110">110 <span style="display:none;">+</span></a></div><div class="refContent">Adair
         JCWoodley
         SLO'Conell
         JBCall
         GKBaringer
         JR Aseptic meningitis following cardiac transplantation: clinical characteristics and relationship to immunosuppressive regimen. <i>Neurology.</i> 1991;41249- 252<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.41.2_Part_1.249" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-111">111 <span style="display:none;">+</span></a></div><div class="refContent">Chan
         GLWeinstein
         SSWright
         CE
     et al.  Encephalopathy associated with OKT3 administration: possible interaction with indomethacin. <i>Transplantation.</i> 1991;52148- 150<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007890-199107000-00031" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-112">112 <span style="display:none;">+</span></a></div><div class="refContent">Thomas
         DMNicholls
         AJFeest
         TGRiad
         H OKT3 and cerebral oedema. <i>BMJ.</i> 1987;2951486<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/bmj.295.6611.1486-b" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-113">113 <span style="display:none;">+</span></a></div><div class="refContent">Capone
         PMCohen
         ME Seizures and cerebritis associated with administration of OKT3. <i>Pediatr Neurol.</i> 1991;7299- 301<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0887-8994(91)90050-U" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-114">114 <span style="display:none;">+</span></a></div><div class="refContent">Osterman
         JDTrauner
         DAReznik
         VMLemire
         J Transient hemiparesis associated with monoclonal CD3 antibody (OKT3) therapy. <i>Pediatr Neurol.</i> 1993;9482- 484<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0887-8994(93)90030-G" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-115">115 <span style="display:none;">+</span></a></div><div class="refContent">Agarwal
         RKOstaszewski
         MLFeld
         LGSpringate
         JEMoxey-Mims
         MMO'Neill
         KM Tumor necrosis factor and interleukin-6 in cerebrospinal fluid of a patient with recurrent adverse central nervous system events following OKT3. <i>Transplant Proc.</i> 1993;253143- 3144<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-116">116 <span style="display:none;">+</span></a></div><div class="refContent">Kormos
         RLArnitage
         JMDummer
         JSMiyamoto
         YGriffith
         BPHardesty
         RL Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin. <i>Transplantation.</i> 1990;49306- 311<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007890-199002000-00016" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-117">117 <span style="display:none;">+</span></a></div><div class="refContent">Massanari
         RMartin
         MSmith
         J
     et al.  Aseptic meningitis among kidney transplant recipients receiving a newly marketed murine monoclonal antibody preparation. <i>JAMA.</i> 1986;2561873<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.256.14.1873" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-118">118 <span style="display:none;">+</span></a></div><div class="refContent">Uribe Roca
         MCZurru
         MCGatto
         EMMaggiora
         ECAgost Carreno
         CLuciano
         M Aseptic meningitis due to OKT3. <i>Neurologia.</i> 1998;1398- 99<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-119">119 <span style="display:none;">+</span></a></div><div class="refContent">Rizzo
         JDRowe
         SA Meningism in a ten-month-old infant during OKT3 therapy. <i>J Heart Transplant.</i> 1990;9727- 728<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-120">120 <span style="display:none;">+</span></a></div><div class="refContent">Farmer
         LEchlin
         FALoughin
         WCBreakey
         ASDuvoisin
         R Pachymeningitis apparently due to penicillin hypersensitivity. <i>Ann Intern Med.</i> 1960;54910- 914<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-121">121 <span style="display:none;">+</span></a></div><div class="refContent">Durand
         MLCalderwood
         SBWeber
         DJ
     et al.  Acute bacterial meningitis in adults: a review of 493 episodes. <i>N Engl J Med.</i> 1993;32821- 28<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1056/NEJM199301073280104" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-122">122 <span style="display:none;">+</span></a></div><div class="refContent">Barrons
         RWMurray
         KMRichey
         RM Populations at risk for penicillin-induced seizures. <i>Ann Pharmacother.</i> 1992;2626- 29<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-123">123 <span style="display:none;">+</span></a></div><div class="refContent">Stewart
         WFLipton
         RBCelentano
         DD
     et al.  Prevalence of migraine headache in the United States. <i>JAMA.</i> 1992;26764- 69<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1992.03480010072027" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-124">124 <span style="display:none;">+</span></a></div><div class="refContent">Montalbán
         JCervera
         RFont
         J
     et al.  Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. <i>Neurology.</i> 1992;42681- 682<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.42.3.681" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-125">125 <span style="display:none;">+</span></a></div><div class="refContent">Markus
         HSHopkinson
         N Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. <i>J Neurol.</i> 1992;23939- 42<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1007/BF00839210" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-126">126 <span style="display:none;">+</span></a></div><div class="refContent">Geiseler
         PJNelson
         KELevin
         SReddi
         KTMoses
         VK Community-acquired purulent meningitis: a review of 1316 cases during the antibiotic era, 1954-1976. <i>Rev Infect Dis.</i> 1980;2725- 745<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clinids/2.5.725" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-127">127 <span style="display:none;">+</span></a></div><div class="refContent">Roos
         KLTunkel
         ARScheld
         WM Acute bacterial meningitis in children and adults. Scheld
         WMWhitley
         RJDurack
         DTeds<i>Infections of the Central Nervous System</i>  New York, NY Raven Press1991;335- 409<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-128">128 <span style="display:none;">+</span></a></div><div class="refContent">Connolly
         KJHammer
         SM The acute aseptic meningitis syndrome. <i>Infect Dis Clin North Am.</i> 1990;4599- 622<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-129">129 <span style="display:none;">+</span></a></div><div class="refContent">Jeffery
         KJMRead
         SJPeto
         TEAMayon-White
         RTBangham
         CRM Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results. <i>Lancet.</i> 1997;349313- 317<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0140-6736(96)08107-X" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-130">130 <span style="display:none;">+</span></a></div><div class="refContent">Ellis
         SGVerity
         MA Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. <i>Semin Arthritis Rheum.</i> 1979;8212- 221<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0049-0172(79)80009-8" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-131">131 <span style="display:none;">+</span></a></div><div class="refContent">Gibson
         TMyers
         AR Nervous system involvement in systemic lupus erythematosus. <i>Ann Rheum Dis.</i> 1975;35398- 406<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/ard.35.5.398" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-132">132 <span style="display:none;">+</span></a></div><div class="refContent">Canoso
         JJCohen
         AS Aseptic meningitis in systemic lupus erythematosus. <i>Arthritis Rheum.</i> 1975;18369- 373<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/(ISSN)1529-0131" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-133">133 <span style="display:none;">+</span></a></div><div class="refContent">Kovacs
         KBors
         LTóthfalusi
         L
     et al.  Cerebrospinal fluid investigations in migraine. <i>Cephalagia.</i> 1989;953- 57<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1046/j.1468-2982.1989.901053.x" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-134">134 <span style="display:none;">+</span></a></div><div class="refContent">Gómez-Aranda
         FCañadillas
         FMartí-Massó
         JF
     et al.  Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. <i>Brain.</i> 1997;1201105- 1113<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/brain/120.7.1105" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-135">135 <span style="display:none;">+</span></a></div><div class="refContent">Brooks
         PMDay
         RO Nonsteroidal anti-inflammatory drugs: differences and similarities. <i>N Engl J Med.</i> 1991;3241716- 1725<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1056/NEJM199106133242407" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-136">136 <span style="display:none;">+</span></a></div><div class="refContent">Berliner
         SWeisberg
         ASchoenfeld
         Y Ibuprofen may induce meningitis in (NZB × NZW) F1 mice. <i>Arthritis Rheum.</i> 1985;28104- 107<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/(ISSN)1529-0131" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-137">137 <span style="display:none;">+</span></a></div><div class="refContent">Shoenfeld
         YLivni
         EShaklai
         MPinkhas
         J Sensitization to ibuprofen in systemic lupus erythematosus. <i>JAMA.</i> 1980;244547- 548<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1980.03310060011006" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-138">138 <span style="display:none;">+</span></a></div><div class="refContent">Fauci
         ASSteinberg
         ADHaynes
         BF
     et al.  Immunoregulatory aberrations in systemic lupus erythematosus. <i>J Immunol.</i> 1978;1211473- 1474<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-139">139 <span style="display:none;">+</span></a></div><div class="refContent">Derbes
         SJ Aseptic meningitis, trimethoprim, and Sjögren's syndrome. <i>JAMA.</i> 1985;2532192<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1985.03350390034010" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-140">140 <span style="display:none;">+</span></a></div><div class="refContent">de la Monte
         SMHutchins
         GMGupta
         PK Aseptic meningitis, trimethoprim, and Sjögren's syndrome. <i>JAMA.</i> 1985;2532192<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1985.03350390034009" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-141">141 <span style="display:none;">+</span></a></div><div class="refContent">Dalakas
         MC Aseptic meningitis and intravenous inmmunoglobulin therapy. <i>Ann Intern Med.</i> 1995;122316- 317<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-122-4-199502150-00021" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-142">142 <span style="display:none;">+</span></a></div><div class="refContent">Scribner
         CLKapit
         RMPhillips
         ETRickles
         NM Aseptic meningitis and intravenous immunoglobulin therapy. <i>Ann Intern Med.</i> 1994;121105- 306<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-121-4-199408150-00014" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-143">143 <span style="display:none;">+</span></a></div><div class="refContent">Martin
         MAMassanari
         RMNghiem
         DDSmith
         JLCany
         RT Nosocomial aseptic meningitis associated with administration of OKT3. <i>JAMA.</i> 1988;2592002- 2005<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1988.03720130066031" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-144">144 <span style="display:none;">+</span></a></div><div class="refContent">Chatenaud
         LFerran
         CLegendre
         C
     et al.  In vivo cell activation following OKT3 administration. <i>Transplantation.</i> 1990;49692- 702<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-145">145 <span style="display:none;">+</span></a></div><div class="refContent">Charpentier
         BHiesse
         CFerran
         C
     et al.  Acute clinical syndrome associated with OKT3 administration: prevention by single injection of an anti-human TNF monoclonal antibody. <i>Presse Med.</i> 1991;202009- 2011<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-146">146 <span style="display:none;">+</span></a></div><div class="refContent">Williams
         AFGagnon
         J Neuronal cell thy-1 glycoprotein: homology with immunoglobulin. <i>Science.</i> 1982;216696- 703<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1126/science.6177036" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-147">147 <span style="display:none;">+</span></a></div><div class="refContent">Bienbaum
         G Studies on brain thymus cross-reactive antigens. <i>Brain Res.</i> 1975;84111- 121<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0006-8993(75)90804-5" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-148">148 <span style="display:none;">+</span></a></div><div class="refContent">Hilton
         EStroh
         EM Aseptic meningitis associated with administration of carbamazepine. <i>J Infect Dis.</i> 1989;159363- 364<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/infdis/159.2.363-a" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-149">149 <span style="display:none;">+</span></a></div><div class="refContent">Simon
         LTHsu
         BDornato
         BT Carbamazepine-induced aseptic meningitis. <i>Ann Intern Med.</i> 1990;112627- 628<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-112-8-627" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-150">150 <span style="display:none;">+</span></a></div><div class="refContent">Hemet
         CChassagne
         PLevade
         M
     et al.  Aseptic meningitis secondary to carbamazepine treatment of manic-depressive illness. <i>Am J Psychiatry.</i> 1994;1511393<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-151">151 <span style="display:none;">+</span></a></div><div class="refContent">Dang
         CTRiley
         DK Aseptic meningitis secondary to carbamazepine therapy. <i>Clin Infect Dis.</i> 1996;22729- 730<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clinids/22.4.729" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-152">152 <span style="display:none;">+</span></a></div><div class="refContent">Merrin
         PWilliams
         IA Meningitis associated with sulphasalazine in a patient with Sjögren's syndrome and polyarthritis. <i>Ann Rheum Dis.</i> 1991;50645- 646<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/ard.50.9.645" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-153">153 <span style="display:none;">+</span></a></div><div class="refContent">Alloway
         JAMitchell
         SR Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature. <i>J Rheumatol.</i> 1993;20409- 411<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-154">154 <span style="display:none;">+</span></a></div><div class="refContent">Herlihy
         TE Phenazopiridine and aseptic meningitis. <i>Ann Intern Med.</i> 1987;106172- 135<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-106-1-172_2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-155">155 <span style="display:none;">+</span></a></div><div class="refContent">Swedish Adverse Drug Reactions Advisory Committee, <i>Survey of Adverse Effects: Zimeldin</i>. <i>Swedish Adverse Drug Reactions Advisory Committee; 1983. Bulletin 39/40.</i> <br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-156">156 <span style="display:none;">+</span></a></div><div class="refContent">Thordarson
         HTalstad
         I Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy. <i>Acta Med Scand.</i> 1986;220493- 495<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1111/j.0954-6820.1986.tb02801.x" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-157">157 <span style="display:none;">+</span></a></div><div class="refContent">Sergent
         JSLockshin
         MDKlemper
         MSLipsky
         BA Central nervous system disease in systemic lupus erythematosus: therapy and prognosis. <i>Am J Med.</i> 1975;58644- 654<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0002-9343(75)90500-8" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-158">158 <span style="display:none;">+</span></a></div><div class="refContent">Nair
         JStacy
         M Aseptic meningitis associated with salicylate overdose. <i>Psychosomatics.</i> 1993;34372<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0033-3182(93)71876-9" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-159">159 <span style="display:none;">+</span></a></div><div class="refContent">Heinzlef
         OMoguilewski
         ARoullet
         E Meningite aigue aseptique apres vaccination contre l'hepatite B. <i>Presse Med.</i> 1997;26328<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-160">160 <span style="display:none;">+</span></a></div><div class="refContent">Durand
         JMSuchet
         L Ranitidine and aseptic meningitis. <i>BMJ.</i> 1997;312886<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/bmj.312.7035.886a" class="special sans" target="_blank">Link to Article</a></span><br /></div></div></div></span>
                    </div>
                    
                </div>
            


                        
                        
                        
                        <div class="clearAll">
                        </div>
                    </div>
                    <!-- End Tab Content - Start Tab Discussion -->
                    <div class="contentContainer" id="tab2">
                        
        


                        
                    </div>
                    <!-- End Tab Discussion - Start Tab Figures -->
                    <div class="contentContainer" id="tab3">
                        <h2 class="sectionHeader">Figures</h2>
                        
                    </div>
                    <!-- End Tab Figures - Start Tab Tables -->
                    <div class="contentContainer" id="tab4">
                        <h2 class="sectionHeader">Tables</h2>
                        
                                <div class="contentBody">
                                    <a name="ira80415t1"><span style="display:none;">Table Graphic Jump Location</span></a><span class="figureLabel">Table 1.</span> <span class="figureCaption"><span class="figureCaption">Drugs Involved in Drug-Induced Aseptic Meningitis*</span></span><div class="inlineFigureImage"><span class="enlargeImage"><a class="btnImageEnlarger"><span style="display:none;">+</span></a></span><span class="inlineFigureImageContainer"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/s_ira80415t1.png" alt="Image not available." class="contentFigures lazy" /></span><div class="figureLinks"><a class="popUpTable">View Large</a>  | 
    <a class="saveMyStuffs" id="26751640" onclick="addtoMyStuffs(this);">Save Table</a>  | 
    <a rel="nofollow" href="DownloadImage.aspx?image=/data/Journals/INTEMED/11945/ira80415t1.png&sec=26751640&ar=485056&sectionType=1&imagename=" class="downloadSlide">Download Slide (.ppt)</a><span class="viewInContext">
       | 
      <a href="#ira80415t1" class="special">View in Article Context</a></span><div class="tableDialog"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t1.png" alt="Image not available." class="contentFigures lazy" /></div></div></div>
                                </div>
                            
                                <div class="contentBody">
                                    <a name="ira80415t2"><span style="display:none;">Table Graphic Jump Location</span></a><span class="figureLabel">Table 2.</span> <span class="figureCaption"><span class="figureCaption">Clinical Signs and Symptoms of Patients With Drug-Induced Aseptic Meningitis*</span></span><div class="inlineFigureImage"><span class="enlargeImage"><a class="btnImageEnlarger"><span style="display:none;">+</span></a></span><span class="inlineFigureImageContainer"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/s_ira80415t2.png" alt="Image not available." class="contentFigures lazy" /></span><div class="figureLinks"><a class="popUpTable">View Large</a>  | 
    <a class="saveMyStuffs" id="26751644" onclick="addtoMyStuffs(this);">Save Table</a>  | 
    <a rel="nofollow" href="DownloadImage.aspx?image=/data/Journals/INTEMED/11945/ira80415t2.png&sec=26751644&ar=485056&sectionType=1&imagename=" class="downloadSlide">Download Slide (.ppt)</a><span class="viewInContext">
       | 
      <a href="#ira80415t2" class="special">View in Article Context</a></span><div class="tableDialog"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t2.png" alt="Image not available." class="contentFigures lazy" /></div></div></div>
                                </div>
                            
                                <div class="contentBody">
                                    <a name="ira80415t3"><span style="display:none;">Table Graphic Jump Location</span></a><span class="figureLabel">Table 3.</span> <span class="figureCaption"><span class="figureCaption">CSF Characteristics of Patients With Drug-Induced Aseptic Meningitis*</span></span><div class="inlineFigureImage"><span class="enlargeImage"><a class="btnImageEnlarger"><span style="display:none;">+</span></a></span><span class="inlineFigureImageContainer"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/s_ira80415t3.png" alt="Image not available." class="contentFigures lazy" /></span><div class="figureLinks"><a class="popUpTable">View Large</a>  | 
    <a class="saveMyStuffs" id="26751648" onclick="addtoMyStuffs(this);">Save Table</a>  | 
    <a rel="nofollow" href="DownloadImage.aspx?image=/data/Journals/INTEMED/11945/ira80415t3.png&sec=26751648&ar=485056&sectionType=1&imagename=" class="downloadSlide">Download Slide (.ppt)</a><span class="viewInContext">
       | 
      <a href="#ira80415t3" class="special">View in Article Context</a></span><div class="tableDialog"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t3.png" alt="Image not available." class="contentFigures lazy" /></div></div></div>
                                </div>
                            
                                <div class="contentBody">
                                    <a name="ira80415t4"><span style="display:none;">Table Graphic Jump Location</span></a><span class="figureLabel">Table 4.</span> <span class="figureCaption"><span class="figureCaption">Underlying Disorder in Patients With Drug-Induced Aseptic Meningitis*</span></span><div class="inlineFigureImage"><span class="enlargeImage"><a class="btnImageEnlarger"><span style="display:none;">+</span></a></span><span class="inlineFigureImageContainer"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/s_ira80415t4.png" alt="Image not available." class="contentFigures lazy" /></span><div class="figureLinks"><a class="popUpTable">View Large</a>  | 
    <a class="saveMyStuffs" id="26751653" onclick="addtoMyStuffs(this);">Save Table</a>  | 
    <a rel="nofollow" href="DownloadImage.aspx?image=/data/Journals/INTEMED/11945/ira80415t4.png&sec=26751653&ar=485056&sectionType=1&imagename=" class="downloadSlide">Download Slide (.ppt)</a><span class="viewInContext">
       | 
      <a href="#ira80415t4" class="special">View in Article Context</a></span><div class="tableDialog"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t4.png" alt="Image not available." class="contentFigures lazy" /></div></div></div>
                                </div>
                            
                                <div class="contentBody">
                                    <a name="ira80415t5"><span style="display:none;">Table Graphic Jump Location</span></a><span class="figureLabel">Table 5.</span> <span class="figureCaption"><span class="figureCaption">CSF Characteristics in Recurrent Episodes of Drug-Induced Aseptic Meningitis*</span></span><div class="inlineFigureImage"><span class="enlargeImage"><a class="btnImageEnlarger"><span style="display:none;">+</span></a></span><span class="inlineFigureImageContainer"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/s_ira80415t5.png" alt="Image not available." class="contentFigures lazy" /></span><div class="figureLinks"><a class="popUpTable">View Large</a>  | 
    <a class="saveMyStuffs" id="26751657" onclick="addtoMyStuffs(this);">Save Table</a>  | 
    <a rel="nofollow" href="DownloadImage.aspx?image=/data/Journals/INTEMED/11945/ira80415t5.png&sec=26751657&ar=485056&sectionType=1&imagename=" class="downloadSlide">Download Slide (.ppt)</a><span class="viewInContext">
       | 
      <a href="#ira80415t5" class="special">View in Article Context</a></span><div class="tableDialog"><img src="//amaprod.silverchaircdn.com/data/Journals/INTEMED/11945/ira80415t5.png" alt="Image not available." class="contentFigures lazy" /></div></div></div>
                                </div>
                            
                    </div>
                    <!-- End Tab Tables - Start Tab References -->
                    <div class="contentContainer" id="tab6">
                        <h2 class="sectionHeader">References</h2>
                        
                                <div class="contentBody referenceSection">
                                    <div class="refContainer"><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-1">1 <span style="display:none;">+</span></a></div><div class="refContent">Widener
         HLLittman
         BL Ibuprofen-induced meningitis in systemic lupus erythematosus. <i>JAMA.</i> 1978;2391062- 1064<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1978.03280380062020" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-2">2 <span style="display:none;">+</span></a></div><div class="refContent">Wasner
         CK Ibuprofen, meningitis and systemic lupus erythematosus. <i>J Rheumatol.</i> 1978;5162- 164<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-3">3 <span style="display:none;">+</span></a></div><div class="refContent">Samuelson
         COWilliams
         HJ Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus. <i>West J Med.</i> 1979;13157- 59<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-4">4 <span style="display:none;">+</span></a></div><div class="refContent">Bernstein
         RF Ibuprofen-related meningitis in mixed connective tissue disease. <i>Ann Intern Med.</i> 1980;92206<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-92-2-206" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-5">5 <span style="display:none;">+</span></a></div><div class="refContent">Giansiracusa
         DFBlumberg
         SKantrowitz
         FG Aseptic meningitis associated with ibuprofen. <i>Arch Intern Med.</i> 1980;1401553<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/archinte.1980.00330220091037" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-6">6 <span style="display:none;">+</span></a></div><div class="refContent">Ruppert
         GBBarth
         WF Ibuprofen hypersensitivity in a systemic lupus erythematosus. <i>South Med J.</i> 1981;74241- 243<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007611-198102000-00032" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-7">7 <span style="display:none;">+</span></a></div><div class="refContent">Peck
         MGJoyner
         PU Ibuprofen-associated aseptic meningitis. <i>Clin Pharmacol.</i> 1982;1561- 565<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-8">8 <span style="display:none;">+</span></a></div><div class="refContent">Quinn
         JPWeinstein
         RACaplan
         LR Eosinophilic meningitis and ibuprofen therapy. <i>Neurology.</i> 1984;34108- 109<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.34.1.108" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-9">9 <span style="display:none;">+</span></a></div><div class="refContent">Perera
         DRSeiffert
         AKGreeley
         HM Ibuprofen and meningoencephalitis. <i>Ann Intern Med.</i> 1984;100619<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-100-4-619_2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-10">10 <span style="display:none;">+</span></a></div><div class="refContent">Lawson
         JMGrady
         MJ Ibuprofen-induced aseptic meningitis in a previously healthy patient. <i>West J Med.</i> 1985;143386- 387<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-11">11 <span style="display:none;">+</span></a></div><div class="refContent">Bouland
         DLSpecht
         NLHegstad
         DR Ibuprofen and aseptic meningitis. <i>Ann Intern Med.</i> 1986;104731<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-104-5-731_1" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-12">12 <span style="display:none;">+</span></a></div><div class="refContent">Mandell
         BFRaps
         EC Severe systemic hypersensitivity reaction to ibuprofen occurring after prolonged therapy. <i>Am J Med.</i> 1987;82817- 820<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0002-9343(87)90021-0" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-13">13 <span style="display:none;">+</span></a></div><div class="refContent">Jensen
         SGlud
         TKBacher
         TErsgaard
         H Ibuprofen-induced meningitis in a male with systemic lupus erythematosus. <i>Acta Med Scand.</i> 1987;221509- 511<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1111/j.0954-6820.1987.tb01289.x" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-14">14 <span style="display:none;">+</span></a></div><div class="refContent">Katona
         BGWigley
         FMWalters
         JKCaspi
         M Aseptic meningitis from over-the-counter ibuprofen. <i>Lancet.</i> 1988;159<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0140-6736(88)91040-9" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-15">15 <span style="display:none;">+</span></a></div><div class="refContent">Mifsud
         AJ Drug-related recurrent meningitis. <i>J Infect.</i> 1988;17151- 153<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0163-4453(88)91739-2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-16">16 <span style="display:none;">+</span></a></div><div class="refContent">Durback
         MAFreeman
         JSchumacher
         HR Recurrent ibuprofen-induced aseptic meningitis: third episode after only 200 mg of generic ibuprofen. <i>Arthritis Rheum.</i> 1988;31813- 815<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/(ISSN)1529-0131" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-17">17 <span style="display:none;">+</span></a></div><div class="refContent">Gilbert
         GJEichenbaum
         HW Ibuprofen-induced meningitis in an elderly patient with systemic lupus erythematosus. <i>South Med J.</i> 1989;82514- 515<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007611-198904000-00025" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-18">18 <span style="display:none;">+</span></a></div><div class="refContent">Ewert
         BH Resident article: ibuprofen-associated meningitis in a woman with only serologic evidence of a reumathologic disorder. <i>Am J Med Sci.</i> 1989;297326- 327<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00000441-198905000-00010" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-19">19 <span style="display:none;">+</span></a></div><div class="refContent">Grimm
         AMWolf
         JE Aseptic meningitis associated with nonprescription ibuprofen use. <i>DICP.</i> 1989;23712<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-20">20 <span style="display:none;">+</span></a></div><div class="refContent">Chez
         MSila
         CARansohoff
         RMLongworth
         DLWeida
         C Ibuprofen-induced meningitis: detection of intrathecal IgG synthesis and immune complexes. <i>Neurology.</i> 1989;391578- 1580<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.39.12.1578" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-21">21 <span style="display:none;">+</span></a></div><div class="refContent">Agus
         BNelson
         JKramer
         NMahal
         SSRosenstein
         ED Acute central nervous system symptoms caused by ibuprofen in connective tissue disease. <i>J Rheumatol.</i> 1990;171094- 1096<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-22">22 <span style="display:none;">+</span></a></div><div class="refContent">Lortholary
         AVarache
         NBouachour
         GSzapiro
         NBourrier
         PAlquier
         P État de mal comitial généralisé aprés prise d'ibuproféne, révélateur d'un lupus érythémateux disséminé. <i>Rev Med Interne.</i> 1990;11243- 244<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0248-8663(10)80010-4" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-23">23 <span style="display:none;">+</span></a></div><div class="refContent">Kaplan
         BHNevitt
         MPPach
         JMHerman
         DC Aseptic meningitis and iridocyclitis related to ibuprofen. <i>Am J Opthalmol.</i> 1994;117119- 120<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-24">24 <span style="display:none;">+</span></a></div><div class="refContent">Eustace
         SBuff
         B Magnetic resonance imaging in drug-induced meningitis. <i>Can Assoc Radiol J.</i> 1994;45463- 465<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-25">25 <span style="display:none;">+</span></a></div><div class="refContent">Hoffman
         MGray
         RG Ibuprofen-induced meningitis in mixed connective tissue disease. <i>Clin Rheumatol.</i> 1982;1128- 130<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1007/BF02275603" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-26">26 <span style="display:none;">+</span></a></div><div class="refContent">Peterson
         DIChong
         MJ Recurrent meningitis due to nonsteroidal anti-inflammatory drugs. <i>Bull Clin Neurosci.</i> 1987;5340- 42<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-27">27 <span style="display:none;">+</span></a></div><div class="refContent">Thilmann
         AFMobius
         EThilmann
         RRTopper
         R Recurrent aseptic meningitis (Mollaret meningitis): spontaneous and drug-induced origin. <i>Fortschr Neurol Psychiatr.</i> 1991;59493- 497<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1055/s-2007-1000725" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-28">28 <span style="display:none;">+</span></a></div><div class="refContent">Hanson
         L Ibuprofen-induced aseptic meningitis. <i>J Tenn Med Assoc.</i> 1994;8758<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-29">29 <span style="display:none;">+</span></a></div><div class="refContent">Colamarino
         RSoubrier
         MZenut-Leaud
         MPrudat
         MTournillac
         MBussiere
         JC Aseptic meningitis caused by ibuprofen (Nurofen) in connective tissue disease. <i>Therapy.</i> 1993;48516- 518<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-30">30 <span style="display:none;">+</span></a></div><div class="refContent">Horn
         ACJarrett
         SW Ibuprofen-induced aseptic meningitis in rheumatoid arthritis. <i>Ann Pharmacother.</i> 1997;311009- 1011<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-31">31 <span style="display:none;">+</span></a></div><div class="refContent">van der Zwan
         Avan Dam
         JG Ibuprofen meningitis. <i>Ned Tijdschr Geneeskd.</i> 1992;1361613- 1614<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-32">32 <span style="display:none;">+</span></a></div><div class="refContent">Ruppert
         GBBarth
         WF Tolmetin-induced aseptic meningitis. <i>JAMA.</i> 1981;24567- 68<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1981.03310260045029" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-33">33 <span style="display:none;">+</span></a></div><div class="refContent">Ballas
         ZKDonta
         ST Sulindac-induced aseptic meningitis. <i>Arch Intern Med.</i> 1982;142165- 166<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/archinte.1982.00340140167031" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-34">34 <span style="display:none;">+</span></a></div><div class="refContent">Lorino
         GDHardin
         JG Sulindac-induced meningitis in mixed connective tissue disease. <i>South Med J.</i> 1983;761185- 1187<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007611-198309000-00036" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-35">35 <span style="display:none;">+</span></a></div><div class="refContent">Von Reyn
         CF Recurrent aseptic meningitis due to sulindac. <i>Ann Intern Med.</i> 1983;99343- 344<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-99-3-343" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-36">36 <span style="display:none;">+</span></a></div><div class="refContent">Neufeld
         MYKorczyn
         AD Encephalopathy associated with sulindac. <i>Hum Toxicol.</i> 1986;555<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1177/096032718600500112" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-37">37 <span style="display:none;">+</span></a></div><div class="refContent">Yasuda
         YAkiguchi
         IKameyama
         M Sulindac-induced aseptic meningitis in mixed connective tissue disease. <i>Clin Neurol Neurosurg.</i> 1989;91257- 260<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0303-8467(89)90121-2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-38">38 <span style="display:none;">+</span></a></div><div class="refContent">Greenberg
         GN Recurrent sulindac-induced aseptic meningitis in a patient tolerant to other nonsteroidal anti-inflammatory drugs. <i>South Med J.</i> 1988;811463- 1464<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007611-198811000-00034" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-39">39 <span style="display:none;">+</span></a></div><div class="refContent">Sylvia
         LMForlenza
         SWBrocavich
         JM Aseptic meningitis associated with naproxen. <i>DICP.</i> 1988;22399- 401<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-40">40 <span style="display:none;">+</span></a></div><div class="refContent">Roel
         JEGadano
         ACFalcon
         JL Ketoprofen and aseptic meningitis. <i>Medicina (B Aires).</i> 1991;51186<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-41">41 <span style="display:none;">+</span></a></div><div class="refContent">Weksler
         BBLehany
         AM Naproxen-induced recurrent aseptic meningitis. <i>Ann Pharmacother.</i> 1991;251183- 1184<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-42">42 <span style="display:none;">+</span></a></div><div class="refContent">Codding
         CTargoff
         INMcCarty
         GA Aseptic meningitis in association with diclofenac treatment in a patient with systemic lupus erythematosus. <i>Arthritis Rheum.</i> 1991;341340- 1341<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-43">43 <span style="display:none;">+</span></a></div><div class="refContent">Barret
         PVDThier
         SO Meningitis and pancreatitis associated with sulfamethizole. <i>N Engl J Med.</i> 1963;26836- 37<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1056/NEJM196301032680109" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-44">44 <span style="display:none;">+</span></a></div><div class="refContent">Kremer
         IRitz
         RBrunner
         F Aseptic meningitis as an adverse effect of co-trimoxazole. <i>N Engl J Med.</i> 1983;3081481<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-45">45 <span style="display:none;">+</span></a></div><div class="refContent">Haas
         EJ Trimethoprim-sulfamethoxazole: another cause of recurrent meningitis. <i>JAMA.</i> 1984;252346<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1984.03350030020014" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-46">46 <span style="display:none;">+</span></a></div><div class="refContent">Biosca
         Mde la Figuera
         MGarcía-Bragado
         FSampol
         G Aseptic meningitis due to trimethoprim-sulfamethoxazole. <i>J Neurol Neurosurg Psychiatry.</i> 1986;49332- 333<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/jnnp.49.3.332" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-47">47 <span style="display:none;">+</span></a></div><div class="refContent">Streiffer
         RHHudson
         JG Aseptic meningitis and trimethoprim-sulfamethoxazole. <i>J Fam Pract.</i> 1986;23314<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-48">48 <span style="display:none;">+</span></a></div><div class="refContent">Joffe
         AMFarley
         JDLinden
         DGoldsand
         G Trimethoprim-sulfamethoxazole associated aseptic meningitis: case reports and review of the literature. <i>Am J Med.</i> 1989;87332- 338<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0002-9343(89)80160-3" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-49">49 <span style="display:none;">+</span></a></div><div class="refContent">Gordon
         MFAllon
         MCoyle
         PK Drug-induced meningitis. <i>Neurology.</i> 1990;40163- 164<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.40.1.163" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-50">50 <span style="display:none;">+</span></a></div><div class="refContent">Auxier
         GG Aseptic meningitis associated with administration of trimethoprim and sulfamethoxazole. <i>AJDC.</i> 1990;144144- 145<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-51">51 <span style="display:none;">+</span></a></div><div class="refContent">Tunkel
         ARStarr
         K Trimethoprim-sulfamethoxazole–associated aseptic meningitis. <i>Am J Med.</i> 1990;88696<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0002-9343(90)90546-P" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-52">52 <span style="display:none;">+</span></a></div><div class="refContent">Escalante
         AStimmler
         MM Trimethoprim-sulfamethoxazole induced meningitis in systemic lupus erythematosus. <i>J Rheumatol.</i> 1992;19800- 802<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-53">53 <span style="display:none;">+</span></a></div><div class="refContent">Davis
         JDThompson
         JPeimann
         BSBendixen
         BH Drug-induced aseptic meningitis caused by two medications. <i>Neurology.</i> 1994;44984- 985<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.44.5.984" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-54">54 <span style="display:none;">+</span></a></div><div class="refContent">Wong
         JGHathaway
         SCPaat
         JJPaterson
         RWSteele
         GH
         Jr Drug-induced meningitis: a case involving trimethoprim-sulfamethoxazole. <i>Postgrad Med.</i> 1994;96117- 124<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-55">55 <span style="display:none;">+</span></a></div><div class="refContent">River
         YAverbuch-Heller
         LWeinberger
         M
     et al.  Antibiotic induced meningitis. <i>J Neurol Neurosurg Psychiatry.</i> 1994;57705- 708<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/jnnp.57.6.705" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-56">56 <span style="display:none;">+</span></a></div><div class="refContent">Carrillo
         FCubero
         AHernádez Gallego
         JJiménez Santana
         P Meningoencefalitis recurrente inducida por cotrimoxazol. <i>Rev Neurol.</i> 1995;23142- 144<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-57">57 <span style="display:none;">+</span></a></div><div class="refContent">Rudy
         BJRutsein
         R Aseptic meningitis from trimethoprim-sulfamethoxazole in an HIV-infected adolescent. <i>Pediatr Emerg Care.</i> 1997;13216- 217<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00006565-199706000-00010" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-58">58 <span style="display:none;">+</span></a></div><div class="refContent">Blumenfeld
         HCha
         JHCudkowicz
         ME Trimethoprim and sulfonamide-associated meningoencephalitis with MRI correlates. <i>Neurology.</i> 1996;46556- 558<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.46.2.556" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-59">59 <span style="display:none;">+</span></a></div><div class="refContent">Pashankar
         DMcArdle
         MRobinson
         A Co-trimoxazole induced aseptic meningitis. <i>Arch Dis Child.</i> 1995;73257- 258<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/adc.73.3.257" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-60">60 <span style="display:none;">+</span></a></div><div class="refContent">Poles
         LTheodor
         E Trimethoprim-sulfamethoxazole–induced meningitis. <i>Harefuah.</i> 1996;130817- 818<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-61">61 <span style="display:none;">+</span></a></div><div class="refContent">Jurado
         RCarpenter
         SLRimland
         D Case reports: trimethoprim-sulfamethoxazole–induced meningitis in patients with HIV infection. <i>Am J Med Sci.</i> 1996;31227- 29<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00000441-199607000-00005" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-62">62 <span style="display:none;">+</span></a></div><div class="refContent">Derbes
         SJ Trimethoprim-induced aseptic meningitis. <i>JAMA.</i> 1984;2522865- 2866<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1984.03350200051023" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-63">63 <span style="display:none;">+</span></a></div><div class="refContent">Carlson
         JWihlom
         B Trimethoprim-associated aseptic meningitis. <i>Scand J Infect Dis.</i> 1987;19687- 691<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.3109/00365548709117205" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-64">64 <span style="display:none;">+</span></a></div><div class="refContent">Hedlund
         JAurelius
         EAndersson
         J Recurrent encephalitis due to trimethoprim intake. <i>Scand J Infect Dis.</i> 1990;22109- 112<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.3109/00365549009023129" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-65">65 <span style="display:none;">+</span></a></div><div class="refContent">Harrison
         MSSimonte
         SJKauffman
         CA Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review. <i>Clin Infect Dis.</i> 1994;19431- 434<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clinids/19.3.431" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-66">66 <span style="display:none;">+</span></a></div><div class="refContent">Gilroy
         NGottlieb
         TSpring
         PPeiris
         O Trimethoprim-induced aseptic meningitis and uveitis. <i>Lancet.</i> 1997;350112<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0140-6736(05)61813-2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-67">67 <span style="display:none;">+</span></a></div><div class="refContent">Saha
         HLumio
         JPasternack
         A Acute aseptic meningitis induced by trimethoprim. <i>Duodecim.</i> 1998;104257- 261<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-68">68 <span style="display:none;">+</span></a></div><div class="refContent">Garagusi
         VFNeefe
         LIMann
         O Acute meningoencephalitis: association with isoniazid administration. <i>JAMA.</i> 1976;2351141- 1142<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1976.03260370049035" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-69">69 <span style="display:none;">+</span></a></div><div class="refContent">Asperilla
         MOSmego
         MD Eosinophilic meningitis associated with ciprofloxacin. <i>Am J Med.</i> 1989;87589- 590<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0002-9343(89)80620-5" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-70">70 <span style="display:none;">+</span></a></div><div class="refContent">Corson
         APChretien
         JH Metronidazole-associated aseptic meningitis. <i>Clin Infect Dis.</i> 1994;19974<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clinids/19.5.974" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-71">71 <span style="display:none;">+</span></a></div><div class="refContent">Sundstrom
         OSvedberg
         LECarling
         L Meningitretning efter Metronidazol. <i>Lakartidningen.</i> 1984;813480<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-72">72 <span style="display:none;">+</span></a></div><div class="refContent">Creel
         GBHurtt
         M Cephalosporin-induced recurrent aseptic meningitis. <i>Ann Neurol.</i> 1995;37815- 817<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/(ISSN)1531-8249" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-73">73 <span style="display:none;">+</span></a></div><div class="refContent">Bodokh
         ILacour
         JCosta
         IBotcazou
         VChichmanian
         RMOrtonne
         JP Meningite aseptique sous pyrazinamide lors de lupus erythemateux. <i>Presse Med.</i> 1993;22595- 596<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-74">74 <span style="display:none;">+</span></a></div><div class="refContent">Kato
         EShindo
         SEto
         Y
     et al.  Administration of immune globulin associated with aseptic meningitis. <i>JAMA.</i> 1988;2593269- 3271<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1988.03720220017011" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-75">75 <span style="display:none;">+</span></a></div><div class="refContent">Casteels-Van Daele
         MWijndaele
         LHunninck
         KGillis
         P Intravenous immune globulin and acute aseptic meningitis. <i>N Engl J Med.</i> 1990;323614- 615<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-76">76 <span style="display:none;">+</span></a></div><div class="refContent">Vera-Ramirez
         MCharlet
         MParry
         GJ Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. <i>Neurology.</i> 1992;421636- 1637<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.42.8.1636-a" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-77">77 <span style="display:none;">+</span></a></div><div class="refContent">Watson
         JDGGibson
         JJoshua
         DEKronenberg
         H Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. <i>J Neurol Neurosurg Psychiatry.</i> 1991;54275- 276<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/jnnp.54.3.275" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-78">78 <span style="display:none;">+</span></a></div><div class="refContent">Pallares
         DEMarshall
         FS Acute aseptic meningitis associated with administration of intravenous immune globulin. <i>Am J Pediatr Hematol Oncol.</i> 1992;14279<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00043426-199208000-00019" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-79">79 <span style="display:none;">+</span></a></div><div class="refContent">Molina
         J-MCoffineau
         ARain
         J-DLetonturier
         DModai
         J Aseptic meningitis following administration of intravenous immune globulin. <i>Clin Infect Dis.</i> 1992;15564- 565<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clind/15.3.564" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-80">80 <span style="display:none;">+</span></a></div><div class="refContent">Meiner
         ZBen-Hur
         TRiver
         YReches
         A Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis. <i>J Neurol Neurosurg Psychiatry.</i> 1993;56830- 831<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/jnnp.56.7.830-a" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-81">81 <span style="display:none;">+</span></a></div><div class="refContent">De Vlieghere
         FCPeetermans
         WEVermylen
         J Aseptic granulocytic meningitis following treatment with intravenous immunoglobulin. <i>Clin Infect Dis.</i> 1994;181008<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clinids/18.6.1008" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-82">82 <span style="display:none;">+</span></a></div><div class="refContent">Sekul
         EACupler
         EJDalakas
         MC Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. <i>Ann Intern Med.</i> 1994;121159- 262<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-121-4-199408150-00004" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-83">83 <span style="display:none;">+</span></a></div><div class="refContent">Mitterer
         MPescosta
         NVogetseder
         WMair
         MCoser
         P Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura. <i>Ann Hematol.</i> 1993;67151- 152<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1007/BF01701743" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-84">84 <span style="display:none;">+</span></a></div><div class="refContent">Jayabose
         SRoseman
         BGupta
         A "Aseptic meningitis syndrome" after intravenous gammaglobulin therapy for ITP. <i>Am J Hematol Oncol.</i> 1990;12117<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-85">85 <span style="display:none;">+</span></a></div><div class="refContent">Rao
         SPTeitlebaum
         JMiller
         ST Intravenous immune globulin and aseptic meningitis. <i>AJDC.</i> 1992;146539- 540<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-86">86 <span style="display:none;">+</span></a></div><div class="refContent">Ellis
         RJSwenson
         MRBajorek
         J Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis. <i>Muscle Nerve.</i> 1994;17683- 684<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/mus.v17:6" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-87">87 <span style="display:none;">+</span></a></div><div class="refContent">Oddou
         SMolinier
         SCoso
         DBoulet
         JMGastaut
         JABouabdallah
         R Méningite aseptique consécutive á un traitement par immunoglobulines: intéret physiopathologique et pronostique de son déspistage. <i>Presse Med.</i> 1995;24916<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-88">88 <span style="display:none;">+</span></a></div><div class="refContent">Preminger-Shapiro
         RNussinovich
         MSoen
         GVarsano
         I Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin? <i>Eur J Pediatr.</i> 1995;154866- 867<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1007/BF01959803" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-89">89 <span style="display:none;">+</span></a></div><div class="refContent">Mselati
         JCCarlier
         JCRouton
         MCNoui Mehidi
         Fde Gennes
         C Immunoglobulines intraveineuses et méningite aseptique. <i>Arch Fr Pediatr.</i> 1992;49216<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-90">90 <span style="display:none;">+</span></a></div><div class="refContent">Sirvent
         NMonpoux
         FBenet
         LMariani
         R Méningite aseptique au cours d'un traitement par immunoglobulines. <i>Arch Pediatr.</i> 1996;3830- 831<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0929-693X(96)82172-5" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-91">91 <span style="display:none;">+</span></a></div><div class="refContent">Kressebuch
         HSchaad
         UBHirt
         ABianchetti
         MG Cerebrospinal fluid inflammation induced by intravenous immunoglobulins. <i>Pediatr Infect Dis J.</i> 1992;11894- 895<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00006454-199210000-00020" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-92">92 <span style="display:none;">+</span></a></div><div class="refContent">Bussel
         JCunningham-Rundles
         CFeldman
         CHorowitz
         B Transmission of viral infection by preparations of intravenous immunoglobulin. <i>Plasma Ther Transfus Technol.</i> 1988;9193- 205<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0278-6222(88)90051-4" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-93">93 <span style="display:none;">+</span></a></div><div class="refContent">Fernández-Carril
         JMTrejo
         JMSedano
         MJGoñi
         M Meningitis aséptica por inmunoglobulinas intravenosas. <i>Neurología.</i> 1995;10351- 352<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-94">94 <span style="display:none;">+</span></a></div><div class="refContent">Gabor
         EP Intravenous immune globulins. <i>West J Med.</i> 1995;162277- 278<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-95">95 <span style="display:none;">+</span></a></div><div class="refContent">Shorr
         AFKester
         KE Meningitis and hepatitis complicating intravenous immunoglobulin therapy. <i>Ann Pharmacother.</i> 1996;301115- 1116<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-96">96 <span style="display:none;">+</span></a></div><div class="refContent">Kattamis
         ACShankar
         SCohen
         AR Neurological complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G. <i>J Pediatr.</i> 1997;130281- 283<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0022-3476(97)70355-X" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-97">97 <span style="display:none;">+</span></a></div><div class="refContent">Picton
         PChishol
         M Aseptic meningitis associated with high dose immunoglobulin: case report. <i>BMJ.</i> 1997;3151203- 1204<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/bmj.315.7117.1203" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-98">98 <span style="display:none;">+</span></a></div><div class="refContent">Lafferty
         TEDeHoratius
         RJSmith
         JB Aseptic meningitis as a side effect of intravenous immune gammaglobulin. <i>J Rheumatol.</i> 1997;242491- 2492<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-99">99 <span style="display:none;">+</span></a></div><div class="refContent">Van der Merché
         FKleyweg
         R Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. <i>J Neurol Neurosurg Psychiatry.</i> 1992;55981<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-100">100 <span style="display:none;">+</span></a></div><div class="refContent">Emmons
         CSmith
         JFlanigan
         M Cerebrospinal fluid inflammation during OKT3 therapy. <i>Lancet.</i> 1986;2510- 511<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0140-6736(86)90375-2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-101">101 <span style="display:none;">+</span></a></div><div class="refContent">Roden
         JKlintmalm
         GBGHusberg
         BSNery
         JOlson
         LM Cerebrospinal fluid inflammation during OKT3 therapy. <i>Lancet.</i> 1987;2272<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0140-6736(87)90852-X" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-102">102 <span style="display:none;">+</span></a></div><div class="refContent">Thistlethwaite
         JRGaber
         AOHaag
         BW
     et al.  OKT3 treatment of steroid-resistant renal allograft rejection. <i>Transplantation.</i> 1987;43176- 184<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007890-198702000-00003" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-103">103 <span style="display:none;">+</span></a></div><div class="refContent">Rello
         JVallverdú
         IColl
         PGurgí
         MNet
         A Aseptic meningitis associated with muromonab-CD3. <i>DICP.</i> 1990;241233<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-104">104 <span style="display:none;">+</span></a></div><div class="refContent">Joy
         MEMichals
         MLCanafax
         DM Aseptic meningitis associated with muromonab-CD3 therapy. <i>Clin Pharmacol.</i> 1988;7721<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-105">105 <span style="display:none;">+</span></a></div><div class="refContent">Figg
         WD Aseptic meningitis associated with muromonab-CD3. <i>DICP.</i> 1991;251395<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-106">106 <span style="display:none;">+</span></a></div><div class="refContent">Strominger
         MBLiu
         GTSchartz
         NJ Optic disk swelling and abducens palsies associated with OKT3. <i>Am J Ophthalmol.</i> 1995;119664- 665<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-107">107 <span style="display:none;">+</span></a></div><div class="refContent">Costanzo-Nordin
         MRSilver
         MAO'Conell
         JB
     et al.  Successful reversal of acute cardiac allograft rejection with OKT3 monoclonal antibody. <i>Circulation.</i> 1987;76(suppl 5)71- 80<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-108">108 <span style="display:none;">+</span></a></div><div class="refContent">Thistlethwaite
         JRStuart
         JKMayes
         JT
     et al.  Monitoring and complications of monoclonal therapy: complications and monitoring of OKT3 therapy. <i>Am J Kidney Dis.</i> 1988;11112- 119<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0272-6386(88)80192-6" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-109">109 <span style="display:none;">+</span></a></div><div class="refContent">Coleman
         AENorman
         DJ OKT3 encephalophaty. <i>Ann Neurol.</i> 1990;28837- 838<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/(ISSN)1531-8249" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-110">110 <span style="display:none;">+</span></a></div><div class="refContent">Adair
         JCWoodley
         SLO'Conell
         JBCall
         GKBaringer
         JR Aseptic meningitis following cardiac transplantation: clinical characteristics and relationship to immunosuppressive regimen. <i>Neurology.</i> 1991;41249- 252<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.41.2_Part_1.249" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-111">111 <span style="display:none;">+</span></a></div><div class="refContent">Chan
         GLWeinstein
         SSWright
         CE
     et al.  Encephalopathy associated with OKT3 administration: possible interaction with indomethacin. <i>Transplantation.</i> 1991;52148- 150<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007890-199107000-00031" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-112">112 <span style="display:none;">+</span></a></div><div class="refContent">Thomas
         DMNicholls
         AJFeest
         TGRiad
         H OKT3 and cerebral oedema. <i>BMJ.</i> 1987;2951486<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/bmj.295.6611.1486-b" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-113">113 <span style="display:none;">+</span></a></div><div class="refContent">Capone
         PMCohen
         ME Seizures and cerebritis associated with administration of OKT3. <i>Pediatr Neurol.</i> 1991;7299- 301<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0887-8994(91)90050-U" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-114">114 <span style="display:none;">+</span></a></div><div class="refContent">Osterman
         JDTrauner
         DAReznik
         VMLemire
         J Transient hemiparesis associated with monoclonal CD3 antibody (OKT3) therapy. <i>Pediatr Neurol.</i> 1993;9482- 484<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0887-8994(93)90030-G" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-115">115 <span style="display:none;">+</span></a></div><div class="refContent">Agarwal
         RKOstaszewski
         MLFeld
         LGSpringate
         JEMoxey-Mims
         MMO'Neill
         KM Tumor necrosis factor and interleukin-6 in cerebrospinal fluid of a patient with recurrent adverse central nervous system events following OKT3. <i>Transplant Proc.</i> 1993;253143- 3144<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-116">116 <span style="display:none;">+</span></a></div><div class="refContent">Kormos
         RLArnitage
         JMDummer
         JSMiyamoto
         YGriffith
         BPHardesty
         RL Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin. <i>Transplantation.</i> 1990;49306- 311<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1097/00007890-199002000-00016" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-117">117 <span style="display:none;">+</span></a></div><div class="refContent">Massanari
         RMartin
         MSmith
         J
     et al.  Aseptic meningitis among kidney transplant recipients receiving a newly marketed murine monoclonal antibody preparation. <i>JAMA.</i> 1986;2561873<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.256.14.1873" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-118">118 <span style="display:none;">+</span></a></div><div class="refContent">Uribe Roca
         MCZurru
         MCGatto
         EMMaggiora
         ECAgost Carreno
         CLuciano
         M Aseptic meningitis due to OKT3. <i>Neurologia.</i> 1998;1398- 99<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-119">119 <span style="display:none;">+</span></a></div><div class="refContent">Rizzo
         JDRowe
         SA Meningism in a ten-month-old infant during OKT3 therapy. <i>J Heart Transplant.</i> 1990;9727- 728<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-120">120 <span style="display:none;">+</span></a></div><div class="refContent">Farmer
         LEchlin
         FALoughin
         WCBreakey
         ASDuvoisin
         R Pachymeningitis apparently due to penicillin hypersensitivity. <i>Ann Intern Med.</i> 1960;54910- 914<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-121">121 <span style="display:none;">+</span></a></div><div class="refContent">Durand
         MLCalderwood
         SBWeber
         DJ
     et al.  Acute bacterial meningitis in adults: a review of 493 episodes. <i>N Engl J Med.</i> 1993;32821- 28<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1056/NEJM199301073280104" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-122">122 <span style="display:none;">+</span></a></div><div class="refContent">Barrons
         RWMurray
         KMRichey
         RM Populations at risk for penicillin-induced seizures. <i>Ann Pharmacother.</i> 1992;2626- 29<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-123">123 <span style="display:none;">+</span></a></div><div class="refContent">Stewart
         WFLipton
         RBCelentano
         DD
     et al.  Prevalence of migraine headache in the United States. <i>JAMA.</i> 1992;26764- 69<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1992.03480010072027" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-124">124 <span style="display:none;">+</span></a></div><div class="refContent">Montalbán
         JCervera
         RFont
         J
     et al.  Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. <i>Neurology.</i> 1992;42681- 682<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1212/WNL.42.3.681" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-125">125 <span style="display:none;">+</span></a></div><div class="refContent">Markus
         HSHopkinson
         N Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids. <i>J Neurol.</i> 1992;23939- 42<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1007/BF00839210" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-126">126 <span style="display:none;">+</span></a></div><div class="refContent">Geiseler
         PJNelson
         KELevin
         SReddi
         KTMoses
         VK Community-acquired purulent meningitis: a review of 1316 cases during the antibiotic era, 1954-1976. <i>Rev Infect Dis.</i> 1980;2725- 745<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clinids/2.5.725" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-127">127 <span style="display:none;">+</span></a></div><div class="refContent">Roos
         KLTunkel
         ARScheld
         WM Acute bacterial meningitis in children and adults. Scheld
         WMWhitley
         RJDurack
         DTeds<i>Infections of the Central Nervous System</i>  New York, NY Raven Press1991;335- 409<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-128">128 <span style="display:none;">+</span></a></div><div class="refContent">Connolly
         KJHammer
         SM The acute aseptic meningitis syndrome. <i>Infect Dis Clin North Am.</i> 1990;4599- 622<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-129">129 <span style="display:none;">+</span></a></div><div class="refContent">Jeffery
         KJMRead
         SJPeto
         TEAMayon-White
         RTBangham
         CRM Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results. <i>Lancet.</i> 1997;349313- 317<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0140-6736(96)08107-X" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-130">130 <span style="display:none;">+</span></a></div><div class="refContent">Ellis
         SGVerity
         MA Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. <i>Semin Arthritis Rheum.</i> 1979;8212- 221<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0049-0172(79)80009-8" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-131">131 <span style="display:none;">+</span></a></div><div class="refContent">Gibson
         TMyers
         AR Nervous system involvement in systemic lupus erythematosus. <i>Ann Rheum Dis.</i> 1975;35398- 406<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/ard.35.5.398" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-132">132 <span style="display:none;">+</span></a></div><div class="refContent">Canoso
         JJCohen
         AS Aseptic meningitis in systemic lupus erythematosus. <i>Arthritis Rheum.</i> 1975;18369- 373<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/(ISSN)1529-0131" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-133">133 <span style="display:none;">+</span></a></div><div class="refContent">Kovacs
         KBors
         LTóthfalusi
         L
     et al.  Cerebrospinal fluid investigations in migraine. <i>Cephalagia.</i> 1989;953- 57<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1046/j.1468-2982.1989.901053.x" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-134">134 <span style="display:none;">+</span></a></div><div class="refContent">Gómez-Aranda
         FCañadillas
         FMartí-Massó
         JF
     et al.  Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. <i>Brain.</i> 1997;1201105- 1113<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/brain/120.7.1105" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-135">135 <span style="display:none;">+</span></a></div><div class="refContent">Brooks
         PMDay
         RO Nonsteroidal anti-inflammatory drugs: differences and similarities. <i>N Engl J Med.</i> 1991;3241716- 1725<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1056/NEJM199106133242407" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-136">136 <span style="display:none;">+</span></a></div><div class="refContent">Berliner
         SWeisberg
         ASchoenfeld
         Y Ibuprofen may induce meningitis in (NZB × NZW) F1 mice. <i>Arthritis Rheum.</i> 1985;28104- 107<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1002/(ISSN)1529-0131" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-137">137 <span style="display:none;">+</span></a></div><div class="refContent">Shoenfeld
         YLivni
         EShaklai
         MPinkhas
         J Sensitization to ibuprofen in systemic lupus erythematosus. <i>JAMA.</i> 1980;244547- 548<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1980.03310060011006" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-138">138 <span style="display:none;">+</span></a></div><div class="refContent">Fauci
         ASSteinberg
         ADHaynes
         BF
     et al.  Immunoregulatory aberrations in systemic lupus erythematosus. <i>J Immunol.</i> 1978;1211473- 1474<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-139">139 <span style="display:none;">+</span></a></div><div class="refContent">Derbes
         SJ Aseptic meningitis, trimethoprim, and Sjögren's syndrome. <i>JAMA.</i> 1985;2532192<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1985.03350390034010" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-140">140 <span style="display:none;">+</span></a></div><div class="refContent">de la Monte
         SMHutchins
         GMGupta
         PK Aseptic meningitis, trimethoprim, and Sjögren's syndrome. <i>JAMA.</i> 1985;2532192<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1985.03350390034009" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-141">141 <span style="display:none;">+</span></a></div><div class="refContent">Dalakas
         MC Aseptic meningitis and intravenous inmmunoglobulin therapy. <i>Ann Intern Med.</i> 1995;122316- 317<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-122-4-199502150-00021" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-142">142 <span style="display:none;">+</span></a></div><div class="refContent">Scribner
         CLKapit
         RMPhillips
         ETRickles
         NM Aseptic meningitis and intravenous immunoglobulin therapy. <i>Ann Intern Med.</i> 1994;121105- 306<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-121-4-199408150-00014" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-143">143 <span style="display:none;">+</span></a></div><div class="refContent">Martin
         MAMassanari
         RMNghiem
         DDSmith
         JLCany
         RT Nosocomial aseptic meningitis associated with administration of OKT3. <i>JAMA.</i> 1988;2592002- 2005<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1001/jama.1988.03720130066031" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-144">144 <span style="display:none;">+</span></a></div><div class="refContent">Chatenaud
         LFerran
         CLegendre
         C
     et al.  In vivo cell activation following OKT3 administration. <i>Transplantation.</i> 1990;49692- 702<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-145">145 <span style="display:none;">+</span></a></div><div class="refContent">Charpentier
         BHiesse
         CFerran
         C
     et al.  Acute clinical syndrome associated with OKT3 administration: prevention by single injection of an anti-human TNF monoclonal antibody. <i>Presse Med.</i> 1991;202009- 2011<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-146">146 <span style="display:none;">+</span></a></div><div class="refContent">Williams
         AFGagnon
         J Neuronal cell thy-1 glycoprotein: homology with immunoglobulin. <i>Science.</i> 1982;216696- 703<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1126/science.6177036" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-147">147 <span style="display:none;">+</span></a></div><div class="refContent">Bienbaum
         G Studies on brain thymus cross-reactive antigens. <i>Brain Res.</i> 1975;84111- 121<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0006-8993(75)90804-5" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-148">148 <span style="display:none;">+</span></a></div><div class="refContent">Hilton
         EStroh
         EM Aseptic meningitis associated with administration of carbamazepine. <i>J Infect Dis.</i> 1989;159363- 364<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/infdis/159.2.363-a" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-149">149 <span style="display:none;">+</span></a></div><div class="refContent">Simon
         LTHsu
         BDornato
         BT Carbamazepine-induced aseptic meningitis. <i>Ann Intern Med.</i> 1990;112627- 628<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-112-8-627" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-150">150 <span style="display:none;">+</span></a></div><div class="refContent">Hemet
         CChassagne
         PLevade
         M
     et al.  Aseptic meningitis secondary to carbamazepine treatment of manic-depressive illness. <i>Am J Psychiatry.</i> 1994;1511393<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-151">151 <span style="display:none;">+</span></a></div><div class="refContent">Dang
         CTRiley
         DK Aseptic meningitis secondary to carbamazepine therapy. <i>Clin Infect Dis.</i> 1996;22729- 730<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1093/clinids/22.4.729" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-152">152 <span style="display:none;">+</span></a></div><div class="refContent">Merrin
         PWilliams
         IA Meningitis associated with sulphasalazine in a patient with Sjögren's syndrome and polyarthritis. <i>Ann Rheum Dis.</i> 1991;50645- 646<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/ard.50.9.645" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-153">153 <span style="display:none;">+</span></a></div><div class="refContent">Alloway
         JAMitchell
         SR Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature. <i>J Rheumatol.</i> 1993;20409- 411<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-154">154 <span style="display:none;">+</span></a></div><div class="refContent">Herlihy
         TE Phenazopiridine and aseptic meningitis. <i>Ann Intern Med.</i> 1987;106172- 135<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.7326/0003-4819-106-1-172_2" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-155">155 <span style="display:none;">+</span></a></div><div class="refContent">Swedish Adverse Drug Reactions Advisory Committee, <i>Survey of Adverse Effects: Zimeldin</i>. <i>Swedish Adverse Drug Reactions Advisory Committee; 1983. Bulletin 39/40.</i> <br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-156">156 <span style="display:none;">+</span></a></div><div class="refContent">Thordarson
         HTalstad
         I Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy. <i>Acta Med Scand.</i> 1986;220493- 495<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1111/j.0954-6820.1986.tb02801.x" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-157">157 <span style="display:none;">+</span></a></div><div class="refContent">Sergent
         JSLockshin
         MDKlemper
         MSLipsky
         BA Central nervous system disease in systemic lupus erythematosus: therapy and prognosis. <i>Am J Med.</i> 1975;58644- 654<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/0002-9343(75)90500-8" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-158">158 <span style="display:none;">+</span></a></div><div class="refContent">Nair
         JStacy
         M Aseptic meningitis associated with salicylate overdose. <i>Psychosomatics.</i> 1993;34372<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1016/S0033-3182(93)71876-9" class="special sans" target="_blank">Link to Article</a></span><br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-159">159 <span style="display:none;">+</span></a></div><div class="refContent">Heinzlef
         OMoguilewski
         ARoullet
         E Meningite aigue aseptique apres vaccination contre l'hepatite B. <i>Presse Med.</i> 1997;26328<br /></div></div><div class="refRow clearfix"><div class="refNumber left"><a name="ref-ira80415-160">160 <span style="display:none;">+</span></a></div><div class="refContent">Durand
         JMSuchet
         L Ranitidine and aseptic meningitis. <i>BMJ.</i> 1997;312886<br /><span class="crossrefDoi"><a href="http://dx.doi.org/10.1136/bmj.312.7035.886a" class="special sans" target="_blank">Link to Article</a></span><br /></div></div></div>
                                </div>
                            
                    </div>
                    <!-- End Tab References - Start Tab Letters -->
                    <div class="contentContainer" id="tab7">
                        <div class="contentBody">
                            

<div class="clearfix letterSubmitForm">
    <h2 id="scm6MainContent_ucUserLetterSubmit_dvLetters" class="sectionHeader">Correspondence</h2>
    <div class="submitLetterButton tool_letter">      
        <a href="ss/SubmitALetter.aspx" id="scm6MainContent_ucUserLetterSubmit_lnkSubmitLetter" rel="nofollow" class="letterLink">
        Submit a Letter
        </a>
    </div>
</div>
                            <div class="letterBody">
                                

                                <div class="lettersCitation">
                                </div>
                            </div>
                        </div>
                    </div>
                    <!-- End Tab Letters - Start tab CME -->
                    <div class="contentContainer" id="tab8">
                        
<div class="cmeTabContainer">

	<div class="cmeQuizContainer">
        <div id="scm6MainContent_quizMain_updateProgressSubmit" style="display:none;">
	
			<div class="progressBackgroundFilter">
			</div>
			<div class="processMessage">
				Loading...<br />
				<br />
				<img alt="Loading" src="//amaprod.silverchaircdn.com/Images/multimedia/ajax-loader.gif?v=1" />
			</div>
		
</div>


			<div class="headerSection">
				<div class="headerCME">CME</div>
				<div id="scm6MainContent_quizMain_divCMEExpires" class="expires">
					
				</div>
			</div>
			<div class="clearAll"></div>

        <div id="scm6MainContent_quizMain_upCME">
	
                
		        
					<div class="courseBox">
						<div class="educationalObjective">
							<span id="scm6MainContent_quizMain_lblEducationalObjective"></span>
						</div>
						<div class="clearAll"></div>
						<input type="submit" name="ctl00$scm6MainContent$quizMain$btnQuizStart" value="START COURSE" id="scm6MainContent_quizMain_btnQuizStart" class="button" />
					</div>
					<div class="clearAll"></div>
					<div id="scm6MainContent_quizMain_ucCMEStatesMet_divStatesMet" class="StatesMet">
	<span class="meetsText">Also Meets CME requirements for:</span> 
    <span class="stateList">
        
    </span>
</div>

					<a href="/cme.aspx?browseState=true" class="browseStates">Browse CME for all U.S. States</a>
					<div class="accreditationInfoHeader">
						Accreditation Information
					</div>
					<div class="accreditationInfo">
						The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
						The AMA designates this journal-based CME activity for a maximum of 1 <i>AMA PRA Category 1 Credit</i><sup>TM</sup> per course.  Physicians should claim only the credit commensurate with 
						the extent of their participation in the activity.  Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for <i>AMA PRA Category 1 Credit</i><sup>TM</sup>.
					</div>
		        

		        
		            
			        <div class="passNote">
				        <span>Note:</span> <span>You must get at least  of the answers correct to pass this quiz.</span>
			        </div>
	
			        





                    
                    <div class="didYouRead">
                        <label>
                            <input name="ctl00$scm6MainContent$quizMain$chkDidYouRead" type="checkbox" id="scm6MainContent_quizMain_chkDidYouRead" class="chkDidYouRead" onclick="if ($(this).is(&#39;:checked&#39;)) { $(&#39;#pnlEnsureReadError&#39;).hide(); }" />
                            <span>I have read the full article associated with this CME.</span>
                        </label>
                    </div>
                    
			        <div class="quizButtons">
				        <input type="submit" name="ctl00$scm6MainContent$quizMain$btnQuizTakeSubmit" value="SUBMIT ANSWERS" id="btnQuizTakeSubmit" class="button" /><a id="scm6MainContent_quizMain_btnQuizTakeClear" href="javascript:__doPostBack(&#39;ctl00$scm6MainContent$quizMain$btnQuizTakeClear&#39;,&#39;&#39;)">Clear Answers</a> |
				        <a id="scm6MainContent_quizMain_btnQuizTakeSave" href="javascript:__doPostBack(&#39;ctl00$scm6MainContent$quizMain$btnQuizTakeSave&#39;,&#39;&#39;)">Save For Later</a>
			        </div>
                    
                    <div id="pnlEnsureReadError">
                        Please click the checkbox indicating that you have read the full article in order to submit your answers.
                    </div>
		        

		        
			        <div class="passNote">
				        <span></span>
				        <span>Your answers have been saved for later.</span>
			        </div>

			        <div class="quizButtons">
				        <input type="submit" name="ctl00$scm6MainContent$quizMain$btnQuizReturn" value="RETURN TO COURSE" id="scm6MainContent_quizMain_btnQuizReturn" class="button" />
			        </div>
		        

		        
			            <div class="passNote">
				            <div class="information">
					            You have not filled in all the answers to complete this quiz
				            </div>
			            </div>
                        <div class="subHeader">
                            The following questions were not answered:
                        </div>
                    
			            <div class="passNote">
				            <div class="information">
					            Sorry, you have unsuccessfully completed this CME quiz with a score of <span id="scm6MainContent_quizMain_lblQuizErrorFailScore"></span>
				            </div>
			            </div>
                        <div class="subHeader">
                            The following questions were not answered correctly:
                        </div>
                    

<input type="submit" name="ctl00$scm6MainContent$quizMain$btnQuizErrorReturn" value="Return to Course" id="scm6MainContent_quizMain_btnQuizErrorReturn" class="button" />
				
				
				
					
					<div class="completedBox">
						
						<div class="commitmentToChange">
							<div class="commitToChange">
								<a id="btnEvalTake" href="javascript:__doPostBack(&#39;ctl00$scm6MainContent$quizMain$btnEvalTake&#39;,&#39;&#39;)">Commitment to Change</a> <span class="optional">(optional):</span>
							</div>
							<div class="clearAll"></div>
							<div class="commitText">
								Indicate what change(s) you will implement in your practice, if any, based on this CME course.
							</div>
						</div>
						
					</div>
					
						<div class="quizResultsHeader">
							<div class="quizHeader">Your quiz results:</div>
							<div class="clearAll"></div>
							<div class="resultsOverview">The filled radio buttons indicate your responses.  The preferred responses are <span class="highlighted">highlighted</span></div>
						</div>
						<div class="clearAll"></div>
						



					
					<div id="committmentDialog">
						<div class="cmeCourse">
							For CME Course:
							<span id="scm6MainContent_quizMain_lblCMECourseName">A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes</span>
						</div>
						<div class="information">
							Indicate what changes(s) you will implement in your practice, if any, based on this
							CME course.
						</div>
						<textarea name="ctl00$scm6MainContent$quizMain$txtCommittmentChanges" rows="2" cols="20" id="txtCommittmentChanges">
</textarea>
						<div class="buttons">
							<div class="submit" id="submit">
							</div>
							<div class="cancel" id="cancel">
							</div>
						</div>
					</div>

				


			
</div> 
	</div>
</div>


<script language="javascript">

    function BindQuizTake()
    {
        $('#btnQuizTakeSubmit').removeAttr("onclick");
        $('#btnQuizTakeSubmit').click(function () {
            if ($('.chkDidYouRead').is(':checked')) {
                scrollToTabs(); //this is in article.aspx
                $('#pnlEnsureReadError').hide();
                return true;
            }
            else {
                $('#pnlEnsureReadError').show();
                return false;
            }
        });
    }

    function BindCommitChange()
    {
        //Committment to change dialog
        $('#btnEvalTake').click(function (e) {
            e.preventDefault();
            $('#committmentDialog').dialog({
                closeText: "X Close",
                width: 735,
                height: 425,
                title: "Commitment to Change",
                modal: true,
                overlay: { opacity: 0.7, background: 'gray' }
            });
            $('#committmentDialog').parent().appendTo($('#Form1'));
        });
        $('#submit').click(function () {
            $('#committmentDialog').dialog('close');
        });
        $('#cancel').click(function () {
            $('#txtCommittmentChanges').val(' ');
            $('#committmentDialog').dialog('close');
        });
    }
</script>


                        <div class="contentBody">
                        </div>
                    </div>
                    <!-- End Tab CME - Start Tab Citing Articles -->
                    <div class="contentContainer" id="tab9">
                        <div class="contentBody refContainer">
                        </div>
                    </div>
                    <!-- End Tab Citing Articles - Start Tab Comments -->
                    <div class="contentContainer" id="tab10">
                        <div class="contentBody">
                            
<script type="text/javascript">
    $(document).ready(function () {
        $('#commentForm .btnSubmit').click(function () {
            //Validate Form and Submit
            if (validateCommentForm()) processCommentForm();
        });
        //Open the Comment Form Dialog
        $('.commentLink').click(function () {
            /* Anonymous & Institutional Anonymous Users should not be able to Submit Comments - Login/Challenge. */
            if ($("#hfSubmitComment").val() == "1") {
                if($('html').attr('class')=='ui-mobile'){
                    $("#commentFormContainer").show();
                }
                else{
                    scroll(0,0);
                    $("#commentFormContainer").dialog({
                        //position: [200,200],
                        modal: false,
                        height: "auto",
                        width: "600",
                        dialogClass: 'boxshadow',
                        closeOnEscape: false,
                        closeText: 'X Close',
                        resizable: true,
                        overlay: { opacity: 0.7, background: 'gray' },
                        open: function () {
                        },
                        close: function (evnt, args) {
                            resetCommentForm();
                        }
                    });
                }
            }
            else {
               
                //openSignInPopup();    // SignIn Dialog Changes - ManojK:01/04/2012
                var mode = $("#hfSubmitComment").val();
                if (mode == "MustSignInOrBuyThisArticle") {
                    $('#globalSignIn11_PurchaseSubscription').show()
                    $('#globalSignIn11_PersonalAccountRegistration').hide()
                }

                if (mode == "MustSignInOrRegisterForFreeAccount") {
                    $('#globalSignIn11_PurchaseSubscription').hide()
                    $('#globalSignIn11_PersonalAccountRegistration').show()
                }

                $('#signinDialog').dialog({
                    closeText: "x Close",
                    width: 800,
                    height: 250,
                    modal: true,
                    overlay: { opacity: 0.7, background: 'gray' }
                });
                $('#signinDialog').parent().appendTo($('#Form1'));
                $signInDialog.dialog('open');
                $("#globalSignIn11_divMustSignInStatement").show();
                $("#globalSignIn11_divNoAccessStatement").hide(); 
            }
            return false;
        });
        //Close the Comment Form Dialog
        $('.btnCancel').click(function () {
            if($('html').attr('class')=='ui-mobile'){
                $("#commentFormContainer").hide();
            }
            else{
                $("#commentFormContainer").dialog("close");
            }
        });
        $('#noConflict').change(function () {
            if ($(this).is(':checked')) {
                $('#txtDisclosure').attr('disabled', 'disabled');
            }
            else {
                $('#txtDisclosure').removeAttr('disabled');
            }
        });
    });
    //Validate Form Data
    function validateCommentForm() {
        resetCommentFormValidation();
        //Validate Form Using Validity Plugin
        $.validity.setup({ outputMode: "label" });
        $.validity.start();
        $("#commentForm .required").require();
        var result = $.validity.end();
        //Additional Validation required for Disclosure Input and Checkbox
        if (!$('#noConflict').is(':checked') && $('#txtDisclosure').val() == '') {
            $('.disclosure.error').show();
            return false;
        }
        else if (result.valid) return true;
        else return false;
    }
    //Capture Form Data and Send back to Server
    function processCommentForm() {
        $("#commentForm .pleaseWait").show();
        var oJSON = "{";
        $('#commentForm input[type=checkbox]').each(function () {
            var value =  $(this).is(':checked');           
            oJSON += '"' + $(this).attr('name') + '" :' + '"' + value + '"' + ", ";            
        });
        $('#commentForm input[type=text], #commentForm textarea').each(function () {
            var value = $(this).val();
            var replacevalue=/"/g;
            var replacevaluewith='\\\"';
            if (typeof (value) == "string") {value = (value.replace(replacevalue, replacevaluewith));}
             //Replace Double Quotes with &quot;
				//In the Callback event on the server, replace &quot; with "" after the JS Deserialization is complete.
				oJSON += '"' + $(this).attr('name') + '" :' + '"' + value.replace(/"/g, "&quot;") + '"' + ", ";
        });
        oJSON = $.trim(oJSON);
        oJSON = oJSON.substring(0, oJSON.length - 1);      
        oJSON += "}";
        CallBack(oJSON);
    }
    //Reset Form to Initial State
    function resetCommentForm() {
        $("#displayAlert, .captchaAlert").hide().html('');
        $("commentForm .pleaseWait").hide();
        $("#commentForm").show();
        $("input, textarea", $('#commentForm')).val('');
        $('#noConflict').removeAttr('checked');
        resetCommentFormValidation();
    }
    //Clear Error Messages
    function resetCommentFormValidation() {
        $('#commentForm .error').not('.disclosure.error').remove();
        $('#commentForm .disclosure.error').hide();
    }
    function DatafromServer(args) {
        scroll(0,0);
        var arg = args.split(":");
        if (parseInt(arg[0]) > 0) {
            $("#commentForm").hide();
            $("#displayAlert").html("<strong>Thank you for submitting a comment on this article. It will be reviewed by the editors of <em>JAMA Internal Medicine</em> and published at their discretion.\r\n You will be notified when your comment has been published.</strong>").css({ 'color': 'auto' }).show();
            $("#CaptchaImage").attr("src", "CaptchaImageHandler.axd?"+Math.random());
        } else if (arg[0]="-1"){
            $(".captchaAlert").html("You have entered an invalid code.").css({ 'color': '#C60C46' }).show();
        }
        else {
            $("#displayAlert").html("Comments not saved. Please Try Again").css({ 'color': '#C60C46' }).show();
        }
        //Tracking Code
        var key = 'UserCommentsWidget';
        var value = 'SubmitButton Clicked';
        this.UserSessionItem = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
        this.ActionType = new ActionType(1, key);
        doTracking(this.ActionType, value.toString(), "10/14/2015 4:02:23 PM", this.UserSessionItem, (window.location).toString());
        $("#commentForm .pleaseWait").hide();
    }
//    function openSignInPopup() {
//        var w = 800;
//        var h = 800;
//        var left = (screen.width / 2) - (w / 2);
//        var top = (screen.height / 2) - (h / 2);
//        window.open("/SignInPopup.aspx", "mywindow", "menubar=0,resizable=0,width=800,height=400,top=" + top + ",left=" + left);
//    };

    
        Telerik.Web.UI.RadCaptcha.prototype.onAudioPlay = function (e) {

            if (this._objectElement) {
                this._objectElement.Play();
            }
            else if ($telerik.isChrome || this._audioElement) {

                this._audioElement.load();
                this._audioElement.play();

            }
            return $telerik.cancelRawEvent(e);
        } 
</script>
<div id="commentFormContainer" class="clearfix" style="display: none;" title="Submit a Comment">
    
    <div id="commentForm">
        <p class="description"><strong>Instructions</strong></p>
        <p class="description">Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.</p>
        <p class="description">Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author.  Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
        </p>
        <p>
            <span class="asterisk">*</span> = Required Field</p>
        <div class="commentRow">
            <label for="txtCommentAuthors" id="commentAuthors">
                <strong>Comment Author(s)</strong><span class="asterisk">*</span> (if multiple authors, separate
                names by comma)</label>
            <input type="text" id="txtCommentAuthors" name="Authors" title="Authors" class="required" />
            <div class="tooltipComments">
                Example: John Doe</div>
        </div>
        <div class="commentRow">
            <label for="txtCommentAffiliation" id="commentAffiliation">
                <strong>Affiliation & Institution</strong><span class="asterisk">*</span></label>
            <input type="text" id="txtCommentAffiliation" class="required" name="Affiliations"
                title="Affiliations" />
        </div>
        <div class="commentRow disclosure"><p>
            <label for="txtCommentDisclosure" id="commentDisclosure">
                <strong>Disclosure of Any Conflicts of Interest</strong><span class="asterisk">*</span>
                Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.  
            </label>
            </p>
            <textarea id="txtDisclosure" name="Disclosure" title="Disclosure" rows="5" cols="5"></textarea>
            <div class="disclosure error">
                Please disclose any conflicts of interest or check the box below.</div>
            <input type="checkbox" id="noConflict" title="NoConflicts" name="NoConflicts" />
            No potential conflicts or relevant financial interests
        </div>
        <div class="commentRow">
            <label for="txtCommentTitle" id="commentTitle">
                <strong>Comment Title</strong><span class="asterisk">*</span></label>
            <input type="text" id="txtCommentTitle" name="CommentTitle" title="Comment Title"
                class="required" />
        </div>
        <div class="commentRow last">
            <label for="txtComment" id="comment">
                <strong>Comment</strong><span class="asterisk">*</span></label>
            <textarea id="txtComment" class="required" name="Comment" title="Comment" rows="5"
                cols="5"></textarea>
        </div>
        <div id="scm6MainContent_ucUserComments_UpdatePanel1">
	
                <div id="scm6MainContent_ucUserComments_RadCaptcha1" class="RadCaptcha RadCaptcha_Default">
		<!-- 2010.2.713.20 --><div id="scm6MainContent_ucUserComments_RadCaptcha1_SpamProtectorPanel">
			<img id="scm6MainContent_ucUserComments_RadCaptcha1_CaptchaImage" class="rcCaptchaImage" alt="" src="Telerik.Web.UI.WebResource.axd?type=rca&amp;isc=false&amp;guid=be48ab35-d61d-4e5a-af7d-9607f0ab1fe8" height="50" width="180" style="display:block;" /><a href="Telerik.Web.UI.WebResource.axd?type=cah&amp;isc=false&amp;guid=be48ab35-d61d-4e5a-af7d-9607f0ab1fe8" id="scm6MainContent_ucUserComments_RadCaptcha1_CaptchaAudioCode" class="rcCaptchaAudioLink">Get Audio Code</a>
		</div><input id="scm6MainContent_ucUserComments_RadCaptcha1_ClientState" name="scm6MainContent_ucUserComments_RadCaptcha1_ClientState" type="hidden" />
	</div>
            
</div>
        <input type="text" id="txtCaptchaData" class="captcha" name="CaptchaData" maxlength="5" />
        <div class="captchaAlert">
        </div>
        <div class="submitRow">
            <img class="pleaseWait" src="//amaprod.silverchaircdn.com/Images/multimedia/ajax-loader.gif?v=1" alt="Please Wait..." />
            <a id="scm6MainContent_ucUserComments_btnSubmit" class="btnSubmit">Submit</a> <a href="#" class="btnCancel">Cancel</a>
        </div>
    </div>
    <span class="alertmsg" id="displayAlert"></span>
</div>

                            <div class="commentBody">
                                
<div class="comments clearfix">
    <script type="text/javascript">
        $(window).load(function () {

            // Only show the lower Comments link if there is a comment shown
            (function () {
                var c$ = $('.commentHeader');
                var s$ = $('#SubmitaCommentLeft')

                if (typeof (c$.length) && c$.length > 0) {
                    s$.show();
                    console.log('comments');
                }

            });


        });
    </script>
   <a href="UserControls/#" id="aSubmitaComment" class="commentLink right" alt="Submit a Comment"><span class="left ir toolbox_sprite tool_comment"></span>Submit a Comment</a>

   <div class="clearAll">
    </div>
    
    

</div>

                            </div>
                        </div>
                    </div>
                    <!-- End Tab Citing - Start Tab Video -->
                    <div class="contentContainer" id="tab5">
                        <h2 class="sectionHeader">Multimedia</h2>
                        
                    </div>
                    <!-- End Tab multimedia - Start Tab supplemental -->
                    <div class="contentContainer" id="tab12">
                        <div class="SupplementContainer">
                            
<div class="acContent" style="width: 460px; padding: 0px;">
    
</div>

                        </div>
                        <div class="dataSupplementDialog"></div>
                    </div>
                </div>
                <!-- End Content Holders -->
                <!-- Section to display during Tab Clicks-->
                <div id="divSignInSubscriptionUpsell" style="display: none;" class="contentContainer signInUpsell">
                    <div>
                        <div class="right divSubmitLetterButton" style="display: none;">
                            <img src="//amaprod.silverchaircdn.com/Images/icons/b_download.png?v=1" alt="" id="img1" />
                            <a href="ss/SubmitALetter.aspx" id="scm6MainContent_lnkSubmitLetter" rel="nofollow" class="letterLink">Submit a Letter</a>
                        </div>
                        <div class="right divSubmitCommentButton" style="display: none;">
                            <img src="//amaprod.silverchaircdn.com/Images/icons/b_download.png?v=1" alt="" id="imgDown" />
                            <a id="scm6MainContent_lnkSubmitComment" class="commentLink">
                                <span id="scm6MainContent_lblSubmitCommentText">Submit a Comment</span></a>
                        </div>
                        <div class="clearAll">
                        </div>
                    </div>
                    <div id="divSignInContainer">
                        <div id="globalSignIn3" class="divSignInForNonArticleTabs" style="display: none;">
                            
<script type="text/javascript">
    $(window).load(function () {
        //For each unique instance of this control setup simple validation for input fields
        $('.globalSignIn').each(function () {
            var globalSignIn = $(this);
            $('.signInButton', $(globalSignIn)).click(function (e) {
                if ($(globalSignIn).find('.field input').val() == '') {
                    $(globalSignIn).find('.errorMessageSection .validationControl').html("The username and/or password is blank. Please try again.");
                    //Prevent propagation of post-back binding generated via .net
                    return false;
                }
            });
        });
    });
</script>

<div id="scm6MainContent_globalSignIn3_divSsoGlobalSignIn" class="ssoGlobalSignIn clearfix">
    
    
    
    <div id="scm6MainContent_globalSignIn3_ssoLeftSignIn" class="ssoSignInBox">
        <div class="ssoLoginInfo">
            <div id="scm6MainContent_globalSignIn3_ssoSignInHeader" class="ssoSignInHeader">
                <h3 id="scm6MainContent_globalSignIn3_ssoSignInHeader1">Sign in
                </h3>
            </div>
            <div id="scm6MainContent_globalSignIn3_divSsoCustomSignIn" class="ssoULTop">
                <div id="scm6MainContent_globalSignIn3_divPersonalSignInLink" class="divPersonalSignInLink">
                    <span>
                        <span id="scm6MainContent_globalSignIn3_ssoPersonalSignInBullet" class="ssoSignInBullet">•</span>
                        <a href="/OAuthSignIn.aspx?return_url=http%3a%2f%2farchinte.jamanetwork.com%2farticle.aspx%3farticleid%3d485056" id="scm6MainContent_globalSignIn3_aOAuthSignIn" rel="nofollow" class="ssoSignInIndividualAccount">Sign in</a> to your
                        personal account </span>
                </div>
                <div id="scm6MainContent_globalSignIn3_divSsoInstitutionalSignInLinks" class="ssoInstitutionalSignInLinks ssoSignInLink">
                    <span>
                        <span id="scm6MainContent_globalSignIn3_ssoInstitutionSignInBullet" class="ssoSignInBullet">•</span>
                        Institutional sign in:
                            <a id="scm6MainContent_globalSignIn3_lnkbtnLoginViaAthensSso" href="javascript:__doPostBack(&#39;ctl00$scm6MainContent$globalSignIn3$lnkbtnLoginViaAthensSso&#39;,&#39;&#39;)"> Athens</a>&nbsp;|
                            <a href="/SignInShibboleth.aspx">Shibboleth</a>&nbsp; </span>
                </div>
            </div>
            
            <div id="scm6MainContent_globalSignIn3_ssoPersonalAccountRegistration">
                <div id="scm6MainContent_globalSignIn3_ucSsoPersonalAccountRegistration_personalAccount" class="personalAccount">

</div>

<div id="scm6MainContent_globalSignIn3_ucSsoPersonalAccountRegistration_divSsoSubscriptionBox" class="ssoSubscriptionBox left">
	<div id="scm6MainContent_globalSignIn3_ucSsoPersonalAccountRegistration_divCreateFreePersonalAccountSso" class="CreateFreePersonalAccount">
		<span>
			<a href="https://login.ama-assn.org/account/signup?appId=scweb&return_url=http%3a%2f%2farchinte.jamanetwork.com%2farticle.aspx%3farticleid%3d485056" id="aSsoCreateFreePersonalAccount" rel="nofollow" class="ssoSignInLink ssoCreateAccount">Create a free personal account</a>
		</span>
	</div>
</div>

<script type="text/javascript">
    function OpenLink(url) {
        var popUpUrl = null;
        if (url != null) {
            popUpUrl = url;
        } else {
            popUpUrl = "/store/home.aspx";
        }
        if (window.opener != null && !window.opener.closed) {
            // for signpopup.aspx. this is a popup
            window.opener.location.href = popUpUrl;
            window.close();
        } else {
            // personalsignin.aspx. this is not a popup
            window.location.href = popUpUrl;
        }
    };
</script>

            </div>
            
        </div>
    </div>

    <div id="scm6MainContent_globalSignIn3_ssoRightSignIn" class="ssoRightSignIn">
        
        <div id="scm6MainContent_globalSignIn3_ssoPurchaseSubscription">
            

<div id="scm6MainContent_globalSignIn3_ucSsoPurchaseSubscription_divSsoPurchaseAccess" class="ssoPurchaseAccess">
    <h4 id="scm6MainContent_globalSignIn3_ucSsoPurchaseSubscription_ssoPurchaseOptionsLabel">Purchase Options
    </h4>
    <div class="ssoPurchaseOptions">
        <div id="scm6MainContent_globalSignIn3_ucSsoPurchaseSubscription_dvSspBuThisArticle"><span>•&nbsp;<a id="scm6MainContent_globalSignIn3_ucSsoPurchaseSubscription_hlSsoBuThisArticle" class="ssoSignInLink" rel="nofollow" href="http://store.jamanetwork.com/productDetails.aspx?articleid=485056">Buy</a>&nbsp;this article</span></div>
        <div><span>•&nbsp;<a id="scm6MainContent_globalSignIn3_ucSsoPurchaseSubscription_hlSsoSubscribeToJournal" class="ssoSignInLink" rel="nofollow" href="http://store.jamanetwork.com/productDetails.aspx?journalid=71">Subscribe</a>&nbsp;to the journal</span></div>
        <div style="display:none"><span>•&nbsp;<a id="scm6MainContent_globalSignIn3_ucSsoPurchaseSubscription_hlRentThisArticle" href="/RentArticle.ashx?articleid=485056">Rent</a></span>&nbsp;this article <a class="aRentThisArticle" href="#">?</a></div>
    </div>
</div>



<script type="text/javascript">
    function OpenLink(url) {
        var popUpUrl = null;
        if (url != null) {
            popUpUrl = url;
        } else {
            popUpUrl = "/store/home.aspx";
        }
        if (window.opener != null && !window.opener.closed) {
            // for signpopup.aspx. this is a popup
            window.opener.location.href = popUpUrl;
            window.close();
        } else {
            // personalsignin.aspx. this is not a popup
            window.location.href = popUpUrl;
        }
    }
</script>

<script type="text/javascript">
    
    function RentArticleFromPopup() {
        alert("Hey wass up");
    }
    $(document).ready(function () {
        try {
            $(".signupForAlert input").attr("checked", "checked");
            $(".ssoCreateAccount").attr("href", $("#hfAlertUrl").val());
            var ssoSignInIndividualAccountHref = $(".ssoSignInIndividualAccount").attr("href");
            if (ssoSignInIndividualAccountHref.indexOf("alert=1") < 0) {
                if (ssoSignInIndividualAccountHref.indexOf("?") < 0) {
                    $(".ssoSignInIndividualAccount").attr("href", ssoSignInIndividualAccountHref + "?alert=1");
                } else {
                    $(".ssoSignInIndividualAccount").attr("href", ssoSignInIndividualAccountHref + "&alert=1");
                    if ($(".ssoSignInIndividualAccount").attr("href").indexOf(".aspx&") >= 0) {
                        $(".ssoSignInIndividualAccount").attr("href", $(".ssoSignInIndividualAccount").attr("href").replace(".aspx&", ".aspx?"));
                    }
                }
            }
        } catch(e) { } 


        $(".signupForAlert input").click(function () {
            var $link = $(this).parent().parent().parent().parent().parent().parent().prev().find(".ssoCreateAccount");
            var $personalSignInLink = $(this).parent().parent().parent().parent().parent().parent().prev().find(".ssoSignInIndividualAccount");

            if ($(this).is(":checked")) {
                $link.attr("href", $("#hfAlertUrl").val());
                if (ssoSignInIndividualAccountHref.indexOf("alert=1") < 0) {
                    if (ssoSignInIndividualAccountHref.indexOf("?") < 0) {
                        $personalSignInLink.attr("href", ssoSignInIndividualAccountHref + "?alert=1");
                    } else {
                        $personalSignInLink.attr("href", ssoSignInIndividualAccountHref + "&alert=1");
                        if ($personalSignInLink.attr("href").indexOf(".aspx&") >= 0) {
                            $personalSignInLink.attr("href", $personalSignInLink.attr("href").replace(".aspx&", ".aspx?"));
                        }
                    }
                }
            } else {
                $link.attr("href", $("#hfNoAlertUrl").val());
                $personalSignInLink.attr("href", ssoSignInIndividualAccountHref.replace("?alert=1", ""));
                $personalSignInLink.attr("href", ssoSignInIndividualAccountHref.replace("&alert=1", ""));
                $link.attr("href", $link.replace("&alert=1", ""));

            }
        });
        function displayRentThisArticleDialog() {
            var rentThisArticleDialog = $('#rentThisArticleDialog').dialog({
                closeText: "x Close",
                width: 600,
                height: 160,
                modal: true,
                overlay: { opacity: 0.7, background: 'gray' }
            });
            rentThisArticleDialog.parent().appendTo($('#Form1'));
            rentThisArticleDialog.dialog('open');
        }
        $('.aRentThisArticle').click(function (e) {
            e.preventDefault();
            $('.ui-icon-closethick').trigger('click'); // close sign-in model
            displayRentThisArticleDialog();
        });
    });
</script>

        </div>
        
    </div>
</div>

                        </div>
                    </div>
                    <div class="clearAll">
                    </div>
                </div>
                <div class="relatedArticlesMobile">
                </div>
                <div class="collectionsMobile">
                </div>
            </div>
            <div class="right portletColumn eqColumn">
                <!--Buttons for sliding Panel Right and Left-->
                <div class="btnSlider">
                    <div class="btnSlideRight">
                    </div>
                    <div class="btnSlideLeft">
                    </div>
                </div>
                     
                   
                    
                 
                   

<div class="ssArticleWidget clearfix">
	<div id="scm6MainContent_ucWidgetArticleSS_ucSelfServe">
	<div class="selfServe">
		<!--
<div style="border: 1px solid #000000; padding: 10px; margin: 0px !important; background-color: #ffffcc;">
<p style="font-weight: 700; margin-bottom: 10px; padding: 0px !important; text-align: center;">* * MAINTENANCE NOTICE * *</p>
<p style="margin: 0px !important; padding: 0px !important;">Maintenance will be performed tonight between 8<span style="font-variant: small-caps; margin-left: 1px;">pm</span>&ndash;2<span style="font-variant: small-caps; margin-left: 1px;">am</span> CST that should not affect site performance. Thank you for your patience.</p>
</div>
-->
<script type="text/javascript">
  var ord = window.ord || Math.floor(Math.random() * 1e16);
  document.write('<script type="text/javascript" src="http://ad.doubleclick.net/N6479/adj/ama.archinte/selfpromotion;s1=selfpromotion;sz=328x80;ord=' + ord + '?"><\/script>');
</script>
<noscript>
<a href="http://ad.doubleclick.net/N6479/jump/ama.archinte/selfpromotion;s1=selfpromotion;sz=328x80;ord=123456789?">
<img src="http://ad.doubleclick.net/N6479/ad/ama.archinte/selfpromotion;s1=selfpromotion;sz=328x80;ord=123456789?" width="328" height="80" />
</a>
</noscript>
<!-- START GRA TAG PLEASE DO NOT REMOVE -->
<script type="text/javascript">
/* <![CDATA[ */
var google_conversion_id = 994279176;
var google_custom_params = window.google_tag_params;
var google_remarketing_only = true;
/* ]]> */
</script>
<script type="text/javascript" src="//www.googleadservices.com/pagead/conversion.js">
</script>
<noscript>
<!-- <div style="display:inline;"> -->
<img height="1" width="1" style="border-style:none;" alt="" src="//googleads.g.doubleclick.net/pagead/viewthroughconversion/994279176/?value=0&amp;guid=ON&amp;script=0"/>
<!-- </div> -->
</noscript>
<!-- END GRA TAG -->
<style>
    .requireSsoRegistrationForFreePdfs {
    display: none;
    }
</style>
	</div>
</div>
</div> 

                <div class="portletTabMenu">

                    <!--Portlet Right Tab Menu-->
                    <div class="hiddenTabs clearfix">

                        <div id="scm6MainContent_divToolBoxMsg" class="aboveToolBoxMsg">
                            <p>
                                Some tools below are only available to our subscribers or users with an online account.
                            </p>
                        </div>
                        <div class="rightTabInfo">
                        </div>
                        <div id="scm6MainContent_ToolBox" class="aLinks clearfix">
                            

<script type="text/javascript">
    function test(o) { }
    function downloadFile(filename) {
        var url = filename;
        window.location.href = url;
    }
</script>
<div class="module-widget toolbox">
    <ul id="rightPopupMenu" class="rightpopup tools" style="list-style-type:none;">
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$hfAlerts" id="hfAlerts" value="MustSignInOrRegisterForFreeAccount" />
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$hfGetCitation" id="hfGetCitation" value="1" />
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$hfEmail" id="hfEmail" value="1" />
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$hfShareThis" id="hfShareThis" />
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$hfPrintableView" id="hfPrintableView" value="1" />
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$hfSlideset" id="hfSlideset" />
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$hfDataSupplement" id="hfDataSupplement" />
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$hfSubmitComment" id="hfSubmitComment" value="MustSignInOrRegisterForFreeAccount" />
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$hfSubmitLetter" id="hfSubmitLetter" value="CanAccess" />
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$hfPDFDownload" id="hfPDFDownload" value="MustSignInOrRegisterForFreeAccount" />
        
        <li id="scm6MainContent_ucArticleToolbox_tbFeaturePrint" class="firstLI"> 
            <a id="scm6MainContent_ucArticleToolbox_printTool" class="printArticle" title="Print"><span class="left ir toolbox_sprite tool_print"></span>Print</a> <!--class="printMenu"-->
        </li>

        <li id="scm6MainContent_ucArticleToolbox_tbFeaturePDF" class="firstLI">
            <a id="hypPDFlink" class="linkPDF" alt="PDF" target="_blank"><span class="left ir toolbox_sprite tool_pdf"></span>PDF</a>
        </li>

        <li id="scm6MainContent_ucArticleToolbox_tbFeatureEmail">
            <a class="sendEmail" alt="Email"><span class="left ir toolbox_sprite tool_email"></span>Email</a>
            
<style>
#emailForm
{
    background-color: #eee;
    border:none;
    padding:10px;
    margin:10px;
    margin-left:0px;
}
#emailForm h3
{
    margin:0px;
    padding:0px 0px 10px 0px;
    font-size:135%;
}
.emailRow
{
    width:100%;
    overflow:hidden;
    padding-bottom:5px;
    height:34px;
    margin:10px 0px;
}
.emailRow label
{
    width:140px;
    float:left;
    color: #333;
    font-weight:bold;
    padding-top:5px;
    
}
.emailRow input[type="text"], .emailRow textarea
{
    width:250px;
    padding:5px;
    border:1px solid #ccc;
}

#txtEmailSubject, #txtEmailMessage
{
    width:540px;
}

#txtEmailMessage
{
    min-height:120px;
    overflow:auto;
    border:1px solid #ccc;
    padding:5px;
}

.tooltipEmail
{
    height:16px;
    font-size:11px;
    color: #8A1919;
    display:none;
    float:none;
    background-repeat:no-repeat;
    background-position:left center;
    padding:0px 20px;
    padding-left:142px;
}

#emailMessageInfo
{
    height:16px;
    font-size:11px;
    float:none;
    padding:0px 20px;
    padding-left:142px;
}
    
</style>

<script type="text/javascript">
    function setSubjectText() {
        txtEmailSubject.value = txtSenderName.value + hfSubjectEnd.value;
    }
</script>

<div class="emailPopupDialog">
    <div id="scm6MainContent_ucArticleToolbox_ucSendEmail_dvWidgetTitle" class="logoBrand">Email Article</div>

    <div id="upBody">
	

    

    

    

    <div id="divErrorMessage">
        <div class="sentMsg">
            You must be logged in as an individual user to share content.
        </div>
        <div class="returnTo">
            <br />
            Return to: <span style="font-weight:bold;">The Challenge of Drug-Induced Aseptic Meningitis</span>
        </div>
    </div>
        
        
</div>

    <div class="copyText">
        <br />
        <div id="scm6MainContent_ucArticleToolbox_ucSendEmail_dvCopyrightParagraph"></br>This feature is provided as a courtesy. By using it you agree that that you are requesting the material solely for personal, non-commercial use, and that it is subject to the AMA's <a href="../public/ConditionsOfUse.aspx">Terms of Use</a>. The information provided in order to email this article will not be shared, sold, traded, exchanged, or rented. Please refer to The JAMA Network's <a href="../public/privacypolicy.aspx">Privacy Policy</a> for additional information.</div>
    </div>
    <div id="scm6MainContent_ucArticleToolbox_ucSendEmail_dvCopyrightInfo" class="copyrightInfo"><a href="../public/Copyright.aspx">&copy; 2015 American Medical Association. All Rights Reserved.</a></div>
</div>

<script type="text/javascript">
    var bool;
    var prm = Sys.WebForms.PageRequestManager.getInstance();
    prm.add_endRequest(function (s, e) {
        bool = true
    });

    function resetEmailConfirmation() {
        __doPostBack('upBody', '');
    }
</script>
        </li>

        

        <li id="scm6MainContent_ucArticleToolbox_tbFeatureGetCitation"><a class="getCitation" alt="Get Citation"><span class="left ir toolbox_sprite tool_citation"></span>Get Citation</a>
            
<script type="text/javascript">
    $(document).ready(function () {
        var source = $('.mastHead').find('.siteHeader').children('.siteLogo').find('img').clone();
        $('.logoBrand').append(source);
    });
</script>
<style type="text/css">
.logoBrand img{width:280px;}
</style>

<div class="getCitationPopupDialog">
    <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$ucGetCitation$articleId" id="scm6MainContent_ucArticleToolbox_ucGetCitation_articleId" value="485056" />
    <div class="logoBrand"></div>
    <div id="scm6MainContent_ucArticleToolbox_ucGetCitation_citationCopyPaste" class="citationCopyPaste">
        <span id="scm6MainContent_ucArticleToolbox_ucGetCitation_txtCopyPaste" class="copyPaste" border="0" style="display:inline-block;">Moris G, Garcia-Monco J. The Challenge of Drug-Induced Aseptic Meningitis. <i>Arch Intern Med. </i>1999;159(11):1185-1194. doi:10.1001/archinte.159.11.1185. </span>
    </div>
    <div class="citationLinks">
        <p>Download citation file: </p>
        <div class="citationLink"><a id="scm6MainContent_ucArticleToolbox_ucGetCitation_hlRIS" rel="nofollow" href="downloadCitation.aspx?format=ris&amp;articleid=485056">RIS (Zotero)</a></div>
        <div class="citationLink"><a id="scm6MainContent_ucArticleToolbox_ucGetCitation_hlEndNote" rel="nofollow" href="downloadCitation.aspx?format=enw&amp;articleid=485056">EndNote</a></div>
        <div class="citationLink"><a id="scm6MainContent_ucArticleToolbox_ucGetCitation_hlBibTex" rel="nofollow" href="downloadCitation.aspx?format=bibtex&amp;articleid=485056">BibTex</a></div>
        <div class="citationLink"><a id="scm6MainContent_ucArticleToolbox_ucGetCitation_hlMedlars" rel="nofollow" href="downloadCitation.aspx?format=txt&amp;articleid=485056">Medlars</a></div>
        <div class="citationLink"><a id="scm6MainContent_ucArticleToolbox_ucGetCitation_hlProCite" rel="nofollow" href="downloadCitation.aspx?format=ris&amp;articleid=485056">ProCite</a></div>
        <div class="citationLink"><a id="scm6MainContent_ucArticleToolbox_ucGetCitation_hlRefWorks" rel="nofollow" href="downloadCitation.aspx?articleid=485056">RefWorks</a></div>
        <div class="citationLink"><a id="scm6MainContent_ucArticleToolbox_ucGetCitation_hlReferenceManager" rel="nofollow" href="downloadCitation.aspx?format=ris&amp;articleid=485056">Reference Manager</a></div>
    </div>
	<div class="copyrightInfo">&copy; American Medical Association</div>
</div>


        </li>

        <li id="scm6MainContent_ucArticleToolbox_tbFeatureReprintsAndPermissions">
            <a id="scm6MainContent_ucArticleToolbox_aReprintsPermissions" class="reprintsPermissions" onclick="window.open(&#39;http://s100.copyright.com/AppDispatchServlet?publisherName=AMA&amp;publication=0003-9926&amp;title=The Challenge of Drug-Induced Aseptic Meningitis&amp;publicationDate=06/14/1999&amp;volumeNum=159&amp;issueNum=11&amp;author=Moris, German, Garcia-Monco, Juan Carlos&amp;startPage=1185&amp;endPage=1194&amp;contentID=485056&amp;orderBeanReset=True&#39;, &#39;Permissions&#39;, &#39;width=500,height=500,left=150,top=200,scrollbars=1,toolbar=no,status=1&#39;);"><span class="left ir toolbox_sprite tool_permissions"></span>Get Permissions</a>
        </li>

        <li id="scm6MainContent_ucArticleToolbox_tbFeatureArticleAlerts">
            <a class="showAlerts" id="alertTool" alt="Article Alerts"><span class="left ir toolbox_sprite tool_alerts"></span>Get Alerts</a>
            
<div class="alertPopupDialog">
    <div id="progressBar" style="font-family:Verdana;font-weight:bold;font-size:13pt;" class="userAlertPopupProgressBar">
        <img src="//amaprod.silverchaircdn.com/Images/multimedia/ajax-loader.gif?v=1" alt="Please Wait..." />
        Processing your request... Please Wait.
    </div>
    <div id="scm6MainContent_ucArticleToolbox_ucUserAlerts_divMessage" class="alertPopupMessage">
    
    </div>
    <br />
    <div id="scm6MainContent_ucArticleToolbox_ucUserAlerts_divLogin">
        
    </div>
    <div id="scm6MainContent_ucArticleToolbox_ucUserAlerts_divEmailConfirmation" class="UserAlertEmailConfirmation">
        <input type="text" id="txtUserAlertEmailAddress" class="editableField" onblur="getNewEmailAddress(this);"  />
        <button id="btnConfirm" class="button" clientidmode="Static" onclick="callBackUserAlert();">Confirm</button>
        <input type="hidden" name="ctl00$scm6MainContent$ucArticleToolbox$ucUserAlerts$hfOriginalEmailAddress" id="hfOriginalEmailAddress" />
    </div>
</div>

        </li> 
                             
        <li id="scm6MainContent_ucArticleToolbox_tbFeatureSubmitLetter">
            <a href="ss/SubmitALetter.aspx" id="scm6MainContent_ucArticleToolbox_aSubmitLetter" rel="nofollow" class="lettersToEditor" alt="Submit a Letter" style="Visibility:visible;"><span class="left ir toolbox_sprite tool_letter"></span>Submit a Letter</a>
        </li>

         <li id="scm6MainContent_ucArticleToolbox_tbFeatureSubmitComments">
            <a href="#" class="commentLink" id="toolComment" alt="Submit a Comment"><span class="left ir toolbox_sprite tool_comment"></span>Submit a Comment</a>
        </li>
        
        

        
    </ul>
</div>

                        </div>
                        <div class="resetAfter">
                        </div>
                    </div>
                </div>
                <div class="portletContentHolder">
                    <!--Portlet Content Holder Starts-->
                    <div class="portletWrapper clearfix">

                        <!-- Altmetrics -->
                        <div class="portlet" id="divArticleLevelMetrics">
                                <div class="widget-ArticleLevelMetrics widget-instance-AMA_ArticleMetrics">
        





    <div class="artmet-condensed-wrap clearfix">
        <div class="artmet-condensed-stats clearfix">
            <div class="artmet-item artmet-views">
                <span class="artmet-number">6,592</span>
                <span class="artmet-text">Views</span>
            </div>

            <div class="artmet-item artmet-citations">
                <span class="artmet-number">
                     <a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=WOS:000080823800006&amp;DestLinkType=CitingArticles&amp;DestApp=ALL_WOS&amp;UsrCustomerID=61f30d8ae69c46f86624c5f98a3bc13a" target="_blank">83</a>
                </span>
                <span class="artmet-text">Citations</span>
            </div>
    
            <div class="artmet-item artmet-altmetric">
    <div class="widget-AltmetricLink widget-instance-ArticleLevelMetrics_AltmetricLinkSummary">
            <!-- Altmetrics -->
    <div id="altmetricEmbedId" runat="server" class='altmetric-embed' data-link-target="_blank" data-badge-type="donut" data-hide-no-mentions="false" data-doi="10.1001/archinte.159.11.1185"
     
        
        ></div>
         <script type='text/javascript' src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'></script>
 
    </div>

            </div>
        </div>

            <div class="artmet-modal-trigger-wrap clearfix">
                <a class="artmet-modal-trigger" data-article-id="485056"><i class="icon-metrics"></i><span>View Metrics</span></a>
            </div>
    </div>

 
    </div>

                        </div>

                        <div id="globalSignIn2">
                            
                        </div>
                        <div class="relatedContentHeading" id="noMove">
                            <h3>Related Content</h3>
                            <p>
                                Customize your page view by dragging & repositioning the boxes below.
                            </p>
                        </div>
                        <div class="portletContainer">
                            <div class="portlet thirdParty editorsChoice" id="item11">
                                
                            </div>
                            <div class="portlet" id="divMultimediaRelatedByTopic">
                                
                            </div>
                            <div class="portlet" id="divRelatedArticles">
                                <div id="scm6MainContent_ucRelatedArticles_divModuleWidgetMain" class="module-widget">
    <div class="configure">
        <script type="text/javascript" language="javascript">

    	
    	    $(document).ready(function () {
    		    bindToggle('#ctl00_scm6MainContent_ucRelatedArticles_divRelatedArticles #ctl00_scm6MainContent_ucRelatedArticles_aShowMoreArticles',
                    '#ctl00_scm6MainContent_ucRelatedArticles_divArticleContent',
                    'invisible',
                    '[+] View More',
                    '[-] View Fewer',
                    'RelatedArticlesWidget',
                    'e0mq2r2zvrcct5d4lg3vkzhg',
                    '10/14/2015 4:02:24 PM');

    		    bindFilterTerms('#ctl00_scm6MainContent_ucRelatedArticles_divRelatedArticles #ctl00_scm6MainContent_ucRelatedArticles_aFilterHeader',
    		    '#ctl00_scm6MainContent_ucRelatedArticles_divRelatedArticles .filterTermsArticle',
    		    '#ctl00_scm6MainContent_ucRelatedArticles_divRelatedArticles .filterLinkArticle',
    		    scm6MainContent_ucRelatedArticlesCallback
    		    );
    	    });
        
               function ArticleDatafromServer(args) {
           	    var obj = JSON.parse(args, "");
           	    $('#ctl00_scm6MainContent_ucRelatedArticles_divArticleContent').html(obj._ContentHTML);

           	    syncViewMoreToggle('#ctl00_scm6MainContent_ucRelatedArticles_divRelatedArticles #ctl00_scm6MainContent_ucRelatedArticles_aShowMoreArticles',
           		    '#ctl00_scm6MainContent_ucRelatedArticles_divArticleContent',
           		    'invisible');
               }

        </script>

        <span id="scm6MainContent_ucRelatedArticles_lblWidgetTitle" class="widgetTitle">Articles Related By Topic</span>
        <span class="moveicon"></span>
        <span id="articleWidgetConfigureIcon" class="configureicon"></span>
        <div class="clearAll"></div>
    </div>
    <div id="ctl00_scm6MainContent_ucRelatedArticles_divRelatedArticles" class="portlet-content">
        <div id="scm6MainContent_ucRelatedArticles_divFilterTop">
            <a id="ctl00_scm6MainContent_ucRelatedArticles_aFilterHeader" class="selected filterTitle">Filter By Topic ></a>
            <div class="filterTermsArticle">
                <a id="0" class="filterLinkArticle">All Articles</a>
            </div>
        </div>
        <div class="contentFilter">
            
                    <ul class="filterTermsArticle">
                
                        <li><a id='81' class="filterLinkArticle">antibiotics</a></li>
                
                        <li><a id='9437' class="filterLinkArticle">aseptic meningitis</a></li>
                
                        <li><a id='9667' class="filterLinkArticle">meningitis</a></li>
                
                        <li><a id='14499' class="filterLinkArticle">anti-inflammatory agents, non-steroidal</a></li>
                
                    </ul>
                
        </div>
    
        <div id="ctl00_scm6MainContent_ucRelatedArticles_divArticleContent" class="relatedArticlesContent">
            
                    <div id="scm6MainContent_ucRelatedArticles_rptArticleContent_divPortletContentSection_0" class="mostChild">
                        <div class="contentTitle">
                            <a href="http://archinte.jamanetwork.com/article.aspx?articleid=485158" id="scm6MainContent_ucRelatedArticles_rptArticleContent_aArticleLink_0">
                                 <span id="scm6MainContent_ucRelatedArticles_rptArticleContent_spTitle_0" class="aTitle">Meningococcal Disease in a Large Urban Population (Barcelona, 1987-1992)<span class="titleSeparator">: </span><span class="subTitleBreak"><span style="display:none;"> </span></span><span class="subTitle">Predictors of Dismal Prognosis</span></span>
                            </a>
                        </div>
                        <div id="scm6MainContent_ucRelatedArticles_rptArticleContent_divCitation_0" class="contentInfo"><i>Arch Intern Med. </i>1999;159(19):2329-2340. doi:10.1001/archinte.159.19.2329. </div>
                    </div>
            
                
                    <div id="scm6MainContent_ucRelatedArticles_rptArticleContent_divPortletContentSection_1" class="mostChild">
                        <div class="contentTitle">
                            <a href="http://archinte.jamanetwork.com/article.aspx?articleid=649633" id="scm6MainContent_ucRelatedArticles_rptArticleContent_aArticleLink_1">
                                 <span id="scm6MainContent_ucRelatedArticles_rptArticleContent_spTitle_1" class="aTitle">A Fresh Look at the Definition of Susceptibility of Streptococcus pneumoniae to β-Lactam Antibiotics</span>
                            </a>
                        </div>
                        <div id="scm6MainContent_ucRelatedArticles_rptArticleContent_divCitation_1" class="contentInfo"><i>Arch Intern Med. </i>2001;161(21):2538-2544. doi:10.1001/archinte.161.21.2538. </div>
                    </div>
            
                
                    <div id="scm6MainContent_ucRelatedArticles_rptArticleContent_divPortletContentSection_2" class="mostChild invisible" style="display:none;">
                        <div class="contentTitle">
                            <a href="http://archinte.jamanetwork.com/article.aspx?articleid=2451282" id="scm6MainContent_ucRelatedArticles_rptArticleContent_aArticleLink_2">
                                 <span id="scm6MainContent_ucRelatedArticles_rptArticleContent_spTitle_2" class="aTitle">Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone</span>
                            </a>
                        </div>
                        <div id="scm6MainContent_ucRelatedArticles_rptArticleContent_divCitation_2" class="contentInfo"><i>JAMA Intern Med. </i> Published online October 05, 2015.;():1-9. doi:10.1001/jamainternmed.2015.5389. </div>
                    </div>
            
                
                    <div id="scm6MainContent_ucRelatedArticles_rptArticleContent_divPortletContentSection_3" class="mostChild invisible" style="display:none;">
                        <div class="contentTitle">
                            <a href="http://archinte.jamanetwork.com/article.aspx?articleid=2442505" id="scm6MainContent_ucRelatedArticles_rptArticleContent_aArticleLink_3">
                                 <span id="scm6MainContent_ucRelatedArticles_rptArticleContent_spTitle_3" class="aTitle">Inappropriate Antibiotic Therapy in a Patient With Heart Failure and Prolonged QT Interval<span class="titleSeparator">: </span><span class="subTitleBreak"><span style="display:none;"> </span></span><span class="subTitle">A Teachable Moment</span></span>
                            </a>
                        </div>
                        <div id="scm6MainContent_ucRelatedArticles_rptArticleContent_divCitation_3" class="contentInfo"><i>JAMA Intern Med. </i> Published online September 21, 2015.;():1-2. doi:10.1001/jamainternmed.2015.5047. </div>
                    </div>
            
                
                    <div id="scm6MainContent_ucRelatedArticles_rptArticleContent_divPortletContentSection_4" class="mostChild invisible" style="display:none;">
                        <div class="contentTitle">
                            <a href="http://archinte.jamanetwork.com/article.aspx?articleid=2337253" id="scm6MainContent_ucRelatedArticles_rptArticleContent_aArticleLink_4">
                                 <span id="scm6MainContent_ucRelatedArticles_rptArticleContent_spTitle_4" class="aTitle">Effects of Excessive Antibiotic Use in Nursing Homes </span>
                            </a>
                        </div>
                        <div id="scm6MainContent_ucRelatedArticles_rptArticleContent_divCitation_4" class="contentInfo"><i>JAMA Intern Med. </i>2015;175(8):1339-1341. doi:10.1001/jamainternmed.2015.2774. </div>
                    </div>
            
                
        </div>
        <div id="ctl00_scm6MainContent_ucRelatedArticles_divViewMore" class="relatedArticlesViewMore widgetViewMore">
            <a id="ctl00_scm6MainContent_ucRelatedArticles_aShowMoreArticles" class="selected">[+] View More</a>
        </div>

         

    </div>
</div>
                            </div>
                            <div class="portlet" id="divRelatedCollections">
                                
<div class="module-widget">
    <div class="configure"> 
        <script type="text/javascript" language ="javascript">
            $(document).ready(function () {
                // Tracking category clicks : Added by Santosh K on 05/11/11
                $('.widgetCollection').click(function () {
                    var value = 'category id = ' + $(this).attr('id');
                    var key = 'WidgetRelatedCollections';
                    var session = this.UserSessionItem;
                    var action = this.ActionType;
                    session = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
                    action = new ActionType(1, key);
                    doTracking(action, value.toString(), "10/14/2015 4:02:24 PM", session, (window.location).toString());
                });
            });
        </script>
        <div id="scm6MainContent_ucRelatedCollections_widgetTitle" class="portlet-title">Related Collections</div>
        <span class="moveicon"></span>
        <span class="configureicon"></span>
        <div class="clearAll"></div>
    </div>
    <div class="portlet-content">
	    <div class="portletContentSection">
            <ul>
                
                        <li><a href="collection.aspx?categoryid=5702">Infectious Diseases</a></li>
                    
                        <li><a href="collection.aspx?categoryid=5747">Meningitis</a></li>
                    
                        <li><a href="collection.aspx?categoryid=5777">Neurology</a></li>
                    
                        <li><a href="collection.aspx?categoryid=5958">Viral Infections (not HIV)</a></li>
                    
            </ul>
        </div>
        
    </div>
</div>
                            </div>
                            <div class="portlet" id="divRelatedCME">
                                
                            </div>
                            <div class="portlet thirdParty" id="divRelatedPubMed">
                                
<div class="module-widget">
    <div class="configure">

        
        <script type="text/javascript" language="javascript" >
            $(document).ready(function () {
                $('#pubmedwidgetConfigureIcon').click(function () {
                    var id = $(this).attr('class');
                    var value = id.toString() + ' is Clicked';

                    var key = 'RelatedPubMedWidget';
                    //popuate the input object and call the pagebase method to update the database
                    var session = this.UserSessionItem;
                    var action = this.ActionType;
                    session = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
                    action = new ActionType(1, key);
                    doTracking(action, value.toString(), "10/14/2015 4:02:24 PM", session, (window.location).toString());
                });
                $('#dvViewMore').click(function () {
                    var id = $(this).attr('class');
                    var value = id.toString() + ' is Clicked';

                    var key = 'RelatedPubMedWidget';
                    //popuate the input object and call the pagebase method to update the database
                    var session = this.UserSessionItem;
                    var action = this.ActionType;
                    session = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
                    action = new ActionType(1, key);
                    doTracking(action, value.toString(), "10/14/2015 4:02:24 PM", session, (window.location).toString());
                });
            });
        </script>
	    <span class="widgetTitle">PubMed Articles</span>
        <span id="scm6MainContent_ucRelatedPubMed_spnMoveIcon" class="moveicon"></span>
        <span id="pubmedwidgetConfigureIcon" class="configureicon"></span>
    </div>
    <div class="portlet-content pubmedwidget">
        <div class="portletContentSection">
            
                    <div class="contentTitle">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1299979" id="scm6MainContent_ucRelatedPubMed_rptFilter_aArticleLink_0" target="_blank">[Drug-induced aseptic meningitis].</a>
                        <span>
                            <span id="scm6MainContent_ucRelatedPubMed_rptFilter_spnSubtitle1_0" class="subtitle1"><i>Therapie</i></span>
                            <span id="scm6MainContent_ucRelatedPubMed_rptFilter_spnSubtitle2_0" class="subtitle2">;47(5):399-402.</span>
                        </span>
                    </div>
                
                    <div class="contentTitle">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/10371226" id="scm6MainContent_ucRelatedPubMed_rptFilter_aArticleLink_1" target="_blank">The challenge of drug-induced aseptic meningitis.</a>
                        <span>
                            <span id="scm6MainContent_ucRelatedPubMed_rptFilter_spnSubtitle1_1" class="subtitle1"><i>Arch Intern Med</i></span>
                            <span id="scm6MainContent_ucRelatedPubMed_rptFilter_spnSubtitle2_1" class="subtitle2">1999;159(11):1185-94.</span>
                        </span>
                    </div>
                
        </div>
        <div id="scm6MainContent_ucRelatedPubMed_dvViewMore" class="viewMore">
            <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=antibiotics+AND+aseptic+meningitis+AND+meningitis+AND+muromonab-cd3" id="scm6MainContent_ucRelatedPubMed_aViewMore" target="_blank">View More</a>
        </div>
        <div id="scm6MainContent_ucRelatedPubMed_dvPubMedLogo" class="pubMedLogo">
            Results provided by:
            <img src="//amaprod.silverchaircdn.com/Images/buttons/logo_widget_PubMed.png" align="right" />
        </div>
    </div>
</div>

                            </div>
                            <div id="scm6MainContent_divRelatedJobs" class="portlet thirdParty">
                                

<div class="configure">
    Jobs
    <span class="moveicon"></span>
    <span class="configureicon"></span>
</div>
<div class="portlet-content">
    <div id="scm6MainContent_ucRelatedJobs_AdicioJobsWidget_dvPhysicianJobs" class="adicio jobs-widget section">
    
    <div id="jobframe"></div>
    <p class="small footer">More Listings at<br /><a class="special" href="http://www.jamacareercenter.com">JAMACareerCenter.com &gt;</a></p>
</div>
<script type="text/javascript">

//    function loadJSWithoutBlocking(url) {
//        var a = document.createElement('script');
//        a.type = 'text/javascript';
//        a.src = url;
//        document.getElementsByTagName('head')[0].appendChild(a);
//    }
    
    $(window).load(function () {

//        loadJSWithoutBlocking('http://jama.careers.adicio.com/js/xmlScrollView2.js');
//        loadJSWithoutBlocking('http://jama.careers.adicio.com/qjs/?clientid=ama&stringVar=xmlString&pageSize=2&outFormat=jsxml');

        var myFeaturedFrame = new xmlScrollView();
        myFeaturedFrame.disableScroll();
        myFeaturedFrame.setOutPutElement('jobframe');
        myFeaturedFrame.setItemRoot('Job');
        myFeaturedFrame.declareVariable('Title', '%jobTitle%');
        myFeaturedFrame.declareVariable('Employer', '%jobEmployer%');
        myFeaturedFrame.declareVariable('Location', '%jobLocation%');
        myFeaturedFrame.declareVariable('Url', '%jobLink%');
        myFeaturedFrame.setTemplate('<p><a class="jobTitle" href="%jobLink%" target="_blank">%jobTitle%</a><br />\
	<span class="employer">%jobEmployer%</span><br />\
	<span class="location">%jobLocation%</span></p>');
        myFeaturedFrame.outputFromString(xmlString);
    });

</script>


    
</div>
                            </div>
                            <div id="scm6MainContent_divJamaEvidence" class="portlet thirdParty">
                                

<div class="configure jamaevidence">
	<span class="title">JAMAevidence.com</span>
    <span class="moveicon"></span>
    <span id="jamaevidenceConfigureIcon" class="configureicon"></span>
</div>

<div class="portlet-content jamaevidence">
    
            <p>
                The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
                <br />
                <a class="bold" href="http://jamaevidence.mhmedical.com/content.aspx?bookid=845&sectionId=61364719" target="_blank">Evidence to Support the Update</a>
            </p>
        
            <p>
                The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
                <br />
                <a class="bold" href="http://jamaevidence.mhmedical.com/content.aspx?bookid=845&sectionId=61364720" target="_blank">Evidence Summary and Review 1</a>
            </p>
        

    <p class="small footer">
            All results at <br />
        <a class="special externalLink bold" href="http://jamaevidence.mhmedical.com/searchresults.aspx?q=antibiotics">JAMAevidence.com &gt;</a>  
	</p>

</div>
                            </div>
                        </div>
                        <div class="adPortlet">
                            <div class="addHead">
                                















<div id="advertisingBlocksRightSkyscraperArticle" class="advertisingBlocks" contentplaceholderid="RightSkyscraperArticle">
    
   

<!-- Begin Ad Body Tag -->
<div class="center-block center">
<div><small><a href="http://jamanetwork.com/SS/Advertising_Disclaimer.aspx">Advertisement</a></small></div>

<script type="text/javascript">
    googletag.cmd.push(function () { googletag.display('advertisingBlocksRightSkyscraperArticle') });
</script>

</div>
<!-- End Ad Body Tag -->

    
    
    
</div>














                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
        <div class="artmet-modal" id="MetricsModal"> 
            <div class="artmet-modal-contents"> 
                <a class="artmet-close-modal">&#215;</a> 
            </div> 
        </div>
        <div id="displaypopup" class="expMsg" style="font-size: 10pt; display: none;">
            <b>You do not have access to this content.</b><br />
            <br />
            You either do not have a subscription or your subscription has expired. <a style="color: Blue; font: Bold;" href="http://scm6devstore.silverchair.com/">Click here</a> to Renew Now
        </div>
        <div id="append">
        </div>
    </div>
    <input type="hidden" name="ctl00$scm6MainContent$hfSessionID" id="hfSessionID" value="e0mq2r2zvrcct5d4lg3vkzhg" />

            </div>
            <div class="footerWrap clearfix">
                
 <div class="journalFooter">
    <div id="footerNav1" class="left column">
        <h4><span id="journalFooter_lblJournal">JAMA Internal Medicine</span></h4>
        <h6>Content</h6>
        <ul>
            <li><a href="http://archinte.jamanetwork.com" id="journalFooter_journalHome">Home</a></li>
            <li id="journalFooter_liJournalCurrentIssue"><a href="issue.aspx" id="journalFooter_journalCurrentIssue">Current Issue</a></li>
            <li id="journalFooter_liJournalAllIssues"><a href="issues.aspx" id="journalFooter_journalAllIssues">All Issues</a></li>
            <li id="journalFooter_liOnlineFirst"><a href="onlineFirst.aspx" id="journalFooter_onlineFirst">Online First</a></li>
            <li id="journalFooter_liTopicCollections"><a href="collections.aspx" id="journalFooter_topicCollections">Collections</a></li>
            <li id="journalFooter_licme"><a href="cme.aspx" id="journalFooter_cme">CME</a></li>
            <li id="journalFooter_liMultimedia"><a href="multimedia.aspx" id="journalFooter_multimedia">Multimedia</a></li>
            
            <li id="journalFooter_liJournalRss"><a href="rssfeeds.aspx" id="journalFooter_journalRss">RSS</a></li>
            <li id="journalFooter_liJournalPodcasts"><a href="multimedia.aspx#AuthorInterviews" id="journalFooter_journalPodcasts">Podcasts</a></li>
        </ul>
        <h6>Services</h6>
        <ul>
            <li><a href="public/ForAuthors.aspx" id="journalFooter_A1">For Authors</a></li>
            <li id="journalFooter_liJournalReviewers"><a href="public/Reviewers.aspx" id="journalFooter_journalReviewers">For Reviewers</a></li>
            <li><a href="http://archinte.jamanetwork.com/ss/readers.aspx" id="journalFooter_aReaders">For Readers</a></li>
            <li><a href="public/About.aspx" id="journalFooter_journalAbout">About</a></li>
            <li id="journalFooter_liJournalEditorsPublishers"><a id="journalEditorsPublishers" href="javascript:__doPostBack(&#39;ctl00$journalFooter$journalEditorsPublishers&#39;,&#39;&#39;)">Editors & Publishers</a></li>
            <li id="journalFooter_liJournalSubscribe"><a href="http://store.jamanetwork.com/productDetails.aspx?journalid=71" id="journalFooter_journalSubscribe" rel="nofollow">Subscribe</a></li>
            <li><a href="public/contact.aspx" id="journalFooter_journalContact">Contact Us</a></li>
 			<li><a id="lnkAboutMobile2" href="http://mobile.jamanetwork.com">About Mobile</a></li>
       </ul>
    </div>
    <div id="footerNav2" class="left column">
        <h4>The JAMA Network</h4>
        <h6>Sites</h6>
        <ul>
            <li><a href="http://jama.jamanetwork.com" id="journalFooter_jama">JAMA</a></li>
            <li><a href="http://archderm.jamanetwork.com" id="journalFooter_archOfDerm">JAMA Dermatology</a></li>
            <li><a href="http://archfaci.jamanetwork.com" id="journalFooter_archOfFPS">JAMA Facial Plastic Surgery</a></li>
            <li><a href="http://archinte.jamanetwork.com" id="journalFooter_archOfInternalMed">JAMA Internal Medicine</a></li>
            <li><a href="http://archneur.jamanetwork.com" id="journalFooter_archOfNeurology">JAMA Neurology</a></li>
            <li><a href="http://oncology.jamanetwork.com" id="journalFooter_jamaOncology">JAMA Oncology</a></li>
            <li><a href="http://archopht.jamanetwork.com" id="journalFooter_archOfOphth">JAMA Ophthalmology</a></li>
            <li><a href="http://archotol.jamanetwork.com" id="journalFooter_archOfOtolaryngology">JAMA Otolaryngology–Head &amp; Neck Surgery</a></li>
            <li><a href="http://archpedi.jamanetwork.com" id="journalFooter_archOfPeds">JAMA Pediatrics</a></li>
			<li><a href="http://archpsyc.jamanetwork.com" id="journalFooter_archOfGeneralPsych">JAMA Psychiatry</a></li>
            <li><a href="http://archsurg.jamanetwork.com" id="journalFooter_archOfSurg">JAMA Surgery</a></li>
            <li><a href="http://archneurpsyc.jamanetwork.com" id="journalFooter_archOfNP">Archives of Neurology &amp; Psychiatry</a></li>
            <li><a href="http://jamaevidence.com/" id="journalFooter_jamaEvidence">JAMAevidence</a></li>
            <li><a href="http://ebm.jamanetwork.com">Evidence-Based Medicine: An Oral History</a></li>
            <li><a href="http://webcasts.jamanetwork.com">JAMA Network Webcasts</a></li>
            <li><a href="http://broadcast.jamanetwork.com" target="_blank">The JAMA Report</a></li>
            <li><a href="http://sites.jamanetwork.com/" target="_blank">Featured</a></li>
        </ul>
        <h6>AMA Publishing Group Journals</h6>
        <ul>
            <li><a href="http://virtualmentor.ama-assn.org/" id="journalFooter_virtualMentor">AMA Journal of Ethics</a></li>
        </ul>
    </div>
    <div id="footerNav3" class="left column">
        <h2>&nbsp;</h2>
        <h6>Information For</h6>
        <ul>
            <li><a href="../public/InstitutionsLibrarians.aspx">Institutions/Librarians</a></li>
            <li><a href="http://media.jamanetwork.com" id="journalFooter_aForTheMedia">Print Media</a></li>
            <li><a href="http://broadcast.jamanetwork.com" target="_blank">Broadcast Media</a></li>
            <li><a href="../public/Advertisers.aspx">Advertisers</a></li>
            <li><a href="http://jamanetwork.com/public/SubscriptionAgents.aspx" id="journalFooter_aSubscriptionAgents">Subscription Agents</a></li>
            <li><a href="http://www.jamacareercenter.com/">Employers & Job Seekers</a></li>
        </ul>
        <h6>Services</h6>
        <ul>
            <li><a href="http://store.jamanetwork.com/productDetails.aspx?journalid=71" id="journalFooter_lnkSubscriptions" rel="nofollow">Subscriptions & Renewals</a></li>
            <li><a href="/account/myalerts.aspx#myEmail" id="lnkEMailAlerts" rel="nofollow" class="footerEmailAlerts">Email Alerts</a></li>
            <li id="journalFooter_liServiceRss"><a href="http://jamanetwork.com/rssfeeds.aspx" id="journalFooter_serviceRss" target="_blank">RSS</a></li>
            <li><a href="http://jamanetwork.com/SS/ReprintsPermissions.aspx" id="lnkReprintsPermissions" rel="nofollow">Reprints & Permissions</a></li>
            <li><a href="http://jamanetwork.com/public/ForAuthors.aspx" id="journalFooter_aJamaNetworkForAuthors">For Authors</a></li>
			<li><a id="lnkAboutMobile" href="http://mobile.jamanetwork.com">About Mobile</a></li>
            <li><a href="http://jamanetwork.com/public/Help.aspx" id="journalFooter_aHelp">Help</a></li>
        </ul>
        <input name="ctl00$journalFooter$hfFooterPersonalUserIsLoggedIn" type="hidden" id="journalFooter_hfFooterPersonalUserIsLoggedIn" value="0" />
    </div>
    <div id="footerNav4" class="left column">
        <h4>Content Resources</h4>
        <ul>
            <li><a href="http://www.amamanualofstyle.com">AMA Manual of Style</a></li>
            <li><a href="http://www.peerreviewcongress.org/index.html">Peer Review Congress</a></li>
            <li><a href="http://www.icmje.org">ICMJE</a></li>
            <li><a href="http://www.wame.org">WAME</a></li>
        </ul>
        <h4>Other Resources</h4>
        <ul>
            <li><a href="http://www.jamacareercenter.com">Physician Jobs</a></li>
            <li><a href="http://jamanetwork.com/public/MedicalMeetings.aspx" id="journalFooter_aMedicalMeetings">Medical Meetings</a></li>
            <li><a href="http://jamanetwork.com/public/ConditionsOfUse.aspx" id="journalFooter_aConditionsOfUse" rel="nofollow">Conditions of Use</a></li>
            <li><a href="http://jamanetwork.com/public/PrivacyPolicy.aspx" id="journalFooter_aPrivacyPolicy" rel="nofollow">Privacy Policy</a></li>
            <li><a href="http://jamanetwork.com/public/Copyright.aspx" id="journalFooter_aCopyright">Copyright</a></li>
            <li><a href="http://jamanetwork.com/data/pdfs/ads/adPrinciples.pdf" id="journalFooter_aAdvertisingPolicy">Advertising Policies</a></li>
        </ul>
    </div>
    <div class="clearAll"></div>
    <hr />
</div>
<script type="text/javascript">
    $(window).load(function () {
        // /JS/scm6.global.js
        var footerColumns = equalHeight($('.journalFooter .column'));
    });
</script>

                <div class="Footer">
                    

<div class="siteFooter" itemscope itemtype="http://schema.org/Organization">
    <a class="networkLogo"></a>
    <div class="copyright"><a href="../public/Copyright.aspx">&copy; 2015 <span itemprop="name">American Medical Association</span>. All Rights Reserved.</a><br />Powered by<a href="http://www.silverchair.com" class="sscLogo" target="_blank"></a><a href="http://www.silverchair.com" target="_blank">Silverchair Information Systems</a></div>
</div>
                </div>
                
            </div>
            
            <div id="signinDialog" style="display: none">
                
<script type="text/javascript">
    $(window).load(function () {
        //For each unique instance of this control setup simple validation for input fields
        $('.globalSignIn').each(function () {
            var globalSignIn = $(this);
            $('.signInButton', $(globalSignIn)).click(function (e) {
                if ($(globalSignIn).find('.field input').val() == '') {
                    $(globalSignIn).find('.errorMessageSection .validationControl').html("The username and/or password is blank. Please try again.");
                    //Prevent propagation of post-back binding generated via .net
                    return false;
                }
            });
        });
    });
</script>

<div id="globalSignIn11_divSsoGlobalSignIn" class="ssoGlobalSignIn clearfix">
    <div id="globalSignIn11_divMustSignInStatement" class="mustSigninStatement">
        You must sign in to your personal account to access this feature:
    </div>
    <div id="globalSignIn11_divNoAccessStatement" class="noAccessStatement">
        You do not currently have access to this content.
    </div>
    <div id="globalSignIn11_divRequireSsoRegistrationForFreePdfs" class="mustSigninStatement">
        Sign in to download this free article PDF
    </div>
    <div id="globalSignIn11_ssoLeftSignIn" class="ssoSignInBox">
        <div class="ssoLoginInfo">
            <div id="globalSignIn11_ssoSignInHeader" class="ssoSignInHeader">
                <h3 id="globalSignIn11_ssoSignInHeader1">Sign in
                </h3>
            </div>
            <div id="globalSignIn11_divSsoCustomSignIn" class="ssoULTop">
                <div id="globalSignIn11_divPersonalSignInLink" class="divPersonalSignInLink">
                    <span>
                        <span id="globalSignIn11_ssoPersonalSignInBullet" class="ssoSignInBullet">•</span>
                        <a href="/OAuthSignIn.aspx?return_url=http%3a%2f%2farchinte.jamanetwork.com%2farticle.aspx%3farticleid%3d485056" id="globalSignIn11_aOAuthSignIn" rel="nofollow" class="ssoSignInIndividualAccount">Sign in</a> to your
                        personal account </span>
                </div>
                <div id="globalSignIn11_divSsoInstitutionalSignInLinks" class="ssoInstitutionalSignInLinks ssoSignInLink">
                    <span>
                        <span id="globalSignIn11_ssoInstitutionSignInBullet" class="ssoSignInBullet">•</span>
                        Institutional sign in:
                            <a id="globalSignIn11_lnkbtnLoginViaAthensSso" href="javascript:__doPostBack(&#39;ctl00$globalSignIn11$lnkbtnLoginViaAthensSso&#39;,&#39;&#39;)"> Athens</a>&nbsp;|
                            <a href="/SignInShibboleth.aspx">Shibboleth</a>&nbsp; </span>
                </div>
            </div>
            
            <div id="globalSignIn11_ssoPersonalAccountRegistration">
                <div id="globalSignIn11_ucSsoPersonalAccountRegistration_personalAccount" class="personalAccount">

</div>

<div id="globalSignIn11_ucSsoPersonalAccountRegistration_divSsoSubscriptionBox" class="ssoSubscriptionBox left">
	<div id="globalSignIn11_ucSsoPersonalAccountRegistration_divCreateFreePersonalAccountSso" class="CreateFreePersonalAccount">
		<span>
			<a href="https://login.ama-assn.org/account/signup?appId=scweb&return_url=http%3a%2f%2farchinte.jamanetwork.com%2farticle.aspx%3farticleid%3d485056" id="aSsoCreateFreePersonalAccount" rel="nofollow" class="ssoSignInLink ssoCreateAccount">Create a free personal account</a>
		</span>
	</div>
</div>

<script type="text/javascript">
    function OpenLink(url) {
        var popUpUrl = null;
        if (url != null) {
            popUpUrl = url;
        } else {
            popUpUrl = "/store/home.aspx";
        }
        if (window.opener != null && !window.opener.closed) {
            // for signpopup.aspx. this is a popup
            window.opener.location.href = popUpUrl;
            window.close();
        } else {
            // personalsignin.aspx. this is not a popup
            window.location.href = popUpUrl;
        }
    };
</script>

            </div>
            
        </div>
    </div>

    <div id="globalSignIn11_ssoRightSignIn" class="ssoRightSignIn">
        
        <div id="globalSignIn11_ssoPurchaseSubscription">
            

<div id="globalSignIn11_ucSsoPurchaseSubscription_divSsoPurchaseAccess" class="ssoPurchaseAccess">
    <h4 id="globalSignIn11_ucSsoPurchaseSubscription_ssoPurchaseOptionsLabel">Purchase Options
    </h4>
    <div class="ssoPurchaseOptions">
        <div id="globalSignIn11_ucSsoPurchaseSubscription_dvSspBuThisArticle"><span>•&nbsp;<a id="globalSignIn11_ucSsoPurchaseSubscription_hlSsoBuThisArticle" class="ssoSignInLink" rel="nofollow" href="http://store.jamanetwork.com/productDetails.aspx?articleid=485056">Buy</a>&nbsp;this article</span></div>
        <div><span>•&nbsp;<a id="globalSignIn11_ucSsoPurchaseSubscription_hlSsoSubscribeToJournal" class="ssoSignInLink" rel="nofollow" href="http://store.jamanetwork.com/productDetails.aspx?journalid=71">Subscribe</a>&nbsp;to the journal</span></div>
        <div style="display:none"><span>•&nbsp;<a id="globalSignIn11_ucSsoPurchaseSubscription_hlRentThisArticle" href="/RentArticle.ashx?articleid=485056">Rent</a></span>&nbsp;this article <a class="aRentThisArticle" href="#">?</a></div>
    </div>
</div>

<div id="divSsoRequireRegistration" class="ssoRequireRegistration right">
    <h4 id="globalSignIn11_ucSsoPurchaseSubscription_H1">A free personal account provides
    </h4>
    <div class="ssoRequireRegistrationBenefits">
        <div id="globalSignIn11_ucSsoPurchaseSubscription_Div2">
            <span>•&nbsp;Free current issues on
                <a id="globalSignIn11_ucSsoPurchaseSubscription_hplJamaNetworkReader" class="ssoSignInLink" href="http://mobile.jamanetwork.com/reader.html">The JAMA Network Reader</a></span>
        </div>
        <div>
            <span>•&nbsp;Free quizzes on
                <a id="globalSignIn11_ucSsoPurchaseSubscription_hypJamaNetworkChallenge" class="ssoSignInLink" href="http://mobile.jamanetwork.com/challenge.html">The JAMA Network Challenge</a></span>
        </div>
        <div>
            <span>•&nbsp;Commenting and personalized alerts</span>
        </div>
        <div class="left signupForAlertCheckBox">
            <span class="signupForAlert left"><input id="globalSignIn11_ucSsoPurchaseSubscription_cbSignUpForAlert" type="checkbox" name="ctl00$globalSignIn11$ucSsoPurchaseSubscription$cbSignUpForAlert" checked="checked" /><label for="globalSignIn11_ucSsoPurchaseSubscription_cbSignUpForAlert"><span class='bold'>Yes!</span>  Alert me when new content is published.</label></span>
            <input type="hidden" name="ctl00$globalSignIn11$ucSsoPurchaseSubscription$hfAlertUrl" id="hfAlertUrl" value="https://login.ama-assn.org/account/signup?appId=scweb&amp;returnurl=http%3a%2f%2farchinte.jamanetwork.com%2fOAuthSignIn.aspx%3freturn_url%3dhttp%3a%2f%2farchinte.jamanetwork.com%2farticle.aspx%3farticleid%3d485056%26alert%3d1" />
            <input type="hidden" name="ctl00$globalSignIn11$ucSsoPurchaseSubscription$hfNoAlertUrl" id="hfNoAlertUrl" value="https://login.ama-assn.org/account/signup?appId=scweb&amp;returnurl=http%3a%2f%2farchinte.jamanetwork.com%2fOAuthSignIn.aspx%3freturn_url%3dhttp%3a%2f%2farchinte.jamanetwork.com%2farticle.aspx%3farticleid%3d485056" />
        </div>
        <div class="privacyPolicy">
            <a class="privacyPolicyUrl" href="http://jamanetwork.com/public/PrivacyPolicy.aspx">Privacy Policy</a>
        </div>
    </div>
</div>

<script type="text/javascript">
    function OpenLink(url) {
        var popUpUrl = null;
        if (url != null) {
            popUpUrl = url;
        } else {
            popUpUrl = "/store/home.aspx";
        }
        if (window.opener != null && !window.opener.closed) {
            // for signpopup.aspx. this is a popup
            window.opener.location.href = popUpUrl;
            window.close();
        } else {
            // personalsignin.aspx. this is not a popup
            window.location.href = popUpUrl;
        }
    }
</script>

<script type="text/javascript">
    
    function RentArticleFromPopup() {
        alert("Hey wass up");
    }
    $(document).ready(function () {
        try {
            $(".signupForAlert input").attr("checked", "checked");
            $(".ssoCreateAccount").attr("href", $("#hfAlertUrl").val());
            var ssoSignInIndividualAccountHref = $(".ssoSignInIndividualAccount").attr("href");
            if (ssoSignInIndividualAccountHref.indexOf("alert=1") < 0) {
                if (ssoSignInIndividualAccountHref.indexOf("?") < 0) {
                    $(".ssoSignInIndividualAccount").attr("href", ssoSignInIndividualAccountHref + "?alert=1");
                } else {
                    $(".ssoSignInIndividualAccount").attr("href", ssoSignInIndividualAccountHref + "&alert=1");
                    if ($(".ssoSignInIndividualAccount").attr("href").indexOf(".aspx&") >= 0) {
                        $(".ssoSignInIndividualAccount").attr("href", $(".ssoSignInIndividualAccount").attr("href").replace(".aspx&", ".aspx?"));
                    }
                }
            }
        } catch(e) { } 


        $(".signupForAlert input").click(function () {
            var $link = $(this).parent().parent().parent().parent().parent().parent().prev().find(".ssoCreateAccount");
            var $personalSignInLink = $(this).parent().parent().parent().parent().parent().parent().prev().find(".ssoSignInIndividualAccount");

            if ($(this).is(":checked")) {
                $link.attr("href", $("#hfAlertUrl").val());
                if (ssoSignInIndividualAccountHref.indexOf("alert=1") < 0) {
                    if (ssoSignInIndividualAccountHref.indexOf("?") < 0) {
                        $personalSignInLink.attr("href", ssoSignInIndividualAccountHref + "?alert=1");
                    } else {
                        $personalSignInLink.attr("href", ssoSignInIndividualAccountHref + "&alert=1");
                        if ($personalSignInLink.attr("href").indexOf(".aspx&") >= 0) {
                            $personalSignInLink.attr("href", $personalSignInLink.attr("href").replace(".aspx&", ".aspx?"));
                        }
                    }
                }
            } else {
                $link.attr("href", $("#hfNoAlertUrl").val());
                $personalSignInLink.attr("href", ssoSignInIndividualAccountHref.replace("?alert=1", ""));
                $personalSignInLink.attr("href", ssoSignInIndividualAccountHref.replace("&alert=1", ""));
                $link.attr("href", $link.replace("&alert=1", ""));

            }
        });
        function displayRentThisArticleDialog() {
            var rentThisArticleDialog = $('#rentThisArticleDialog').dialog({
                closeText: "x Close",
                width: 600,
                height: 160,
                modal: true,
                overlay: { opacity: 0.7, background: 'gray' }
            });
            rentThisArticleDialog.parent().appendTo($('#Form1'));
            rentThisArticleDialog.dialog('open');
        }
        $('.aRentThisArticle').click(function (e) {
            e.preventDefault();
            $('.ui-icon-closethick').trigger('click'); // close sign-in model
            displayRentThisArticleDialog();
        });
    });
</script>

        </div>
        
    </div>
</div>

            </div>
            <div id="forgotPassDialog" style="display: none">
                
	
<script language="javascript" type="text/javascript">
    function cvUsernameEmail_ClientValidate(sender, args) {
        // Clear the label which may contain error message from
        // the server side validation associated with the submit button
        // having been clicked.
        $('#lblPasswordResetRequestResult').empty();
        
        // Make sure the UserName and Password are required.
        var userName = $('#ctl03_txtReqPwdUsername').val();
        var emailAddress = $('#ctl03_txtReqPwdEmailAddress').val();

        if ((userName.length == 0) || (emailAddress.length == 0)) {
            // Either the UserName or Email Address or both are blank.
            args.IsValid = false;
        }
        else {
            args.IsValid = true;
        }
    }
</script>

<div class="forgotPassword loginInfo">
    <div class="top">
        <a id="close" href="#"><b>Close</b></a>
    </div>
	<div id="ctl03_upPasswordReset">
	
			<h4 class="passwordHeader">
			    <span id="ctl03_lblTitle">Forgot Your Password?</span>
			</h4>
			<p>
			    <span id="ctl03_lblInstructions">Enter your username and email address. We'll send you a link to reset your password.</span>
			</p>
			<div class="field">
			    <span id="ctl03_lblUsernameFieldText" class="fieldText">Username:*</span>        
				<input name="ctl00$ctl03$txtReqPwdUsername" type="text" id="ctl03_txtReqPwdUsername" class="requestPasswordResetEmailAddress enterEmail" />
				<div class="required">(required)</div>
			</div>
			<div class="field">
			    <span id="ctl03_lblEmailFieldText" class="fieldText">Email:*</span>
				<input name="ctl00$ctl03$txtReqPwdEmailAddress" type="text" maxlength="50" id="ctl03_txtReqPwdEmailAddress" class="requestPasswordResetEmailAddress enterEmail" />
				<div class="required">(required)</div>
				
			</div>
			<div class="buttonsContainer">
				<input type="submit" name="ctl00$ctl03$btnRequestPasswordReset" value="Submit" onclick="javascript:WebForm_DoPostBackWithOptions(new WebForm_PostBackOptions(&quot;ctl00$ctl03$btnRequestPasswordReset&quot;, &quot;&quot;, true, &quot;requestPasswordReset&quot;, &quot;&quot;, false, false))" id="ctl03_btnRequestPasswordReset" class="requestPasswordResetSubmitButton submitButton signInButton" />
			</div>
			<div class="errorMessageSection">
				
				
				
			</div>
            <div class="instructions">
                <p>Enter your username and email address.&nbsp; We&#39;ll send instructions on how to reset your password to the email address we have on record.</p><br /><p>Need assistance?</p><br /><a href="http://jamanetwork.com/public/contact.aspx" target="_blank">Contact Customer Support</a>
            </div>
		
</div>
</div>
            </div>
            <div class="popupDialog" id="loginServicesDialog" style="display: none;">
                <p>
                    
                    <span class="bold">Athens</span> and <span class="bold">Shibboleth</span> are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.
                
                </p>
            </div>
            <div id="rentThisArticleDialog" style="display: none">
                <div>
                    <h2>What is this ?</h2>
                    <div>Article rental gives users the ability to access the full text of an article and its supplementary content for 24 hours.
                    Access to the PDF is only available via article purchase.</div><br/>
                </div>
            </div>
        </div>
        
    <script src="https://display-mathml.googlecode.com/hg/display-mathml.js?r=stable" type="text/javascript"></script>
    <script type="text/javascript" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-53346900644c40ac"></script>


    <script type="text/javascript">
        var whichPanel = "wrapper";
        var mobileFireEvent = "article";
        var count = 0;
        var JumpId = '';
        var emailUserAlert = "";
        var emailOnPopupChanged = false;

        //******************USER ALERT RELATED FUNCTIONS******************
        function displayAlertMessage(msg) {
            $(".alertPopupMessage").html(msg);
            $('.UserAlertEmailConfirmation').hide();    // Hide Textbox and Confirm Button
            $('.userAlertPopupProgressBar').hide(); // hide the progress bar after the message is displayed.
        }
        function trim(stringToTrim) {
            return stringToTrim.replace(/^\s+|\s+$/g, "");
        }
        // Capture the new/Changed Email Address when and if the user changes it on User Alerts popup dialog.
        function getNewEmailAddress(o) {
            emailOnPopupChanged = true;
            emailUserAlert = o.value;
        }
        // function that is called for User Alerts Callback 
        function callBackUserAlert() {
            var email;
            email = emailOnPopupChanged ? emailUserAlert : $('#hfOriginalEmailAddress').val();
            if (emailOnPopupChanged) {
                emailOnPopupChanged = false;
            }
            var emailPattern = /\w+([-+.']\w+)*@\w+([-.]\w+)*\.\w+([-.]\w+)*/;
            var emailTrimmed = trim(email);
            if (emailTrimmed.length == 0) {
                $(".alertPopupMessage").html('Email Address is blank. Please try again.');
                return false;
            }
            var regEx = new RegExp(emailPattern);
            var bMatch = regEx.test(emailTrimmed);
            if (bMatch == false) {
                $(".alertPopupMessage").html('Email address must be valid. Ex: name@domain.com');
                return false;
            }
            $('.userAlertPopupProgressBar').show();
            callBackSaveAlert(emailTrimmed);
        }
        function detailsHandler(href) {
            var hiddenField = document.getElementById('hfArticleId').value;
            href = href + "&articleid=" + hiddenField;
            window.location = href;
        }
        function displaypopup() {
            $('#displaypopup').attr("style", "displaylock;font-family:Arial;font-weightold;font-size:10pt;");
            $("#displaypopup").dialog({
                position: 'center',
                modal: true,
                height: 150,
                width: 525,
                dialogClass: 'boxshadow',
                closeOnEscape: false,
                overlay: { opacity: 0.7, background: 'gray' },
                close: function (evnt, args) {
                    window.location.href = "account/myalerts.aspx";
                }
            });
        }
        function eventhandler(evt) {
            var value = evt.data.service;
            var key = 'Share';
            this.UserSessionItem = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
            this.ActionType = new ActionType(1, key);
            doTracking(this.ActionType, value.toString(), "10/14/2015 4:02:24 PM", this.UserSessionItem, (window.location).toString());
        }
        $(document).ready(function () {
            $('#txtUserAlertEmailAddress').val($('#hfOriginalEmailAddress').val());
            var browserversion = $.browser;
            if (browserversion.mozilla && parseInt(browserversion.version) < 2) {
                $('.saveMyStuff').click(function () {
                    if (previewMode) {
                        alert('Saving is disabled in preview mode.');
                    } else {
                        var _id = this.id;
                        AddItemstoMyStuff(_id);
                    }
                });
            }
            if ($('.customvalidator').css('visibility') == 'hidden') {
                $('.errorMessageSection').hide();
                $('.customvalidator').css('visibility', 'hidden');
            } else {
                $('.errorMessageSection').show();
                $('.customvalidator').css('visibility', 'visible');
            }

            // in JAMA-282 originally there sounded to be a need to have a popup for Supplemental content
            // later the client decided to not ever present a sign up requirement for supplemental content
            // we are leaving this here in the event they change their minds again
            var restrictSupplementalContentPdFs = false;
            if (restrictSupplementalContentPdFs == true)
            {
                $(".supplementary-material-pdf, .supplementLink, .supplementary-material, .linkPDF").each(function () {
                    $(this).attr("click", "");
                    $(this).attr("href", "#");
                    $(this).closest('.ui-dialog-content').dialog('close'); //close modal if this link is already in a modal
                    $(this).click(function (e) {
                        e.preventDefault();
                        displaySignInDialog('MustSignInOrRegisterForFreeAccount');
                    });
                });
            } else {
                /***************************************/
                /*    Supplementary Material Pop-Up    */
                /***************************************/
                $('.supplementary-material').click(function () {
                    $('.dataSupplementDialog').html($('.SupplementContainer').html());
                    $('.dataSupplementDialog').dialog('open');
                });
            }

            //This is a pdf change put in place 2/26/2015 to swap out the link generated by the article toolbox for a hotfix
            $('#scm6MainContent_ucArticleToolbox_tbFeaturePDF').empty();
            var pdfLink = "<a id=\"hypPDFlinkReplacement\" onclick=\"openPDFWindow('485056')\" class=\"linkPDFReplacment\" target=\"_blank\" alt=\"PDF\"><span class=\"left ir toolbox_sprite tool_pdf\"></span>PDF</a>";
            $('#scm6MainContent_ucArticleToolbox_tbFeaturePDF').append(pdfLink);
        });
        $(window).load(function () {
            $('.crsRef').click(function () {
                var tab = $(this).context.innerText;
                if (!tab) {
                    tab = $(this).context.textContent;
                }
                var key = 'CrossReferenceLink';
                this.UserSessionItem = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
                this.ActionType = new ActionType(1, key);
                doTracking(this.ActionType, tab.toString(), "10/14/2015 4:02:24 PM", this.UserSessionItem, (window.location).toString());
            });
            $('.pubmedLink').click(function () {
                var tab = $(this).attr('href');
                var key = 'CrossReferenceLink';
                this.UserSessionItem = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
                this.ActionType = new ActionType(1, key);
                doTracking(this.ActionType, tab.toString(), "10/14/2015 4:02:24 PM", this.UserSessionItem, (window.location).toString());
            });
            $('.rightpopup li a').click(function () {
                var id = $(this).attr('class');
                var value = id.toString() + ' is Clicked';
                var key = 'ToolBox';
                this.UserSessionItem = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
                this.ActionType = new ActionType(1, key);
                if (id == 'linkPDF') {
                    doTracking(this.ActionType, value.toString(), "10/14/2015 4:02:24 PM", this.UserSessionItem, ActionURL, "sync");
                } else {
                    doTracking(this.ActionType, value.toString(), "10/14/2015 4:02:24 PM", this.UserSessionItem, ActionURL);
                }
            });
            $(".tabtracking").click(function () {
                var key = "Tabs";
                var tab = $(this).context.innerText;
                if (!tab) {
                    tab = $(this).context.textContent;
                }
                var value = tab + " was clicked ";
                this.ActionType = new ActionType(1, key);
                this.UserSessionItem = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
                doTracking(this.ActionType, value.toString(), "10/14/2015 4:02:24 PM", this.UserSessionItem, ActionURL);
            });
            $(".jumpLinks a").click(function () {
                var thisLink = $(this).index();
                var tab = $(this).context.innerText;
                if (!tab) {
                    tab = $(this).context.textContent;
                }
                var imageClicked = tab + " was clicked ";
                this.ActionType = new ActionType(1, tab);
                this.UserSessionItem = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
                doTracking(this.ActionType, imageClicked.toString(), "10/14/2015 4:02:24 PM", this.UserSessionItem, ActionURL);
            });
            $(".popUpTable").click(function () {
                var thisLink = $(this).index();
                var tab = $(this).context.innerText;
                if (!tab) {
                    tab = $(this).context.textContent;
                }
                var imageClicked = tab + " was clicked ";
                this.ActionType = new ActionType(1, tab);
                this.UserSessionItemDetail = new UserSessionItemDetail("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0, 103895, 0);
                doTracking(this.ActionType, imageClicked.toString(), "10/14/2015 4:02:24 PM", this.UserSessionItemDetail, ActionURL);
            });
            $(".popUpFigure").click(function () {
                var thisLink = $(this).index();
                var tab = $(this).context.innerText;
                if (!tab) {
                    tab = $(this).context.textContent;
                }
                var imageClicked = tab + " was clicked ";
                this.ActionType = new ActionType(1, tab);
                this.UserSessionItemDetail = new UserSessionItemDetail("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0, 103895, 0);
                doTracking(this.ActionType, imageClicked.toString(), "10/14/2015 4:02:24 PM", this.UserSessionItemDetail, ActionURL);
            });
            $(".saveMyStuff").click(function () {
                if (!previewMode) {
                    var thisLink = $(this).index();
                    var tab = $(this).context.innerText;
                    if (!tab) {
                        tab = $(this).context.textContent;
                    }
                    var id = $(this).attr('id');
                    var imageClicked = tab + " was clicked with id = " + id;
                    this.ActionType = new ActionType(1, tab);
                    this.UserSessionItem = new UserSessionItem("e0mq2r2zvrcct5d4lg3vkzhg", 0, 0);
                    doTracking(this.ActionFilterType, imageClicked.toString(), "10/14/2015 4:02:24 PM", this.UserSessionItem, ActionURL);
                }
            });
            $('.signInButton').each(function () {
                $(this).click(function () {
                    if ($('.customvalidator').css('visibility') == 'hidden') {
                        $('.errorMessageSection').hide();
                        $('.customvalidator').css('visibility', 'hidden');
                    } else {
                        $('.errorMessageSection').show();
                        $('.customvalidator').css('visibility', 'visible');
                    }
                });
            });
        });
    
    </script>

    <script type="text/javascript">
        $(document).ready(function () {
            //fixes links in cme promo self serve box. -ajh
            $(".cmeSelfServeBody").children("a").eq(0).attr("href", $("#globalHeader_SSOHeader_hlSignup").attr("href"));
            $(".cmeSelfServeBody").children("a").eq(1).attr("href", $("#rmn-signin").attr("href"));
            
            //hide jama reader ad when the cme promo is visible. -ajh
            if ($(".cmeSelfServe").children().length > 0) {
                $(".selfServe").hide();
            }
        });

        function clickCMETab() {
            $('.tabCME').trigger('click'); 
            scrollToTabs();
        }

        function scrollToTabs() {
            var container = $('.mainContainer').first();
            var scrollTo = container.find('.atabs').first();
            window.scrollBy(0, scrollTo.offset().top - $(document).scrollTop());
        }

        var addthis_offset_top = 450;
        var addthis_offset_left = 800;
        var addthis_config = { "data_track_clickback": true,
            services_compact: "facebook, twitter, linkedin, citeulike",
            services_expanded: "facebook, twitter, linkedin, citeulike",
            services_exclude: "email"
        };
        addthis.addEventListener('addthis.menu.share', eventhandler);
        var addthis_share = {
            // ... other options
            title: 'The Challenge of Drug-Induced Aseptic Meningitis',
            url_transforms: {
                shorten: {
                    twitter: 'bitly'
                }
            },
            shorteners: {
                bitly: {}
            }
        };
    </script>


    <script src="//cdn.jsdelivr.net/chartist.js/latest/chartist.min.js" type="text/javascript"></script>
    <script type="text/javascript" src="//amaprod.silverchaircdn.com/combres.axd/article-js/1923383648/"></script>
    



        <!--Global Page Content Ends-->
        
    

<script type="text/javascript">
//<![CDATA[
(function() {var fn = function() {$get("scm6ScriptManager_HiddenField").value = '';Sys.Application.remove_init(fn);};Sys.Application.add_init(fn);})();Sys.Application.add_init(function() {
    $create(Sys.Extended.UI.TextBoxWatermarkBehavior, {"ClientStateFieldID":"globalHeader_txtWaterMark2_ClientState","WatermarkCssClass":"watermark txtBorder","WatermarkText":"Search The JAMA Network","id":"globalHeader_txtWaterMark2"}, null, null, $get("txtSearchTerm2"));
});
Sys.Application.add_init(function() {
    $create(Telerik.Web.UI.RadCaptcha, {"_audioUrl":"/Telerik.Web.UI.WebResource.axd?type=cah&isc=false&guid=be48ab35-d61d-4e5a-af7d-9607f0ab1fe8","_enableAudio":true,"clientStateFieldID":"scm6MainContent_ucUserComments_RadCaptcha1_ClientState"}, null, null, $get("scm6MainContent_ucUserComments_RadCaptcha1"));
});
//]]>
</script>
</form>
    
</body>
</html>
